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Abstract 
Chemical Exchange Saturation Transfer (CEST), is an emerging Magnetic Resonance 
Imaging (MRI) technique. CEST indirectly measures exchangeable protons contained 
in either endogenous or exogenous compounds by measuring the water signal 
reduction due to magnetisation exchange between these compounds and the 
surrounding water. CEST offers sensitivity enhancement compared to any method 
which directly measures these compounds. The complexity of the CEST signal in-vivo 
limits direct quantitative interpretation. However, the technique is inherently 
sensitive to a range of physiological parameters, such as temperature, pH and 
metabolite concentration.  
In order to investigate the relative importance of these different contributing factors, 
the work described in this thesis used the Bloch-McConnell equation system to model 
the CEST effect, for CEST sequence optimisation and data interpretation. Bovine 
Serum Albumin (BSA) phantoms were scanned with a CEST sequence and the results 
were compared to standard contrast methods (T1, T2). The CEST effects were 
correlated with changes in environmental pH, temperature and metabolite 
concentration. 
Next, a spectroscopic CEST sequence was implemented for spinal cord CEST and two 
models of neurodegenerative diseases were investigated. First, a model of 
Amyotrophic Lateral Sclerosis (ALS), revealed no changes in the CEST signal over the 
time course of the disease; the finding matched post-mortem soluble protein 
concentration analysis. Second, a model of Spinal and Bulbar Muscular Atrophy 
(SBMA), revealed no changes in the CEST signal of affected mice scanned at 10 and 
12 months of age. However, changes in the CEST signal were observed in control mice 
and this again agreed with post-mortem protein concentration analysis. 
Finally, the potential for CEST to measure regional pH changes in a piglet model of 
Hypoxic Ischemia (HI) was investigated. CEST data were compared and found to 
agree with 31P MRS, measuring intracellular pH (pHi) and 1H MRS, measuring 
cerebral lactate levels. 
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Chapter 1. Introduction 
 
1.1.  A brief overview on Chemical Exchange Saturation 
Transfer applications 
Proton exchange was first introduced by Wolff and Balaban in 1989 [1] as an MR 
imaging technique capable to study chemical interactions between labile protons1 and 
water through chemical exchange. With those experiments as well as the work 
published a few years later, in 1998 by Guivel-Scharen et al [2], the exchange principle 
was validated as a method providing indirect information on labile protons, but with 
a strong dependency on the concentration and pH of the labile protons. Eventually in 
2000, the technique was named Chemical Exchange Saturation Transfer (CEST) by 
Ward et al [3]. Since then, there have been numerous papers published on different 
applications. Generally CEST is classified into three categories: diamagnetic CEST 
(diaCEST), paramagnetic CEST (paraCEST) and hyperpolarized CEST (hyperCEST), 
due to the different exchangeable sites (also referred to as CEST agents) involved in 
each category. This section intends to provide a short summary of current 
applications of CEST from each different category.  
diaCEST agents 
Diamagnetic particles are commonly used as both endogenous as well as exogenous 
CEST agents. A few examples of their main usage so far are presented below. 
A major area of focus is the study of the CEST signal originating from the amide 
protons (figure 10) found in cellular proteins or peptides. This technique widely 
known as Amide Proton Transfer (APT) can benefit from the pH dependence of the 
proton exchange rate to measure pH changes in tissue. First published by Ward and 
Balaban in 2000 [4] and later by other groups, the APT signal was found to decrease 
                                                          
1 Protons prone to chemical exchange either with their solvent or between them within the 
molecule 
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with pH reduction [5, 6, 7]. Additionally, studies in rats with induced ischemia2 
revealed decreased APT signal in ischemic regions compared to healthy brain regions 
[8, 9]. This is somewhat expected since lack of oxygen supply induces excessive 
production of lactate and therefore reduction of tissue pH. In particular Sun et al in 
2006 [10] reported that APT can give information prior to any visible change from 
structural scans. 
The APT technique is also found to give contrast between healthy and cancerous 
tissue as revealed by the studies of Zhou et al [11] and Salhotra et al [12]. The work 
published in 2010 by Zhou et al deserves special mention in this context, where the 
authors demonstrate differentiation between cancerous tissues and radiation necrosis 
where conventional MR methods failed [13]. 
Hydroxyl groups (-OH) have also been explored as potential CEST contrast agents. 
In 2007 Van Zijl et al demonstrated the use of infused glucagon to image glycogen 
production in mouse liver and named the method glycoCEST [14]. The same year 
Ling et al used CEST to image the hydroxyl groups on Glycosaminoglycans (GAGs) 
found in cartilage, as a diagnostic tool for osteoarthritis with the name gagCEST [15]. 
Lastly, a final method was developed that used native glucose to image high-
metabolic tissues, such as brain and neoplasms, a technique called glucoCEST. The 
technique was demonstrated independently by Chan et al in 2012 in two breast cancer 
cell lines [16] and also by our own group, Walker-Samuel et al 2013 in two colorectal 
tumour cell lines [17]. Both studies showed an elevated glucoCEST signal in the 
tumours as expected due to the Warburg effect, linked to an increase in glucose 
consumption by neoplastic tissues. In our study, glucoCEST was also correlated with 
18F-FDG (fluorodeoxyglucose) autoradiography3, a proof that the technique can give 
similar information to 18F-FDG PET4 (Positron Emission Tomography). The 
GlucoCEST method was also investigated by Nasrallah et al (2013), using a glucose 
analogue, 2-Deoxy-D-glucose (2DG) as a tracer in healthy rat brain [18] and Rivlin et 
                                                          
2 Blood supply restriction which results in insufficient oxygen delivery to tissue 
3 18F-FDG is a glucose analogue used in PET as a radiotracer for the study of glucose 
metabolism 
4 18F-FDG PET is currently the gold standard in tumour detection 
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al 2014, using a different glucose analogue, 3-O-Methyl-D-Glucose (3OMG), in 
imaging tumours [19].  
Moreover, molecules containing amine groups (figure 10) have been considered for 
their ability to exchange and therefore produce CEST contrast. For example Cai et al, 
2012 have proposed the use of CEST to directly detect the amine groups of glutamate 
in the brain, and named the method gluCEST. The technique was applied in rat brain 
undergoing ischemia and an increased gluCEST signal was found in the ischemic 
region compared to the contralateral one. Cai et al in the same paper also presented 
the application of gluCEST in a rat brain tumour model, claiming an increased signal 
in areas of tumour compared to the healthy tissue [20]. This study and its results 
remain controversial in the field, due to the multiple possible sources of amine 
protons in the brain. Another example of native CEST contrast attributed to a single 
metabolite is the possible detection of creatine, first proposed by Kogan et al (2014), 
who applied creatine CEST (crCEST) to investigate metabolic changes in muscle after 
exercise [21]. CrCEST was also found by Haris et al (2014) to distinguish between 
healthy and myocardial infarction5 in-vivo [22]. 
paraCEST agents 
A parallel field of CEST research focuses on the use of paramagnetic particles as 
exogenous CEST contrast agents, a technique given the name paraCEST. Since 1998 
when Aime et al [23] reported the detectability of the paramagnetic particle 
EuDTMA3+ through water exchange with 1H Magnetic Resonance Spectroscopy 
(MRS), a whole new class of CEST agents has been considered. With such a method, 
exogenous contrast agents can be manufactured to be sensitive to different 
parameters such as pH or temperature, with the potential to be used in-vivo as 
biomarkers [24, 25]. An example of such agents is given in the work of Zhang et al 
(2005), in which they presented the use of EU(2)- as a temperature probe with the 
paraCEST technique [26].  
                                                          
5 Lack of blood flow (and therefore oxygen supply) due to blockage resulting in the heart 
muscle damage (Commonly known as heart attack) 
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hyperCEST agents 
Hyperpolarized molecules have also been explored with the potential to become 
CEST agents. In 2006 Schroder et al demonstrated significant signal enhancement 
with the use of hyperpolarized Xenon, up to a factor of >104; much larger than any 
other CEST agent [27]. HyperCEST has been mainly investigated as a temperature 
sensor by Schroder et al [28] and also Schilling et al [29], but remain a laboratory tool 
so far, with a potential long road to translation. 
1.2.  What makes CEST so attractive 
From the few examples outlined in section 1.1 we see how CEST has gained an 
increasing interest throughout the last two decades with enthusiastic researchers 
from all over the world wanting to explore more applications and possibilities within 
this field. What makes it so attractive is the ability to detect substances at very low 
concentrations by exploiting the proton exchange properties with water, resulting in 
amplification of the signal by orders of magnitude and overcoming the low sensitivity 
of MRS [30]. Thus, the possibility of molecular imaging with MRI becomes possible.  
The fact that CEST agents depend on many physiological parameters is in some ways 
the greatest advantage but also disadvantage of the technique. CEST can serve as a 
pH probe, a mechanism that will be more explored in section 2.3, Chapter 4 and 
Chapter 6. It is also able to inform on the concentration of different metabolites and 
can be used for MR thermometry. Thus it can be advantageous in different 
applications and become a biomarker for various diseases. However, its dependency 
on so many parameters renders it rather difficult to quantify for its detractors. Both 
sides of this coin will be explored in this thesis, as explained below. 
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1.3.  The aims of this work 
Enthusiastic about the advantages of the CEST technique, we decided to investigate 
the endogenous signal and explore possibilities in which the CEST technique can be 
useful in-vivo.   
This PhD project aimed first to implement and optimise CEST sequences for in-vitro 
use and compare the findings to the expected theoretical outcomes from a model 
based on the Bloch-McConnell equations. This would allow the study of basic CEST 
principles and further link the results to potential applications in-vivo. 
Another aim was the implementation of CEST sequences for in-vivo use in mouse 
models of neurodegenerative diseases and investigation of the signal compared to 
control mice. The main aim was to see if the method was capable of detecting a subtle 
intracellular accumulation of proteins in the spinal cord of mice, a phenomenon at the 
basis of almost all neurodegenerative conditions. This project was therefore focused 
on the spinal cord, with the challenge to overcome the difficulties of performing an 
advanced MR technique in such a region. 
Furthermore, inspired by the work of other researchers on the pH sensitivity of the 
CEST effect (section 1.1, diaCEST agents) we applied our methodology to with the 
aim to map the pH changes in the piglet brain following Hypoxia Ischemia, as a 
potential new biomarker of disease progression and response to therapy for neonates. 
Hence we had to develop another complete set of techniques and optimise our 
methods for brain applications as well. 
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Chapter 2. Background theory 
 
This chapter aims to familiarise the reader with the CEST concept by underlining the 
fundamental Nuclear Magnetic Resonance (NMR) principles involved. Furthermore, 
the mathematical model which describes the exchange processes is also introduced, 
as well as the different exchange mechanisms. 
2.1.  Introductory Nuclear Magnetic Resonance theory 
The principle of NMR was first introduced in 1946 by Bloch et al (Stanford University, 
[31]) who demonstrated the effect of signal detection from a water sample. 
Simultaneously in the same year Purcell et al (Harvard University, [32]) published 
their work when they managed to measure a contrast proportional to the amount of 
protons contained in a small paraffin sample. Bloch and Purcell shared the Physics 
Nobel Prize in 1952 for demonstrating, in different ways the principle of NMR. Over 
the last six decades NMR has been a major tool for the study of solid structures, 
organic compounds and other physical phenomena such as conductivity, exchange 
rates, etc., in chemistry, biology and physics. Furthermore, the demonstration of 
image formation with the same principle in 1973 by Lauterbur [33] was a milestone 
in modern medicine. Since then, NMR has been used in medical imaging for obtaining 
both structural and functional information from the human body [34].  
Section 2.1 starts with some essential quantum mechanical principles (2.1.1) and then 
moves to the concept of net magnetisation evolution in time (2.1.2). The phenomenon 
of relaxation and the physical principles that govern it are also introduced (2.1.4). 
Finally, the theory of chemical shift in NMR is discussed as it is very important in a 
saturation experiment (CEST, sections 2.2 and 3.1).  
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2.1.1. Essential Quantum Mechanical Principles-Spin 
Behaviour  
The behaviour of atomic nuclei is characterised by their intrinsic quantum mechanical 
properties. In NMR we are mostly interested in the spin quantum number S, (or 
usually referred to as just spin), a fixed quantity which can be either integer or half-
integer and is characterised by the ground state6 of the nucleus. The spin state of each 
nucleus is given by the spin angular momentum number (ms) as follows 
𝑚𝑆 = −𝑆,−𝑆 + 1,−𝑆 + 2,… , 𝑆 − 2, 𝑆 − 1, 𝑆    ( 1) 
On average the human body consists of approximately 60-80 percent of water [35], 
which makes hydrogen is the most abundant nucleus in our body. The variability of 
water content in different tissues [36], makes hydrogen an excellent candidate for 
imaging with NMR. Therefore, unless otherwise stated, hydrogens will be our main 
focus of interest. In a system of hydrogen atoms, each nucleus can have a spin angular 
momentum number of either ½ or -½, due to the spin number of the nucleus being ½. 
The same system under the influenced of a magnetic field B0 along the z axis, 
comprises two energy states, with an energy difference as shown in equation 2 (see 
also illustration of the energy level splitting in figure 1). 
𝛥𝛦 = 𝛾ℏ𝐵0     ( 2) 
where γ is the gyromagnetic ratio, defined as the ratio between the magnetic dipole 
moment and the angular momentum of the specific nucleus and ℏ the reduced 
Planck’s constant (1.055x10-34 Js). 
                                                          
6 The ground state is the state at which a quantum mechanical system is at its lowest energy 
possible 
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Figure 1: shows how, proportional to the static magnetic field B0, the energy gap between the two spin states is 
increased. Spin number of ½ is also referred to as ‘spin up’ while spin number of - ½ as ‘spin down’. 
 
Each spin will precess about the z-axis with an angular frequency (ω0) given by 
equation 3, also known as the Larmor equation named after Sir Joseph Larmor [37]. 
The equation describes in detail the influence of a magnetic field on a single spin in 
isolation. 
𝜔0 = 𝛾𝐵0     ( 3) 
Depending on the z component of the angular momentum number, the two quantised 
spin populations are usually referred to in NMR as ‘spin up’ or ‘spin down’ 
populations, ‘parallel’ or ‘antiparallel’ to the applied magnetic field B0 respectively. 
As spins tend to be in equilibrium at the lowest energy state, and the net spin 
population is align parallel to the applied magnetic field. This spin behaviour is 
described by the Boltzmann distribution where a system with two possible energy 
states favours the lowest energy state, and in thermal equilibrium distribute, as 
shown in equation 4. 
𝑁+
𝑁−
∝ 𝑒−∆𝐸 𝑘𝑇⁄      ( 4) 
Where N+ , N- is the number of spins at high and low energy states respectively, k the 
Boltzmann’s constant (8.62x10-23 J/K), T the system’s temperature (in Kelvin) and ΔΕ 
is the energy difference between the two states as given by equation 2 
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Although each nucleus acts independently with discrete processes, it appears as a 
continuous single process at the macroscopic level due to the large number of nuclei 
involved in NMR. The nuclei group behaviour can be characterised by a single 
quantity, the average magnetic dipole moment density, known as nuclear net 
magnetisation M. Therefore for simplicity we can describe the system with a 
phenomenological approach through the Bloch equation (see below section 2.1.2) 
2.1.2. Magnetisation evolution 
The evolution of magnetization M in time under the influence of a magnetic field B 
can be described by equation (5). 
 
ⅆ𝑀
ⅆ𝑡
= 𝛾𝑀 × 𝐵     ( 5) 
Note that this equation is valid under the assumption that the spin system accounting 
for the net magnetisation, consists of identical spins with no interaction occurring 
between them. However this is not valid as interactions do occur within the spin 
system but also with other external spins as well; resulting in energy dissipation. This 
process, known as relaxation of the magnetisation, takes place when a system of spins 
is driven out of equilibrium by absorption of RF energy. Relaxation is typically 
categorised in longitudinal (along the z axis) and transverse (within the x-y plane); a 
more detailed description is given in section 2.1.4. The combined effect of 
magnetisation evolution taking into account for relaxation processes is described by 
the Bloch equations (given in section 2.1.3 by equations 6a-c). 
2.1.3. Setting the reference frame 
For convenience, the Bloch equations (given by 6(a-c) below) are analysed in terms of 
the Cartesian coordinate system where a static magnetic field B0 exists along the z-
axis and the application of any external RF energy B1  is always perpendicular to B0 
with a precession frequency ωRF. To minimise complications a rotating frame of 
reference is typically preferred over the static laboratory frame (figure 2a). The 
equations described in this section (equations 6 a to c) and moreover the equations 
used to define the CEST model (equation 17) are set in the RF frame (figure 2b). In 
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this case the coordinate system is rotating at frequency ωRF and the applied B1 field is 
static along the x or y axis in the transverse plane.  
 
Figure 2: Illustration of the laboratory (a) and RF (b) frames. The static magnetic field B0 lies along the Z axis 
while the additional B1 field is always perpendicular to the B0 The laboratory frame is stationary with the net 
magnetisation Mz and B1 precessing at angular frequencies of ω0 and ωRF respectively. However, in the RF frame, 
the B1 is static while the net magnetisation Mz precesses at an angular frequency of ω0–ωRF. (When ω0=ωRF the 
external RF pulse is on resonance with the net magnetisation Mz, while at any other frequency the pulse is 
considered as off resonance). 
In section 2.1.2, equation 5 was introduced as an alternative to the quantum 
mechanical descriptions for a spin system. Here the x, y and z components of the same 
equation are modified to account for the relaxation processes (section 2.1.4) and also 
the application of an external RF pulse B1 [37, 38]. The Bloch equations are given in 6 
(a-c) below. 
𝜕𝑀𝑥
𝜕𝑡
= (𝜔0 − 𝜔𝑅𝐹)𝑀𝑦 −
𝑀𝑥
𝑇2
     (6 a) 
𝜕𝑀𝑦
𝜕𝑡
= −(𝜔0 − 𝜔𝑅𝐹)𝑀𝑥 −
𝑀𝑦
𝑇2
+ 2𝜋𝛾𝐵1𝑀𝑧    (6 b) 
      
𝜕𝑀𝑧
𝜕𝑡
= −2𝜋𝛾𝐵1𝑀𝑦 −
𝑀𝑧−𝑀0
𝑇1
      ( 6 c) 
where in this case the RF pulse B1 (in T) is applied along the x axis and the 
magnetisation Mz is tilted from z towards the y axis and γ is given in units of Hz T-1. 
T1 and T2 are given in seconds.  
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2.1.4. Relaxation processes 
The following section is focused on the different processes in NMR which lead to 
magnetisation relaxation. 
2.1.4.1. Longitudinal relaxation 
Consider the application of an RF pulse with enough energy to tilt the net 
magnetisation into the x-y plane (no net magnetisation left along the z axis); this 
system is no longer in equilibrium. The longitudinal relaxation is the process by 
which the net magnetisation returns to the system’s thermal equilibrium (see 
Boltzmann’s distribution, equation 4). In classical mechanics the evolution of the net 
magnetisation can be described by  
𝑀𝑧(𝑡) = 𝑀𝑧
𝑒𝑞 − [𝑀𝑧
𝑒𝑞 − 𝑀𝑧
0]𝑒−𝑡/𝑇1    ( 7) 
where Meqz is the net magnetisation along the z axis when the system is at thermal 
equilibrium, M0z the initial net magnetisation at time t=0 and T1 the longitudinal 
relaxation time constant. Figure 3 is an illustration of the longitudinal relaxation 
process (equation 7) with different relaxation time constants T1. 
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Figure 3: Net magnetisation recovery along the z axis. Illustration of the longitudinal relaxation process following 
an exponential trend with three different relaxation constants T1. 
Relaxation mechanisms 
For nuclei of spin ½ the most effective relaxation processes occur due to the 
interaction of magnetic dipoles between the nuclear spin and other nuclei through 
space; a process called dipolar interaction. Random molecular (rotational and 
translational) motions alter locally the magnetic field at frequencies which energy 
exchange is allowed between spins and other molecules in the existing environment. 
These dipole interactions are strongly dependent on the gyromagnetic ratios (γ) and 
the proximity (r) of the nuclei involved (Dipolar factor β is proportional to (
𝛾1𝛾2
𝑟3
)
2
). 
Due to the gyromagnetic ratio dependence, hydrogens experience a stronger coupling 
(γH=42.576 [MHz/T]) compared to other nuclei such as carbon (γC=10.705 [MHz/T]) or 
phosphorous (γP=17.235 [MHz/T]), [39].  
In addition to dipolar interactions, unpaired electrons (from paramagnetic ions) can 
also cause magnetic fluctuations due to the electron movement in the magnetic field 
generating large magnetic moments. Such fluctuations can improve the relaxation 
efficiency dramatically. In fact, electrons are capable of promoting relaxation with a 
factor of half a million more compared to protons at the same distance from the 
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relaxing nuclei. This is the fundamental basis of paramagnetic contrast agents in 
NMR. Lastly, chemical shift anisotropy (CSA) is an important contribution to 
relaxation for non-symmetric molecules. The induced relaxation through CSA is 
proportional to the square of the field strength and also the chemical shift range 
exhibited by the nucleus. Nuclei with large chemical shift ranges are expected to be 
more prone to such a relaxation mechanism [40]. Hence CSA is of particular 
importance for sodium, phosphorous and fluorine but less for hydrogen [39]. 
Spectral Density function 
The effectiveness of longitudinal relaxation is strongly dependent on the frequency 
of the molecular tumbling, which is described by the Spectral Density function (see 
equation 9 below) defined as the Fourier transform of the Correlation function for a 
given system. In short explanation, the Correlation function describes the temporal 
dynamics of a system driven by random processes at thermal equilibrium. As a first 
approximation the Correlation function is given by a mono-exponential decay, 
described by equation 8, [39] 
𝐺(𝜏) = 𝐺0𝑒
−|𝜏| 𝜏𝑐⁄         ( 8) 
where τc is the correlation time decay factor (short τc indicates fast molecular 
tumbling, liquids, while longer τc refers to slower motions, bound structures). 
Equation 9 below corresponds to the Spectral Density function of such a Correlation 
Function (equation 8). 
𝐽(𝜔, 𝜏𝑐) =
2𝜏𝑐
1+𝜔2𝜏𝑐
2     ( 9) 
where ω=1/τ. Illustration of equation 9 is given in figures 4 and 5, where the Spectral 
density function is shown against the correlation time (τc) and the molecular tumbling 
frequency (ω) respectively (ω0 is 400MHz, resonant frequency of hydrogen at 9.4T). 
For longitudinal relaxation, the closer the molecular tumbling is to the Larmor 
frequency, the more efficient the relaxation becomes. This implies an optimum 
correlation time of τc=1/ω0 where correlation times that are shorter (free molecules) or 
longer (bound structures) than τc=1/ω0 result in less efficient relaxation (longer T1).  
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Figure 4: Spectral Density function with respect to the correlation time (τc). As the function is inversely 
proportional to the relaxation time, the graphs can give us an indication of the relaxation ‘trends’. Longitudinal 
relaxation (in blue), is most efficient (therefore shortest T1 time) when τc=1/ω0, due to the molecular motions 
oscillating at the resonance frequency. For shorter (‘free’ structures) or longer (‘bound’ structures) τc the 
longitudinal relaxation becomes less effective (thus T1 become longer). Transverse relaxation (in red) follows similar 
pattern to longitudinal relaxation for τc=<1/ω0 (therefore for free structures the T2 values are similar to T1). For 
longer τc the transverse relaxations become more effective and as a result bound structures have very short T2. This 
is due to the secular part of relaxation (see section 2.1.4.2) 
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Figure 5: Spectral Density function with respect to the molecular oscillation frequency (ω) at three different 
correlation times (τc). This figure illustrates another way of looking at the relaxation effectiveness, as also seen from 
figure 4. Longitudinal relaxation, as mentioned before (see section 2.1.4.1), is most effective at the resonance 
frequency (ω0), where in the same way, free (in blue) and bound (in red) molecules have longer relaxation times 
than medium sized molecules (in green). Also, close to ω=0, bound structures are the most effective in terms of 
transverse relaxation, due to dephasing. 
 
2.1.4.2. Transverse relaxation 
The longitudinal relaxation section described the general evolution of the net 
magnetisation along the z axis following the application of an RF pulse, which brings 
a proportion of net magnetisation into the x-y plane. Within the x-y plane, the net 
magnetisation decreases exponentially following the equation below 
𝑀𝑥𝑦(𝑡) = 𝑀𝑥𝑦
0 𝑒−𝑡/𝑇2      ( 10) 
Where M0xy is the transverse magnetisation at time zero and T2 the transverse 
relaxation time constant. Figure 6 illustrates the transverse relaxation process (of 
equation 10) with three different relaxation time constants T2. 
34 
 
 
Figure 6: Magnetisation evolution within the x-y plane. Illustration of the transverse relaxation process following 
an exponential trend with three different relaxation constants T2.  
 
Additional transverse relaxation mechanisms 
All processes which result in longitudinal relaxation, also contribute to transverse 
relaxation. Those processes are distinguished as the non-secular part of relaxation and 
they refer to any transitions occurring at or close to ω=ω0. However across the 
transverse plane (x-y), an additional factor contributes towards the effectiveness of 
transverse relaxation, which does not dissipate energy to the surroundings but 
redistributes it within the system through an adiabatic route. This factor, referred to 
as the secular part of relaxation, occurs when the molecular tumbling is most 
restricted (with long correlation times τc and at ω=0). When molecular motion is 
constrained (less tumbling) nuclear spins experience slightly different magnetic fields 
[41]. Local field inhomogeneities cause spins to precess at different Larmor 
frequencies, thus causing a net magnetisation dephasing across the x-y plane. The 
Spectral Density function is now altered to account for the secular part of relaxation, 
as shown in equation 11 (also refer to figures 4 & 5).  
𝐽(𝜔, 𝜏𝑐) = 2𝜏𝑐 +
2𝜏𝑐
1+𝜔2𝜏𝑐
2          ( 11) 
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2.1.5. Chemical shifts 
Chemical shifts in NMR are of fundamental importance as they distinguish 
magnetically non-equivalent atoms that are otherwise identical. In H-NMR 
spectroscopy, hydrogen atoms belonging to different molecules, or even hydrogen 
atoms within the same molecule but at different locations with respect to other nuclei, 
resonate at slightly different frequencies due to the fact that they experience a slightly 
different effective magnetic field Beff. The principle of chemical shifts is the basis of 
NMR spectroscopy, and is equally important to CEST, as discussed in the following 
sections (see sections 2.2 and 3.1).  
Spectroscopic frame Versus CEST frame 
In conventional NMR spectroscopy the reference is usually set to the resonance 
frequency of the Tetramethylsilane  (TMS) molecule. All other NMR signals are 
presented relative to TMS in parts per million (ppm). This was chosen mainly because 
all hydrogen atoms of the molecule are located in such a way that they all experience 
the same net magnetic field; hence only one peak is produced (magnetically 
indistinguishable hydrogen nuclei). Also due to the location of the hydrogen atoms 
relative to the carbon atoms, the shielding is extremely strong (see section 2.1.5.1) 
which means that the majority of the peaks in NMR will appear on the left side of the 
TMS peak (corresponding to a higher resonant frequency). In CEST experiments 
however, water is favoured over TMS as the reference (the water peak is at 4.7ppm 
from TMS, as shown in figure 7). To avoid confusion, the ppm range will always be 
given in reference to water unless otherwise stated.  
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Figure 7: Illustration of the NMR scale for hydrogen. In NMR TMS is typically taken as the reference frequency, 
while water on this scale resonates 4.7ppm away from TMS. In the case of CEST experiments, the water peak is 
used as the reference. Furthermore the figure shows where a proton with no surrounding electrons (non-shielded) 
would resonate in reference to TMS. This is a completely deshielded proton which experiences the magnetic field 
Beff =B0 with no alterations. Any proton with electrons around it will experience a form of shielding which will lead 
to a decrease in the net magnetic field Beff <B0 that it experiences (for more see sections 2.1.5.1-2.1.5.3). In H-NMR 
most of the proton resonances lie within the 0-10 ppm range with water being at 4.7ppm. 
 Causes of chemical shifts include: the Diamagnetic and the Paramagnetic factors as well 
as the Neighbouring Group Anisotropy and Electronegativity. The following sections are 
intended as a brief description of the mentioned factors and their importance 
especially for hydrogen interactions. 
2.1.5.1. The Diamagnetic factor 
The diamagnetic effect causes shielding of a nucleus. Electron circulation in the s-
orbitals7 induces a magnetic field opposing the static B0. Thus, the nuclei surrounded 
by these electrons will experience an effective magnetic field Beff <B0; this nucleus is 
shielded and has a resonance frequency ω shifted towards the TMS resonance 
frequency (refer to figure 7). Proton chemical shifts are highly dependent on the 
diamagnetic effect, also referred to as the shielding factor and the effect is proportional to 
the density of the electron cloud.  
                                                          
7 The s-orbitals are spherical and symmetrical. One orbital can exist within each s-subshell and 
can hold up to two electrons (subject to the Pauli Exclusion Principle). 
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2.1.5.2. The Paramagnetic factor 
The paramagnetic effect can cause larger shifts in the NMR scale compared to the 
diamagnetic factor. Any atom with asymmetric distribution of electrons in the p-
orbital8 can contribute to the paramagnetic factor when by circulation it transits 
between the ground and excited states. The induced currents unlike with the 
diamagnetic effect are in the same direction as the static magnetic field B0 resulting in 
a Beff >B0. Since protons do not have electrons in any p-orbitals, they do not experience 
the paramagnetic effect in a direct way, although they are indirectly affected by 
neighbouring atoms, as described in the next section (2.1.5.3). Note that electron 
orbitals of higher complexity (such as d & f) are not discussed as they do not play an 
important role in organic compounds.  
2.1.5.3. Neighbouring Group Anisotropy and 
Electronegativity 
Magnetically anisotropic atoms or groups, caused either by paramagnetic or 
diamagnetic effects (see sections 2.1.5.1 and 2.1.5.2 above), will also affect the 
neighbouring nuclei through dipolar interaction. The net magnetic dipole due to 
anisotropy will perturb the dipole of nearby nuclei causing alterations of the effective 
magnetic field experienced by them, causing therefore shifts in the resonance 
frequencies. 
Additionally, the electronegativity of adjacent nuclei can create chemical shifts. 
Electronegative atoms have the tendency to attract the sharing electrons within a 
bond towards them. As a result hydrogens attached to electronegative atoms (such as 
oxygen, nitrogen or carbon), get deshielded with chemical shifts away from the TMS 
resonance frequency and towards the ‘naked’ proton resonance (figure 7 for the NMR 
scale and figure 8 for a periodic table illustrating the most electronegative atoms). 
                                                          
8 The p-orbitals are two lobed. Three orbitals can exist within each p-subshell (as it can hold 
up to 6 electrons). Therefore in a Cartesian coordinate system each p-orbital holds different 
dimension (x, y and z) 
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Note that both Neighbouring Group Anisotropy and Electronegativity effects are 
only dependent on the geometry of the molecules and therefore are constant 
regardless of the static magnetic field B0. 
 
Figure 8: Illustration of electronegativity of atoms with a diffusion cartogram. Atoms corresponding to largest 
surface correspond to the most electronegative ones and vice versa. Top right corner elements of the table are the 
most electronegative. Atoms like oxygen, nitrogen, carbon and phosphorous which are found in-vivo, fall in the 
very electronegative range. In blue: Alkali and Alkaline earth metals, in red: transition metals, in green: lanthanide 
and actinide metals and in yellow: non-metals and metalloids. (Figure reproduced with kind permission from 
Winter Mark J., 2011. Full reference: [42]) 
Another important contributor of chemical shifts in NMR spectroscopy is J coupling9, 
otherwise known as fine structure splitting or spin-spin splitting. However, in CEST 
experiments due to the lack of spectroscopic resolution (CEST resolution~in the order 
of 5Hz, while these structures could be as small as ~0.1Hz, [chapter 3.15 in [43]) such 
fine structure chemical shifts are not important as they are not observable [38]. 
Therefore J coupling is only mentioned as a matter of completeness, and will not be 
discussed further. 
 
                                                          
9 J-coupling is a ‘through bond’ interaction caused between neighbouring nuclei. Spin A 
perturbs the electrons surrounding it which therefore perturbs the electron cloud of spin B. 
As a result the energy levels of spin B are slightly affected, leading to frequency splitting 
within only a few Hz.  
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2.2.  Magnetisation exchange mechanisms 
The distinctive resonance frequency of different nuclei or similar nuclei at different 
magnetic environments was explained by the phenomenon of chemical shifts (section 
2.1.5). Consider now two nuclei (named A and B) of the same gyromagnetic ratio (for 
example two hydrogen protons) with a resonance frequency difference (Δω.) between 
them. Spin A has a frequency ωΑ and in a similar manner spin B a frequency ωB (where 
ωΑ  ≠ ωB ). In the absence of any interaction between the two spins if one irradiates the 
system with an RF pulse at frequency ωΑ, in principle spin B should remain 
unaffected. If however an interaction K exists between the two spins, the 
magnetisation state of spin A will affect the state of spin B and vice versa. This is 
otherwise referred to as magnetisation exchange between two set of spins. Figure 9, 
summarises the principle of magnetisation exchange for a system of 2 spins as 
described here (A and B).  
The basis of any saturation experiment is based on the principles of magnetisation 
exchange; in particular (as the name suggests) through chemical exchange. Within the 
next few sections the main mechanisms contributing to the CEST signal10 will be 
explained. Section 2.2.1 is dedicated to chemical exchange while section 2.2.2 
describes dipolar cross relaxation, the mechanism which gives rise to Magnetisation 
Transfer (MT) and also to Nuclear Overhauser Effects (NOE). 
                                                          
10 Not only due to chemical exchange, but dipolar cross relaxation too (including NOE, MT) 
and relaxation contributions from T1 and T2; the name remains CEST and refers to the outcome 
of a saturation experiment. 
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Figure 9: Illustration of the chemical exchange process of protons. Part a shows the labile protons (small pool) and 
the bulk water (large pool) with their corresponding proton signal in NMR with no exchange linking the two pools. 
Part b however, demonstrates the two pools connected via a transfer rate. In a CEST experiment, labile protons are 
irradiated with an RF pulse at their resonance frequency; therefore their signal gets saturated. Due to the constant 
proton exchange between the two pools saturated protons from the small pool are transferred to the large water 
pool. If enough time11 is allowed (in the order of seconds), this process leads to a detectable decrease in the water 
signal. The CEST contrast originates specifically from this signal decrease. 
                                                          
11 How much is enough time is discussed in section 2.3: ‘Factors affecting the CEST signal’. 
41 
 
2.2.1. Chemical exchange 
The term Chemical Exchange in NMR is used to describe the phenomenon of nuclei 
exchanging between different chemical environments. Two types are distinguished, 
intramolecular chemical exchange when nuclei within the same molecule change 
position through internal motions and intermolecular chemical exchange where nuclei 
of one molecule interact with nuclei of another molecule through their shared 
environment [44]. 
The CEST technique in MRI usually refers to intermolecular chemical exchange of 
exchangeable protons of metabolites, peptides or proteins with the water protons 
surrounding them. A detailed description of the chemical exchange mechanism 
between protons of those group and free water is given in figure 9. CEST contrast is 
measured as the reduction in the water signal from part a to part b of the figure. An 
exception is found in paramagnetic CEST agents (paraCEST part in section 1.1), where 
the exchange can also be molecular [45]. However, for the purpose of this work, our 
main interest is the proton exchange. Functional groups prone to proton chemical 
exchange include Hydroxyl, Amine, Amide and Imino groups and are summarised 
below. 
Exchangeable protons 
Exchangeable protons which contribute to the in-vivo CEST signal are believed to 
originate mainly from proteins [45].  Figure 10 shows a peptide illustrating the type 
of protons that can be found in a protein: backbone Amide protons (in blue), and 
Amino acid side chain protons (Hydroxyl in orange, Amines in green and Amides in 
purple). 
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Figure 10: schematic of the peptide Glutamine-Aspartate-Histidine-Proline-Lysine-Leucine (Gln-Asp-His-Pro-
Lys-Leu) to illustrate the different types of protons included on a protein. Non-exchangeable protons (in grey), 
backbone Amide protons (in blue), Hydroxyl protons (in orange), Amine protons (in green) and Amide protons (in 
purple). 
Amide protons (figure 10, illustrated in blue) give a chemical shift ~3.5ppm (CEST 
frequency scale where water is the reference, see figure 7) and are usually found in 
the backbone of proteins. Amide proton exchange rate is in the slow to intermediate 
regime (also see section 2.3) with exchange rates < 30Hz [9] at physiological pH (~7).  
Amine and Amide protons from side chain amino acids (figure 10 in green and purple 
respectively) resonate between 2-3 ppm from water and are in a faster exchange rate 
regime (150-1000 Hz), [46, 47]. Imine protons (-C=NH), a subgroup of Amine protons, 
also contribute to the CEST signal with a chemical shift between 5-6ppm and 
exchange rates ~3000-4000Hz (falling in the fast-intermediate regime), [48].  
Hydroxyl protons (figure 10 in orange) can also contribute to the CEST signal. Like 
Amine protons, they are found on side chain amino acids, but also on smaller 
molecules like glucose, fructose as well as sugar polymers like cellulose, glycogen and 
glycosaminoglycan. Hydroxyl protons also fall in the fast-intermediate exchange rate 
regime (1000-10000Hz, [45]) and they resonate between 0.7 and 3ppm, [17]. Figure 11 
is an illustrative graph of the exchange rate regime for the different hydrogen groups. 
43 
 
 
Figure 11: illustrative graph of the exchange rate regime vs concentration for different hydrogen groups: hydroxyl 
(in orange), backbone Amides (in blue), Amines (in green) and Imines (in yellow). Figure reproduced from Van 
Zijl et al 2011, [45]. 
 
2.2.2. Dipolar-cross relaxation 
Chemical exchange is not the only way magnetisation is transferred between 
hydrogen species. Dipolar-cross relaxation is another transfer mechanism which 
contributes to the profile of the Z-Spectra during a saturation experiment. Unlike 
chemical exchange, dipolar-cross relaxation does not require proton transfer, yet the 
magnetisation exchange occurs through a system of coupled spins. This section 
briefly describes the Nuclear Overhauser Effects (NOE) and conventional 
Magnetisation Transfer (MT) effect, as they both arise from dipole-dipole coupling. 
Both effects can give valuable information [49, 50, 45], nevertheless when the purpose 
is to explore the chemical exchange effects, they might be referred to as ‘CEST signal 
contaminations’  
NOE can be generally categorised into homonuclear (interaction between equivalent 
atomic nuclei) or heteronuclear (interaction between different atoms). During proton-
proton CEST experiments any observable NOEs are a result of homonuclear 
interactions. Medium size molecules (small proteins) can exhibit NOE effects through 
space (dipole-dipole coupling), hence the protons affected must be in very close 
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proximity (4-5 Å). Backbone -CH and –COCH3 (Acetyl) hydrogen atoms once 
irradiated, perturb the magnetisation of water either directly (Direct NOE) or through 
perturbation of exchangeable protons (-NH, -NH2, -0H) which can then interact with 
water (Exchange-relayed NOE). These effects take place within the same molecule, 
hence the NOEs are intramolecular. Intramolecular direct and exchange-relayed NOEs 
are believed to be a possible contributor12 of CEST signal centred at -3.5ppm [51, 50, 
52].  
Intermolecular NOEs (between molecules) also exist however they only start to be 
significant in restricted mobility molecules, i.e. bigger protein chains surrounded by 
bound water (also known as the hydration layer, [53]). Here bound water molecules 
also undergo dipole-dipole interactions; these NOEs contribute to the MT effect. 
Interactions of this kind become faster as the size of macromolecules increases and 
structures become more ‘semisolid’ due to the stronger couplings and shorter 
relaxation times (see section 2.1.4). Hence, MT is not frequency specific but instead 
appears as a general lowering in signal throughout the entire Z-Spectrum (up to 
80ppm away from water), [49] & [50]. Subsequently, the magnetisation is transferred 
from bound to free water molecules.  
2.3.  Factors affecting the CEST signal 
As discussed in Chapter 4, the CEST signal is sensitive to a range of environmental 
factors; the exchangeable protons alone cannot guarantee a significant CEST contrast. 
Factors such as the concentration of metabolites, pH and temperature, field strength 
and T1/T2 relaxation times contribute to the CEST signal and are discussed in this 
section.  
Simulations in this section demonstrating the CEST related parameters, are based on 
a three pool Bloch-McConnell system (see section 2.4). Unless otherwise stated, the 
parameters used for the simulations are given in table 1. 
                                                          
12 See also section 3.1.1, ‘The Z-Spectrum profile’. 
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Pool No. Frequency 
[ppm] 
Pool size   
(ratio to 
water) 
Exchange rate 
[Hz]* 
T1 [ms] T2 [ms] 
1 (Water) 0 1 n/a 1700 37 
2 (Amine) 2  0.0036 400 1000 10 
3 (Amide) 3.5  0.0036 22 1000 10 
*Exchange rates were estimated by the equations 15 and 16, as described by Desmond and Stanisz, 2012 
[54].  
Table 1: parameters used for the simulations in this section 
 
Concentration 
The CEST signal is highly dependent on the concentration of exchangeable protons 
and has been reported by many groups as a method to determine the concentration 
of metabolites, [55, 15]; however the CEST detection threshold is considered to be 
limited to concentrations >5mM [56]. Figure 12 demonstrates the relationship of 
metabolite concentration to the MTRasym calculated from the Z-spectra using equation 
22. 
 
Figure 12: simulation of the MTRasym with different concentration of amide protons (in light blue) and amine 
protons (in pink). Concentration of metabolites is given in percentage fraction to the water concentration. 
MTRasym was calculated at 2ppm and 3.5ppm from water for amine and amide protons respectively. 
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Exchange rate   
The exchange rate between metabolites also significantly affects the CEST signal. The 
exchange rate between the exchangeable site and water should be within the same 
order of magnitude as the chemical shift between them [45]. Ideally exchange rates 
should fall in the intermediate exchange rate regime, as figure 13 shows. Any exchange 
rate below or above the intermediate regime gives a reduced (and eventually no) 
CEST signal.  
At the very slow exchange rate regime (Δω>>K), the CEST effect is limited as 
relaxation effects dominate. This means that the saturated protons do not have 
enough time to sufficiently exchange with water and transfer their magnetisation 
state before relaxation (mainly longitudinal) occurs in water.  Similarly minimised 
CEST effects are found at the very fast exchange rate regime (Δω<<K), where no 
distinction of frequencies is observed between the two individual species as they both 
appear at the same frequency [57].  
 
Figure 13: Illustration of symmetric (same concentration) two-side exchange where each population has a unique 
chemical shift on the NMR spectrum and a Δω shift exists between them. In the no/very slow exchange limit 
(Δω>>K) there is no CEST effect observed, as no transfer of magnetisation can occur without exchange. Likewise 
in the very fast exchange limit (Δω<< K) the two unique chemical shifts no longer exist, rather they merge into a 
single peak.   
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The hydrogen exchange rate (K) is governed by the structure of the molecules. For 
example protons belonging to folded proteins have exchange rates much slower due 
to the folding protection factor [58]. Also protons located in the interior of a molecule 
will have reduced accessibility to the solvent compared to protons on the surface, 
resulting in less contribution in the exchange process. Additionally, the exchange rate 
is greatly affected by environmental changes such as pH [59, 60, 61], temperature [14, 
56] and other exchange catalysts [62] as shown in equation 12. 
𝐾 = 𝑘𝑎 × 10
−𝑝𝐻 + 𝑘𝑏 × 10
𝑝𝐻−𝑝𝐾𝑤 + 𝑘0  ( 12) 
where Ka and kb are the acid- and base-catalysed rate constants respectively and k0 a 
combined constant representing contributions from other exchange catalysts. pKw is 
related to the water auto-dissociation (≈ 14 at 25o C). The three catalyst constants of 
equation 12 (Ka, Kb and K0) are also dependent on the temperature of the solution as 
described by the Arrhenious equation (13) below 
𝑘𝑥 = 𝐴𝑒
−𝐸𝑎 𝑅𝑇⁄      ( 13) 
where R is the universal gas constant (8.314X10-3kJ/mol/K), Ea is the activation energy 
(given in kJ/mol) and A is a reaction constant. 
Depending on the acid- and base-catalysed proton transfer [63, 64], a pKa value 
(logarithmic acid dissociation constant) is assigned for different protons which 
describes the equilibrium state of a solution for a given pH (equation 14). 
[𝑋−]
[𝐻𝑋]
= 10𝑝𝐻−𝑝𝐾𝑎     ( 14) 
 where [HX] and [X] are the relative concentration of ions in the solution. 
Qualitatively and in simplistic terminology, equation 14 states that for a base-
catalysed proton exchange the protonated form (HX) dominates, while in the case of 
an acid-based proton exchange the ionised form (X) dominates instead. Baring in 
mind equation 14, one can deduce the exchange rate versus pH for a variety of 
protons. For example, the exchange rates for Amide and Amine protons are given in 
equations 15 and 16 respectively, as reported by Desmond and Stanisz, 2012 [54]. 
𝑘𝑎𝑚𝑖ⅆ𝑒 = 5.57 × 10
𝑝𝐻−6.4    ( 15) 
where Kamide the exchange rate of Amide protons to water. 
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𝑘𝑎𝑚𝑖𝑛𝑒 = 10
𝑝𝐻−4.4             ( 16) 
where Kamine the exchange rate of Amine protons to water. 
In a range of pH from 3 to 9 the exchange rates of both Amide and Amine protons are 
base-catalysed. Figure 14 shows the relationship of the proton exchange rate with pH 
as described by equation 15, [9]. 
 
Figure 14: Proton exchange rate relationship to pH variation as described by equation 15. 
Figure 15 illustrates simulated data of the MTRasym calculated at the Amide and Amine 
frequency where the exchange rates were modulated by the above equations 
respectively. 
 
Figure 15: simulation of the MTRasym with different pH for amide protons (in light blue) and amine protons (in 
pink).  
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Relaxation times 
Relaxation times also affect the CEST signal, as simulations reveal (figure 16), 
therefore one must be cautious when comparing CEST contrast in tissues with 
different T1 and T2 values. 
 
Figure 16: simulation of the MTRasym with different T1 (figure on left) and T2 (figure on right) of amide protons 
(in light blue) and amine protons (in pink) 
Data in Chapter 4 also demonstrate the relaxation time dependence of the CEST 
signal. 
Field strength 
Field strength affects the CEST signal in an indirect way. For example, the fact that T1 
values increase with higher field strengths, affects the CEST values. In addition, high 
field strength results in greater chemical shifts between metabolites and water 
protons, [65], causing higher spectral resolution across the Z-Spectra and, therefore 
allowing for rapidly exchanging species at low field to become CEST-detectable at 
higher field.  
2.4.  Modelling the CEST signal 
The coupled Bloch-McConnell equations were first introduced to explain MT effects 
[49, 50]. Recently the model was modified to accommodate rapid chemical exchange 
processes from multiple pools [66, 67, 68]. A theoretical model helps with the 
optimization process and the choice of pulse sequence parameters and is a great tool 
for researchers trying to understand the fundamentals of the exchange theory.  
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2.4.1. The coupled Bloch-McConnell equations 
Consider a two pool model where pool A is the large water pool and pool B is much 
smaller and contains the exchangeable site protons, for example amide groups of 
protein molecules. Figure 17 shows the basis of a two pool model where the water 
protons (pool a) and the labile protons (pool b) are considered as individual pools 
with net magnetizations 𝑀0
𝑎 and 𝑀0
𝑏 respectively. 𝑘𝑎𝑏 is the exchange rate of protons 
transferred from pool a to pool b and 𝑘𝑏𝑎 vice versa. In the simplest model these two 
exchange rates are considered equal using a first order approximation [55] and 
therefore one term is used, K. 
 
Figure 17: Illustration of the exchange process between two pools a and b. The exchange rates 𝑘𝑎𝑏= 𝑘𝑏𝑎 = 𝑘 in the 
simplistic form of the model. 𝛥𝜔𝑎 and 𝛥𝜔𝑏 are the chemical shifts of pool a and b respectively. If pool a represents 
water then 𝜔𝑎 = 0 
The model illustrated in figure 17, can be summarised in a matrix form as shown 
below in equation 17. 
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[
 
 
 
 
 
 
 
 
𝜕𝑀𝑥
𝐴 𝜕𝑡⁄
𝜕𝑀𝑦
𝐴 𝜕𝑡⁄
𝜕𝑀𝑧
𝐴 𝜕𝑡⁄
𝜕𝑀𝑥
𝐵 𝜕𝑡⁄
𝜕𝑀𝑦
𝐵 𝜕𝑡⁄
𝜕𝑀𝑧
𝐵 𝜕𝑡⁄ ]
 
 
 
 
 
 
 
 
=
[
 
 
 
 
 
 
 
 
−𝑘𝑎𝑏 𝛥𝜔𝑎 0 𝑘𝑏𝑎 0 0
𝛥𝜔𝑎 −𝑘𝑎𝑏 −𝜔1 0 𝑘𝑏𝑎 0
0 −𝜔1 −𝑘𝑎𝑏 0 0 𝑘𝑏𝑎
𝑘𝑎𝑏 0 0 −𝑘𝑏𝑎 𝛥𝜔𝑏 0
0 𝑘𝑎𝑏 0 𝛥𝜔𝑏 −𝑘𝑏𝑎 −𝜔1
0 0 𝑘𝑎𝑏 0 −𝜔1 −𝑘𝑏𝑎]
 
 
 
 
 
 
 
 
[
 
 
 
 
 
 
 
 
𝑀𝑥
𝑎
𝑀𝑦
𝑎
𝑀𝑧
𝑎
𝑀𝑥
𝑏
𝑀𝑦
𝑏
𝑀𝑧
𝑏]
 
 
 
 
 
 
 
 
−
[
 
 
 
 
 
 
 
 
𝑀𝑥
𝑎 𝑇2
𝑎⁄
𝑀𝑦
𝑎 𝑇2
𝑎⁄
(𝑀0
𝑎 − 𝑀𝑧
𝑎) 𝑇1
𝑎⁄
𝑀𝑥
𝑏 𝑇2
𝑏⁄
𝑀𝑦
𝑏 𝑇2
𝑏⁄
(𝑀0
𝑏 − 𝑀𝑧
𝑏) 𝑇1
𝑏⁄ ]
 
 
 
 
 
 
 
 
  ( 17) 
 
where Mx
A,Β, My
A,Β, Mz
A,Β are the magnetisation components of pool A and B at time t 
along the x, y and z axis respectively. ω1 = 2πγB1 represents the angular speed of the 
magnetisation vector along the x axis due to the B1 field (caused by the application of 
an RF pulse in the x direction). Δωa,b = ωRF − ωa,b, represents the chemical shift 
between the applied RF pulse and the resonance frequency of the pools A and B 
respectively, where ωRF is the frequency of the saturation pulse. Exchange rates 
correspond to kab= kba = k (due to the first order approximation as mentioned 
above).  
This set of differential equations describe the effect of magnetisation loss from pool A 
to pool B, given by kab.𝑀𝑧
𝑎 and as a result the gain of magnetisation of pool B, given 
by kba.𝑀𝑧
𝑏. 
2.4.2. CEST simulator in Matlab 
The set of equations described in section 2.4.1 (equation 17) were the basis for the 
CEST simulator built in Matlab by Francisco Torrealdea (PhD student, Institute of 
Neurology) and myself. Even though the equations here describe a two-pool model, 
it is straightforward to add extra pools and accommodate for additional exchangeable 
sites (see Appendix A). Two versions of the Model were built: a dynamical model, 
which solved the equations as a function of time in order to investigate the 
magnetisation evolution during the saturation process (simulations are also included 
in Walker-Samuel et al, [17]) and a steady state model (equation 18), which was used 
to investigate the Z-spectrum profile with different parameters. 
ⅆ𝑀𝑥
ⅆ𝑡
=
ⅆ𝑀𝑦
ⅆ𝑡
=
ⅆ𝑀𝑧
ⅆ𝑡
= 0     ( 18) 
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Simulated data are used throughout the thesis as part of the discussion, with the 
specific parameters used always provided in an accompanying table. Description of 
the simulated models is included in Appendices B and C for steady state and dynamic 
solutions respectively. 
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Chapter 3. From theory to practice 
 
The theory of magnetisation exchange mechanisms was described in section 2.2. The 
following chapter aims to give the reader a more practical perspective on how to 
acquire CEST data with MRI and how to calculate and interpret the resulting CEST 
contrast once the data have been acquired. 
3.1.  How to obtain Z-Spectra with MRI 
A CEST experiment consists of two parts as described in the following two sections: 
off resonance saturation (section 3.1.2) and on resonance readout (section 3.1.3). The 
water frequency is considered to be on resonance. The Z- Spectrum (also referred to 
as the CEST spectrum) is the range of water signal intensities achieved as a function 
of repeated CEST experiments for multiple off resonance frequencies (more details on 
the shape of the Z-spectrum in section 3.1.1). 
3.1.1. The Z-Spectrum profile 
Let us consider a case where a water phantom is placed in the MRI scanner for a CEST 
experiment. Irradiation at any frequency offset away from water resonance frequency 
should not influence the water magnetisation and the outcome should still be of 
maximum signal. However, when an RF pulse is applied close to water frequency, it 
can perturb the magnetisation by causing direct saturation of water (also known as 
the spillover effect) [69]. Direct saturation is symmetrical around the water frequency 
and depends on the RF pulse bandwidth, frequency offset, length and power. It also 
depends on the relaxation time of water T1 and T2. The shape of the direct saturation 
can be deduced from the steady state solution (equation 18) of the Bloch equations 
(equations 6 a-c), given below in equation 19.  
𝑀𝑧 =
𝑀0
1+
(2𝜋𝜔1)
2𝛵1𝛵2
1+𝛥𝜔𝑟𝑓
2 𝑇2
2
    ( 19) 
where ω1 (Hz) is the applied RF power (γΒ1) at offset ωrf (Hz). 
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Figure 18 shows a simulated Z-Spectrum of a water only pool, deduced from equation 
19. Parameters used for the simulation: M0=1, T2=300ms, T1=3000ms, Β1=0.5μT. 
 
Figure 18: simulation of the direct saturation (Lorentzian shape) as derived from the steady state Bloch equations 
(6 a-c). Parameters used for the simulation: M0=1, T2=300ms, T1=3000ms, Β1=0.5μT. 
If now the water phantom also contains proteins and peptides containing 
exchangeable protons, a decreased signal will be observed at the corresponding 
chemical shifts of each proton. This is due to the magnetisation exchange principle 
(described in section 2.2) of proteins and peptides to the water surrounding them. The 
peaks observed will be related to the concentration of the solutes, the exchange rates, 
temperature and pH (as already explained in section 2.3). Figure 19 shows the 
difference between the water profile (dashed line) and to the profile of a solution 
containing exchangeable protons.  
By looking at the Z-Spectrum, without any further analysis13, there are a few 
characteristic features to comment on. The peaks resonating at 2 and 3.5 ppm from 
water correspond to Amine and Amide protons respectively as discussed in section 
2.2.1 . 
The source of the broad peak in the aliphatic region, centred between -3 and -3.5ppm 
is still a matter of debate [70] as aliphatic groups (-CH) in proteins, phospholipids and 
other fats14 could all potentially be sources. Even though hydrogens from fat do not 
have the ability to chemically exchange with water, when an RF pulse is applied at -
                                                          
13 Data interpretation and further analysis is discussed in section 3.2. 
14 Like mobile lipid droplets, triglycerides, fatty acids, lipoproteins and cholesterol. 
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3.5ppm the fat signal is directly saturated, which therefore decreases the total signal 
at the corresponding frequencies of the Z-spectrum. It is also likely that the peak is 
partially attributed to NOE effects, as discussed in section 2.2.2 or other spin diffusion 
effects [71]. Moreover, the general lowering of the signal compared to the water 
profile is the result of MT (see section 2.2). 
 
 
Figure 19: Sampled data borrowed from Chapter 5 acquired from the spinal cord of a healthy mouse. Z-Spectra for 
comparison of the water profile with (in solid line) and without (dashed line) the influence of other exchangeable 
protons (such as proteins and peptides).  
 
3.1.2. The Saturation part of a CEST acquisition 
A system is considered to be in a state of ‘saturation’ when it exists in a non-
equilibrium state and with net magnetisation zero. Let us first consider again the two 
pool exchange system introduced in section 2.2.1, where pool A corresponds to the 
net magnetisation of water hydrogens (at resonance frequency ωα = 0) and pool B the 
net magnetisation of a molecule with labile hydrogen protons (at resonance frequency 
ωβ). In order to achieve CEST contrast, pool B must remain in a saturation state for a 
period of time which is long enough for sufficient magnetisation exchange to occur 
between the two pools. The saturation scheme is on the order of seconds; typically a 
duration of 5 seconds is enough to reach steady state (see figure 20 for simulations 
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illustrating steady state of Mz, pool A). Therefore during a CEST experiment the 
application of saturation RF pulses is often the longest part of the overall acquisition.  
Saturation can be achieved by either a continuous wave pulse (CW) or a train of 
pulses. CW-CEST, the traditional way to achieve saturation [5], it is more 
straightforward and it can be easily simulated by the Bloch-McConnell equations. The 
use of CW pulses is described in many studies with a variety of pulse durations. Cai 
et al 2012, use a 2 second CW pulse for the investigation of glutamate [20], while Van 
Zijl et al 2007, a 10 second CW pulse for imaging glycogen [14]. Somewhere midway, 
Salhotra et al 2008, use a 4 second CW pulse for the investigation of Amide protons 
in rodents bearing glioblastomas [12]. Despite the simplicity regarding quantification 
from the Bloch McConnell equations, the CW pulse saturation scheme is not suited 
for the hardware in clinical systems nor does it comply with the specific absorption 
rate (SAR) limitations if the pulses used are of long duration. To overcome this, 
pulsed CEST was considered as an alternative option, slightly more complicated in 
terms of quantification, but with feasibility in the clinic. Studies by Zu et al 2008 [5], 
Sun et al 2011 [6], Sun et al 2008 [5] and Dula et al 2013 [72], explore pulsed CEST for 
the use in the clinic, reporting its feasibility and comparable results with CW CEST. 
The duration of the saturation pulses is important in a CEST experiment as it affects 
the excitation frequency bandwidth. This could result in ‘weighting’ some 
frequencies more compare to other ones if not enough time is allowed between each 
saturation experiment. For example in the experiments to follow, a bandwidth of 
52Hz was achieved with pulse duration of 50+5ms (excitation and interpulse delay 
respectively). The off resonance array was acquired in steps of 64Hz, allowing space 
between measurements without interference due to the saturation pulses. 
Figure 20 shows the evolution of Mz (pool A) for pulsed (left) and CW (right) 
saturation schemes, with the effective CEST signal. Data were simulated using a two 
pool dynamic model (based on description in section 2.4, Appendix C) with 
parameters given in table 2 below. The equivalent B1 calculations are shown in 
Appendix D. 
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Figure 20: Simulations of the Mz (water, pool A), showing the CEST effect when connected to pool B via exchange 
rate K (in green) and when not connected to any pool (in blue). The difference of blue to green graph gives the net 
CEST effect in both figures. On the left saturation was achieved by a pulsed CEST acquisition (FA=540, 50 ms 
duration, 95% duty cycle (5ms inter-pulse delay), 200 pulses summing up to 10 s duration of B1rms=0.9μT). On 
the right saturation was achieved by a CW CEST acquisition (CW pulse of 10s duration, and B1rms=0.9μT). B1 RF 
pulses were applied on resonance to the exchangeable pool frequency (3.5ppm). 
 
Pool No. Frequency 
[ppm] 
Pool size   
(ratio to water) 
T1 [ms] T2 [ms] 
1 (Water) 0 1 1700 37 
2 (Amide) 3.5 0.0036 1000 10 
 
Table 2: list of the parameters used for the simulations in figure 20. 
The saturation efficiency depends on the species to be labelled as reported by Snoussi 
et all 2003 [73], Van Zijl et al 2011 [45] and Zais 2013 [74]. Due to the variety of 
exchange rates for different groups (as discussed 2.2), the efficiency will vary with 
saturation power applied, as shown by the following equation (20) for mobile solutes 
(ignoring transverse relaxation). 
𝛼 ≈
(𝛾𝐵1)
2
(𝛾𝐵1)2+𝑘2
     ( 20) 
where α is the labelling efficiency, k the exchange rate between the sites, γ the 
gyromagnetic ratio of hydrogen (rad/s/T) and B1 the RMS amplitude of the saturation 
pulse. The equation indicates that for fast exchangeable protons, higher power is 
required to efficiently saturate them which in the clinic might be a problem due to the 
SAR limitations [45]. Figure 21 is an illustration of equation 20 for a set of B1 and k 
values. 
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Figure 21: illustration of the saturation efficiency (α) for a set of exchange rates (k) and B1 saturation amplitudes. 
In theory, the faster the exchange between protons, the higher the power required to 
maintain a ‘saturation state’. However, this relationship is only true for exchangeable 
protons with large chemical shifts; the closer the chemical shift is to the water 
resonance frequency, the more direct saturation of the water will also be present. 
Figure 22 demonstrates how the maximum CEST signal, calculated by the MTRasym 
(see section 3.2, equation 22) at the frequency of the exchangeable site resonance 
varies with different B1 amplitude (simulation of a four pool Bloch McConnell model, 
see section 2.4 with parameters given in table 3). The figure shows the difference 
between two, otherwise similar exchangeable protons, with different chemical shifts 
(close to water in solid lines and 50ppm off in dashed lines). Light blue solid line 
corresponds to an Amide group, with exchange rate of 30Hz and resonance frequency 
at 3.5ppm, as shown to resonate in vivo [69], while light blue dashed line indicates 
the same group now resonating at 50ppm from water, in order to avoid any direct 
saturation effects. Similarly, pink line corresponds to an Amine group with exchange 
rate of 400Hz resonating at 2ppm (solid line) and 50ppm (dashed line). 
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Figure 22: demonstration of the efficiency of the CEST effect when the exchangeable sites are either close to water 
compared to others further away, but with equal exchange rates and pool sizes. In light blue an Amide group with 
30Hz exchange rate and resonance frequency at 3.5ppm (solid line) compared to the same at a resonance frequency 
of 50ppm (dashed line). Similarly, in pink, an Amine group with 400Hz exchange rate and resonance frequency at 
2ppm (solid line) compared to the same at a resonance frequency of 50ppm. 
 
Pool No. Frequency 
[ppm] 
Pool size   
(ratio to water) 
T1 [ms] T2 [ms] 
1 (Water) 0 1 1700 37 
2 (Amine) 2 & 50 0.0036 1000 10 
3 (Amide) 3.5 & 50 0.0036 1000 10 
4 (Aliphatic) -3.5 0.04 260 0.3 
 
Table 3: Summary of the parameters for the four pool Bloch McConnell model used to produce figure 22. 
For the Amide group (in light blue) while the maximum CEST effect is observed with 
the application of 0.9μT pulse at 3.5ppm, it shifts to 1.3μT at 50ppm. For the Amine 
group (in pink) the change is more significant; for maximum CEST effect at 2ppm the 
required amplitude is 2μT, while at 50ppm it shifts to more than 5μT. This is to 
highlight that one must be aware of analysis close to the water frequency. The 
‘optimum’ saturation power due to the exchange for each site cannot be directly 
calculated from equation 20 in this case; qualitative analysis is more appropriate in 
determining the best saturation scheme. 
The negative asymmetry of the Amide group is due to the Aliphatic peak resonating 
at -3.5pp from water. The model was chosen to be as realistic as possible to the in-
vivo profiles, therefore the fourth pool was dedicated to the contributions in the 
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aliphatic side. Figure 23 shows the Z-Spectra from the four-pool model for different 
saturation powers. 
 
Figure 23: illustration of Z-spectra from the four-pool Bloch McConnell model with different saturation power 
(given in colours as seen in the figure).  
In choosing the correct saturation scheme one must take into account the 
exchangeable protons to target in terms of their exchange rates and chemical shift 
from water. In addition, for clinical applications SAR limitations must be taken into 
account. There is a wide choice in achieving saturation and there are no current 
standardised ways to do so. This brings another factor into discussion, the 
comparison of data between sites. When the saturation schemes differ it is hard to 
compare data and deduce any physiological conclusions from them. It is crucial to 
understand that while this flexibility is favourable to research, data comparison from 
different groups is difficult and one must always take that into account. 
Other than saturation, different readouts will also impact the CEST contrast. The next 
section focuses on signal readout and how to achieve maximum contrast. 
3.1.3. The Readout part of a CEST acquisition 
In principle, signal readout should immediately follow saturation to achieve the 
maximum CEST contrast possible. Ideally all k-space lines should be equally 
saturated prior readout; however, this approach would require a long acquisition. For 
example, if the matrix size was 64x64 and saturation/readout was 5s for 31 offset 
points, 2 hours 45 minutes would be required (64x5x31/60). Such acquisition time 
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would be non-practical in the clinic. Nonetheless, several groups have explored 
alternative imaging sequences, giving similar CEST contrast with accelerated 
temporal resolution.  
The aim is to achieve maximum saturation by the time the centre of K-space15 [65, 75] 
is acquired. This is because the centre of K-space contains the main information 
regarding signal and contrast, while the edges of K-space hold information about 
image details and resolution. Therefore if a compromise is to be made regarding the 
K-space data, this would be to achieve maximum saturation when reading the central 
phase encoding (PE) lines. Figure 24 demonstrates how reconstruction of the K-space 
edges (top left) gives information about the fine details (top right), while 
reconstruction of the K-space centre (bottom left) gives information about the contrast 
of the image (bottom right). 
 
Figure 24: illustrating the image outcome when reconstructing only the edges of K-space (top images), compared 
to reconstruction of k-space centred only (bottom images). Image reproduced from McRobbie et al 2003 [65]. 
 
 
 
                                                          
15 The ‘raw’ data space before reconstruction. Data are stored in frequency domain. 
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Accordingly, two main ways are found to be useful to speed up the CEST 
acquisitions, as first reported by Liu et al 2009, [76]. 
(i) The ‘pulse-acquire’ approach, uses saturation pulses prior to each PE step 
achieving therefore steady state by the centre of K-space [17]; ideally the 
data are acquired in inverse centric k-space order as shown in figure 25 
(2nd figure).  
(ii) The ‘train of pulses-fast readout’ approach, where all saturation is applied 
prior to a fast readout, such as Echo Planar Imaging (EPI), [9, 11] or fast 
Gradient Echo (GE), [76, 30]. Ideally with this scheme the data are acquired 
in centric k-space order, as shown in figure 25 (3rd figure). With such 
ordering the signal acquired has strong CEST weighting during 
acquisition of the central k-space lines, which provide the main contrast in 
the MR images.  
 
Figure 25: Illustration of linear (image on the very left), inverse central (image in the centre) and central (image 
on the very right) k-space filling during MR data collection. Linear k-space ordering (the ‘standard’ in MRI, starts 
at one edge of k-space and fills all lines linearly until the opposite edge is reached. Reverse central ordering starts 
at one edge of the k-space and reaches the centre, alternating from one edge to the other. Central ordering starts at 
the centre of k-space and reaches the edges in an opposite manner to the inverse k-space ordering. 
 
3.2.  CEST signal analysis 
There is a lot of discussion among the community on how to interpret and provide 
quantitative assessment of the CEST data. As it is a relatively new technique there are 
no standardised protocols or post-processing methods that can be followed by 
everyone. Thus, it is not easy to keep consistency or compare results across sites. This 
section focuses on the ways to analyse the CEST data, including fitting, normalisation, 
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B0 correction and signal interpretation. Processing tools such as Matlab or IDL are 
often used for the data processing. For the purpose of the work presented in this 
thesis, Matlab was used for all data processing. For the CEST images (Chapter 6) the 
analysis was performed pixel by pixel, while for the spectroscopic CEST (Chapter 5) 
the analysis was performed for single Z-spectra. 
Data fitting 
Ideally, CEST data should be fitted to a model (like the Bloch-McConnell model 
described in section 2.4), allowing the possibility of full quantification. Yet, due to the 
complexity of the in-vivo cases, using model-based analysis is still challenging. 
Typically, data are fitted to a smoothing spline (Matlab), which is often good enough 
to preserve the Z-spectrum shape (figure 26 for illustration).  
 
Figure 26: demonstration of CEST data set with raw data (in dotted black) fitted to a spline Matlab function (in 
light blue).  
However if data are noisy due to physiological movements or low SNR other 
methods can be used to improve the shape. Such a method is described in section 
5.1.2, developed for spinal cord data processing, based on weighted averaging of 
multiple acquisitions for physiological movement elimination. 
B0 correction 
Once the data are fitted the next step is to correct for B0 shifts, pixel by pixel. This is a 
crucial step of the analysis as the CEST experiments are frequency dependent; if the 
B0 shifts are not corrected for, not all pixels in the image will correspond to the same 
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frequency offset. One way is to use the conventional B0 maps produced by GE-phase 
maps [77], however they are acquired during a separate acquisition leading to slight 
variations of the absolute B0 chemical shift. This is mainly because, especially during 
a clinical scan, power optimisation will occur between acquisitions, leading to slight 
variations of the Larmor frequency calculations. Additionally during the optimisation 
process, the RF is calibrated from the water signal corresponding to the entire field of 
view. Therefore, the calibration might not be centred in the field of interest (which is 
likely to be part of the field of view and not in the center). This will result in a correct 
map across the field of view but potentially centred with a small (few Hz) offset, still 
significantly large for a saturation experiment. Another way, proposed first by Kim 
et al 2009, is to use Water Saturation Shift Referencing (WASSR) maps. This method 
follows the same principle to a CEST acquisition but instead of a wide frequency 
range, offset pulses are applied close to water (±1ppm) with a weak saturation power 
(B1=~0.1μT) and short length. This method assumes contrast is only attributed to the 
direct saturation effect of water, thus the water peak is used as reference per pixel. It 
also has the advantage of providing an absolute measure of the frequency shift, as 
opposed to GE-phase maps, which will be dependent on the scanner’s determination 
of the water frequency. The WASSR method is mostly applied in low field MR 
scanners as the chemical shifts of exchangeable protons are closer to the water 
frequency (broader direct saturation profile) compared to higher field MR (>7T), [78]. 
Lastly, the Z-Spectrum itself can be used for B0 correction if enough frequency offsets 
are acquired and the saturation power is low enough to give a sharp water peak 
(<2μT), [30]. In this way no additional sequences are required for correction and Z-
spectra are effectively corrected to a B0 map acquired at the same time as the rest of 
the CEST data.  
Since the experiments in this thesis were conducted at a 9.4T MR scanner and at low 
powers (<2μT), the Z-Spectra were used for B0 corrections pixel by pixel. 
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Normalisation 
Normalisation of Z-Spectra is yet another non-standardised part of all CEST 
experiments. As discussed in the next section (Z-Spectra interpretation), a variety of 
normalisation factors has been used among research laboratories. In principle, 
normalisation does not change the shape of the Z-spectra, however the values 
deduced as ‘CEST results’ are heavily dependent on the normalisation factor used. 
Figure 27, demonstrates the same data set when normalised at 6ppm (in light blue) 
and normalised at 200ppm (in purple).  
 
Figure 27: illustration of CEST data with two different normalisation factors. In light blue the Z-spectrum was 
normalised at +6ppm, while in purple the same Z-spectrum was normalised at +200ppm from water. Both spectra 
are only scaled differently and therefore present the same shape. 
 
Z-Spectra interpretation 
Numerous ways of analysing CEST data have been reported in the last decade across 
research sites depending on the application. An extensive review is published by Liu 
et al in 2013 [30] and also a summary is given below. 
Earlier work in the field of MT used the magnetisation transfer ratio (MTR) for 
quantification purposes [79]; the equation defining this parameter is given below (21) 
𝑀𝑇𝑅 =
𝑀0−𝑀(+𝛥𝜔)
𝑀0
    ( 21) 
where M0 is the signal of water when no saturation is applied and M(+Δω) the signal 
of water when a saturation pulse of Δω offset is applied. 
67 
 
The most common way to analysed CEST data is by MTR asymmetry (MTRasym) given 
by equation 22, [67, 45]. 
𝑀𝑇𝑅𝑎𝑠𝑦𝑚 = 𝑀𝑇𝑅(𝛥𝜔) − 𝑀𝑇𝑅(−𝛥𝜔) =
𝑀(−𝛥𝜔)−𝑀(+𝛥𝜔)
𝛭0
 ( 22) 
Another approach to CEST quantification is called CEST asymmetry (CESTasym) and 
was reported by Cai et al [20]. Unlike to MTRasym which uses M0 for normalisation, 
CESTasym uses M(-Δω). The mathematical description is given by equation 23 below 
𝐶𝐸𝑆𝑇𝑎𝑠𝑦𝑚 =
𝑀(−𝛥𝜔)−𝛭(+𝛥𝜔)
𝑀(−𝛥𝜔)
    ( 23) 
A third CEST quantification method, proposed by Zaiss et al, [69], uses the ‘inverse 
metric spectrum’, 1/Z. A new parameter was introduced, called Exchange-dependent 
Relaxation MT (MTRex), which was also demonstrated to correct for the direct 
saturation effects and any T1 relaxation contribution. Equation 24 below gives a 
description of MTRex 
𝑀𝑇𝑅𝑅𝑒𝑥 =
1
𝑀(+𝛥𝜔)
−
1
𝛭(−𝛥𝜔)
    ( 24) 
The three equations shown above (22, 23 and 24) all in principle eliminate direct 
saturation and MT effects, however they do not take into account the contributions 
from the aliphatic NOEs and fat resonating on the negative side of the Z-Spectra. 
Therefore, the values calculated will be affected by the aliphatic peak and fat. 
Contaminations such as MT effects, contributions from the aliphatic peak as well as 
direct water saturation of the Z-Spectrum is a major issue in CEST quantification. 
Many ways have been developed by various research groups aiming to calculate the 
CEST signal with the least possible contribution from contaminated sources. A 
common way is the Lorentzian fitting approach [80], where a Lorentzian line shape 
is fitted to the Z-Spectrum and used as the reference. The CEST value is given by the 
difference between the Lorentzian fit and the Z-Spectrum at the specific frequency 
range of interest. This approach follows the idea in figure 19 where the Lorentzian 
shape gives the signal of water in the absence of any exchange processes. While there 
is no need for asymmetric analysis with this method, the calculated CEST value is still 
contaminated by the presence of MT. 
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Another method, named APTpeak (APTp), was implemented and used (see Chapter 
6 for application of APTp) as part of this PhD thesis, [61]. However, the method was 
also reported by Zaiss et al 2013, [69] with the name APT*. As shown in figure 28, a 
straight or curved line is interpolated around the peak of interest; the case of Amides 
(3.5ppm) is illustrated in the figure, where the interpolation is applied between 3.0-
3.1ppm and 3.9-4.0ppm. The APTp/APT* value is defined as the height of the peak 
(difference) between the interpolation line (in red) and the Z-Spectrum (in blue) at 
3.5ppm. 
 
Figure 28: shows an example Z-Spectrum (in blue) with a fitted straight line (in red) around the Amide peak 
centred at 3.5ppm. The APTp or APT* measure is calculated by the height from the red line to the Z-spectrum at 
3.5ppm. 
Similarly to the Lorentzian fit method, the APTp/APT* does not require asymmetric 
analysis, meaning that no contributions from the negative side of the Z-spectrum 
(aliphatic) can alter the signal and furthermore is excludes any MT contaminations. 
However one of the weak points of the Lorentzian fit or the APT* methods, is the use 
of artificial line shape fitting which, if the data are noisy, will introduce additional 
variability to the quantification of the CEST effect. 
Additionally, there is always the option to use the Z-spectra at the frequency range of 
interest, normalised to a far frequency offset. However, this method is only suitable 
for data comparison of the same scanning parameters and for the same group of 
subjects. The values calculated with this approach are the least suitable for further 
comparisons with other groups or other protocols compared to the rest of the 
interpretations described within this section. This is due to the fact that it offers no 
direct saturation or MT corrections, which results in the Z-Spectra having a higher 
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dependency on saturation power compared to other techniques (see equations 22, 23 
and 24). Nonetheless, the signal is not contaminated by contributions which occur on 
the negative site of the Z-Spectrum, such as the aliphatic peak and fat. 
Lastly, it is worth mentioning two other ways of analysing the Z-Spectra, quite similar 
in comparison. The first method, reported by Desmond et al [60] uses decomposition 
in the frequency domain (Z-Spectrum) to separate contributions from different 
exchangeable sites and also MT. The other method by Yadav et al [81], uses the 
deconvolution principle but in the time domain instead.  
Both methods have successfully demonstrated the decomposition of the CEST signal, 
however they require inputs such as the frequency offsets which might not always be 
obvious from the Z-Spectra due to low concentrations or multiple sites with 
resonance frequencies in very close ranges. 
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Chapter 4. Phantom work 
 
4.1.  Introduction 
It is known that CEST effects are directly linked to many factors, including the 
concentration of exchangeable sites, the sample pH, temperature, T1 and T2 relaxation 
times as well as the B1 power used for the experiment. Therefore, investigation of the 
CEST effects where all the above parameters are controlled is crucial for our broader 
understanding of the effect. How does the Z-Spectrum shape change under different 
physiological conditions and how is that related to the ‘quantitative’ values that one 
can obtain by fitting the data to the theoretical model? By only looking at the 
theoretical results obtained from the Bloch- McConnell’s model (see section 2.2), it 
would be easy to be misled by the simplicity of the model and ignore issues that 
appear when the complexity of the system is higher. Bovine Serum Albumin was 
therefore chosen as a model protein for this study as it is a long chained, complex 
protein which resembles in-vivo observations [82].  
This chapter studies the known confounding CEST factors such as pH, temperature 
and concentration with the additional investigation of the saturation powers used. It 
breaks down each factor and explores the effects as individually as possible.  
4.2.  Experimental setup 
4.2.1. Phantom Preparation 
Phantoms with Bovine Serum Albumin (BSA) were prepared at four different 
concentrations (2.5, 5, 7.5 and 10 percentage of grams per volume of solution). For 
each concentration four phantoms where made with pH values ranging from to 7.3 
in steps of 0.3 down to 6.4 (i.e: 7.3, 7.0, 6.7, 6.4). Phosphate buffered saline (PBS) was 
used at a concentration of 0.3 percent in distilled water for all the phantoms. The pH 
was measured using a micro pH probe (Mettler-Toledo International, Inc) and 
adjusted where necessary with the use of Sodium hydroxide (NaOH) and 
71 
 
Hydrochloric acid (HCl). All phantoms were prepared and scanned within the same 
day to avoid potential pH drifts. Phantoms did not go through a degasing process, 
but the solutions were carefully treated and phantom containers were filled avoiding 
air bubbles. Syringes of 1ml volume capacity were used as phantom containers, 
sealed with silicone glue. All phantoms were grouped in sets of four (same 
concentration, and four different pH values). Figure 29 illustrates the arrangement of 
a set of phantoms where all four have the same concentration but different pH values 
(7.3, 7.0, 6.7 and 6.4 clockwise starting from the top).  
 
Figure 29: Image of a set of BSA phantoms with concentration of 5 percent (Radiological convention) indicating 
the location for different pH values. R and L, Right and Left respectively, show the real location of the phantom 
within the MRI scanner.  
4.2.2. Experimental protocols 
The phantoms were scanned in a horizontal 9.4T MR scanner (Agilent Technologies) 
with a volume receive/transmit RF coil of internal diameter 33mm (Rapid 
Biomedical). Temperature was maintained at 38.5o C (experiments were 
complimentary of Chapter 6; piglets were maintained at 38.5o C) with a hot air system 
(Small Animal Imaging Instruments - SAII). Prior to any scanning each phantom was 
allowed 30 minutes for temperature stabilisation. The phantom set with BSA 
concentrations of 10% was also scanned at temperature (T=35.5o C) for investigation 
of the temperature dependence of the CEST effect.  
All phantoms were manually shimmed achieving an overall linewidth of 15±3 Hz 
(0.038±0.008 ppm). T1 and T2 maps where acquired in addition to the CEST 
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acquisitions. Sequence description and parameters per acquisition are given in the 
following sections. 
Reproducibility of the CEST results was checked by rescanning the same phantom set 
(concentration of 5%) at a different location within RF coil. This was achieved by 
rotating the phantom 90 degrees counter clockwise, relative to the original scan and 
re-shimming to the same standards as described above. See figure 30 (a) for the 
original location and figure 30(b) for the positions after rotation. This enabled us to 
investigate whether within different locations of the RF coil the CEST outcome could 
be reproduced. The CEST protocol was acquired twice in each position. 
 
Figure 30: Anatomical image of a set of BSA phantoms with 5 percent concentration (Radiological convention) 
indicating the location for the different pH values when the phantom is rotated counter clockwise shown in (b). 
Comparison with the initial phantom locations in (a). R and L, Right and Left respectively, show the real location 
of the phantom within the MRI scanner.  
4.2.2.1. T1 map 
Inversion Recovery Gradient Echo (GE) sequence was used to quantify the T1 values 
of each phantom. A global adiabatic inversion pulse (flip angle 180o, duration 2ms) 
was applied at the frequency of water followed by an inversion time TI and a GE 
readout with echo time set at the minimum possible value (TE=1.09ms). Phase 
encoding during readout was chosen to be of centric order, i.e.: starting from the 
centre of k-space and continue filling lines outward in an alternative mode. With such 
ordering the signal acquired is heavily weighted to the central k-space lines, which 
gives the contrast in MR images. For illustration of centric k-space ordering refer to 
section 3.1.3 (Chapter 3 From theory to practice). The readout was succeded by a 
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crusher (2ms duration, 10G/cm) and a 15 seconds wait time to achieve full 
magnetization recovery before the next inversion pulse. Figure 31 shows the pulse 
sequence diagram which summarises the acquisition. The sequence was repeated 18 
times with different TI values, exponentially spaced from 70 to 15000ms (denser 
spacing for the shorter TI values) . The entire set of values is summarized in table 4 
below. 
 
Figure 31: Illustration of the T1 map sequence. RF pulses are shown in green, slice select and frequency encoding 
gradients in black and phase encoding gradients in blue. The orange brackets indicate the array of 18 TI values. 
GSS, GPE, GRO correspond to the slice selection, phase encoding and readout gradients respectively. TI corresponds 
to the wait time between the application of the inversion recovery and the readout pulses. All phase encoding lines 
were acquired following a single excitation pulse starting from the centre of k-space and continue in an interleave 
way to the edges. TE was set to 1.09ms (minimum possible) and TRRO=2.03ms (referring to readout TR). Following 
the signal readout a 15 seconds delay was added which also included a spoiler gradient (duration = 1.3s and 
amplitude = 2G/cm). 
Other parameters such as the field of view (FOV= 20x20mm2), matrix size (64x64), 
number of slices (ns=1) and slice thickness (th=4mm), where kept the same during all 
the phantom work. 
 
NUMBER 1 2 3 4 5 6 7 8 9 
TI (ms) 70 97 134 185 257 355 491 680 940 
NUMBER 10 11 12 13 14 15 16 17 18 
TI (ms) 1300 1800 2500 3400 4800 6600 8000 11000 15000 
Table 4: Summarises all the TI values used for the quantification of the T1 maps of all BSA phantoms. Values are 
given in ms. 
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Quantification of T1 maps 
Magnitude images were read into Matlab for the quantification of T1 values for each 
phantom. Assuming mono-exponential decay for the longitudinal relaxation, 
equation 7 was used to fit the magnitude data with initial condition of M0z =-Meqz and 
Mz=|Mz|. 
𝑀𝑧(𝑇𝐼) = 𝑀𝑧
𝑒𝑞
|1 − 2𝑒−𝑇𝐼/𝑇1|   ( 25) 
where, as already defined in section 2.1.4 (Relaxation Processes) Meqz is the net 
magnetisation along the z axis when the system is at thermal equilibrium, M0z the 
initial net magnetisation and T1 the longitudinal relaxation time constant. As the 
magnitude data are always positive the relationship used for fitting, given by 
equation 25, displays only the absolute values of equation 7. 
The analysis was performed pixel by pixel fitting equation 25 for Meqz and T1 values. 
Assuming phantom homogeneity, all pixels were averaged to give a mean T1 value 
and the standard error of the mean per phantom  
4.2.2.2. T2 map 
For the quantification of T2 maps the Carr Purcell Meiboom Gill (CPMG) sequence 
was used. It consisted of a 90 degree excitation pulse in the x axis (of sinc shape and 
duration = 1ms) followed by 40 refocusing pulses in the y axis (flip angle 180 degrees, 
Sinc shape and duration 1ms). Figure 32 is an illustration of the CPMG sequence used 
for T2 mapping and also table 5 gives a complete summary of the echo time range 
used. FOV, matrix size, slice thickness and number of slices (ns=1) were kept the same 
as for T1 mapping. 
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Figure 32: Illustration of the CPMG sequence used for the quantification of T2 maps. As also in figure 31, the RF 
pulses are shown in green, the gradients in black and the phase encode table in blue. Orange colour represents the 
array of echo times (NE=40), where each echo corresponds to a different T2 weighted image. Slice refocusing 
crushers were applied for 2ms at amplitude 10G/cm. 
Due to imperfections in the refocusing pulses, odd numbered echoes give signal at a 
slightly lower level compared to the even ones (for the even ones the imperfection 
artefact is cancelled out). Therefore out of 40 images collected (weighed with different 
TE), only the even ones were taken for the analysis [65]. See figure 33 for an example 
of the T2 profile, taken from BSA phantom of 7.5% concentration at pH 7.3, which 
shows the odd numbered echoes in orange and the even ones in blue.  
 
Figure 33: Shows the average M0 value with different echo times of a BSA phantom (Concentration 7.5% and at 
pH 7.3), chosen for demonstration. In orange: The signal due to odd echoes. In blue: The signal due to even echoes. 
It is clear that the primary echo results in lower signal due to the slice profile. 
NUMBER 1 2 3 4 5 6 7 8 9 10 
TE (ms) 12.78 25.57 38.52 51.14 63.92 76.70 89.49 102.27 115.06 127.84 
NUMBER 11 12 13 14 15 16 17 18 19 20 
TE (ms) 140.62 153.41 166.19 178.98 191.76 204.5 217.3 230.1 242.9 255.7 
Table 5: Shows a summary of all the echo times used for the quantification of the T2 maps of BSA phantoms. Values 
are given in ms. 
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Quantification of T2 maps 
Quantification of the T2 data was also performed in Matlab. As already stated in 
section 4.2.2.2 (T2 map section), the M0 signal due to the even echoes was used and 
fitted to equation 10 assuming mono-exponential signal decay. The analysis was done 
pixel by pixel. Similar to the quantification of T1 values, phantom homogeneity was 
assumed; thus all pixels were averaged to give a single mean value and a standard 
error of the mean per phantom. 
4.2.2.3. Chemical Exchange Saturation Transfer 
The CEST sequence consisted of two parts, pre-saturation at a frequency offset (fsat) 
and readout at the frequency of water (on resonance). Saturation was achieved with 
a train of 100 Gaussian shaped pulses, each at 50ms duration and with an inter-pulse 
delay of 5ms (95% duty cycle). The flip angle of the saturation pulses was altered for 
the investigation of the CEST profile at different saturation powers. Table 6 
summarises the experiments done per phantom group regarding the CEST 
acquisitions.  
FA (μΤEQ) 2.5% 5% 7.5% 10% 
259O (0.4) Yes Yes Yes Yes 
424O (0.7) Yes Yes Yes Yes 
540O (0.9) Yes Yes Yes Yes 
635O (1.0) Yes Yes Yes Yes 
718O (1.1) Yes Yes Yes Yes 
793O (1.3) Yes --- --- --- 
863O (1.4) Yes --- --- --- 
923O (1.5) Yes --- --- --- 
982O (1.6) Yes --- --- --- 
     
 
Table 6: Summarises the CEST acquisitions per phantom set. The table gives values for the flip angle used as well 
as the equivalent B1 amplitude in micro TESLA (μT). The phantom groups correspond to concentrations of 2.5, 5, 
7.5 and 10% and each consist of 4 different phantoms with pH values 6.4, 6.7, 7 and 7.3. Five data sets were 
acquired per phantom group, with different saturation powers as shown in this table. Additionally, the phantom 
group of 2.5% BSA concentration was also explored with four extra saturation powers. Line indicates that no data 
were acquired for the specific saturation power. Also Appendix D for the B1 equivalence calculations. 
 
77 
 
Saturation was followed by a GE readout at minimum echo time (TE=1.1ms), similar 
to the readout of the T1 map sequence (see sections 3.1.3, 3.1.3 and 4.2.2.1). Prior to the 
readout, no inter-pulse delay was added in order to maximise the CEST contrast 
achieved. The sequence was repeated for 77 frequency offsets ranging between ±6.08 
ppm centred at water with steps of 0.16 ppm (64 Hz at 9.4T). Frequencies were 
alternated from positive to negative to compensate for any potential B0 field drifts, 
starting from +6.08ppm all the way to 0 ppm. For the CEST data, 1 slice was acquired 
of 4m thickness. See figure 34 for a schematic of the CEST sequence used.  
 
Figure 34: is an illustration of the CEST sequence used. All RF pulses are displayed in green. Slice select and 
frequency encoding gradients in black and phase encoding gradients in blue. Orange colour indicates the number 
of saturation pulses applied with an inter-pulse delay (in red) of 5ms. The saturation RF pulse prior to the excitation 
pulse is applied with no inter-pulse delay (total number of saturation pulses 100). FAsat indicates the flip angle 
given in the table 6. TRRO refers to the readout time alone, while TRtot to the total time for the 1 frequency offset. 
Total number of frequency offsets (NF=77), displayed in purple. 
 
CEST analysis  
All analysis was done in Matlab. Each CEST acquisition consisted of 77 images (one 
for each frequency offset). All images were sorted from -6.08 ppm to 6.08 ppm and 
pixel by pixel fitting (smoothing spline function) was performed along the frequency 
direction. Data were interpolated to 1001 points which effectively increased the Z 
Spectra resolution from 0.16 to 0.012ppm. Following fitting, data were normalised to 
the average signal of all points between ± 5.5 and 6 ppm as no CEST contrast is 
expected across those frequency offsets. Figure 35 is a set of Z-Spectra showing the 
normalisation frequency points. 
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Figure 35: Shows four Z-Spectra which correspond to BSA phantoms of 10% in concentration. The pH of each 
phantom corresponds to different colour: 7.3 in blue, 7 in light blue, 6.7 in green and 6.4 in red. The two black 
boxes at the edge of the spectra indicate the values used for the normalisation of each data set. NB: The CEST data 
are usually presented with positive frequencies on the left and negative ones on the right. This is due to historical 
reasons as the first time CEST was explored, it was compared with conventional NMR spectroscopy. 
All pixels per phantom were averaged (as also done in T1 and T2 mapping data) to 
give a mean value and the standard error of the mean. For the CEST analysis, 
asymmetry values (MTRasym) and also absolute Z-Spectra values were calculated from 
different frequency ranges, corresponding to signals from amides, amines and 
aliphatic peaks. A few of the ranges included 1.2-1.6ppm, 2.5-3 ppm, 3.9-4ppm as well 
as the value at 3.5ppm and -3.5ppm. In addition, a Lorentzian line-shape (see equation 
19 in section 3.1.1) was fitted to the points of the Z-Spectra centred at 0 ppm (-0.5 to 
0.5 ppm around the water peak) and the full width half maximum (FWHM) values 
were determined. 
4.2.3. Statistical Analysis 
All data sets were assessed for the normality of their distribution, by calculating their 
skewness and kurtosis values. Data sets with kurtosis less than nine and with absolute 
value of skewness less than two [83, 84], were considered normally distributed. Note 
that all data were found to be normal therefore no data were excluded from the 
analysis. Confidence levels (CL) of the 68th, 95th and 99th percentiles were calculated 
per data set taking into account all the pixels within each phantom, as shown in figure 
36 below.  
79 
 
 
Figure 36: Demonstration of a normal distribution showing 68th (yellow), 95th (green) and 99th (blue) percentiles 
(2σ, 4σ and 6σ respectively).  
Statistical significance between data sets was decided based on the percentage of data 
points overlap between them. A star annotation is used throughout the result section 
(4.3) to indicating whether data are statistically different or not. See table 7 below for 
a summary of the annotation and also figure 37 for examples on each case taken from 
the phantom study.  
 
Annotation Level of 
Significance 
Confidence Levels 
(CL) 
P-value  
equivalence 
(***) High  >99% < 0.01 
(**) Standard >95% & <99% < 0.05 
(*) Low >68% & <95% < 0.3 
(~) None <68% > 0.3 
 
Table 7: Summarises the star annotation used throughout the results section (4.3). The confidence level column 
indicates the percentage of different data between two sets.  
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Figure 37: includes four different sets of data where statistical analysis was performed. Each figure uses two types 
of data presentation, the standardised histograms and below each histogram the spread of all the points per set. Top 
left figure: demonstration of high significant difference (***) between the two data sets (BSA phantoms at 10 % 
concentration, both represent the Z-spectrum at 2.75ppm and pH value 6.7. In green the sample at 35.5o C and in 
black at 38.5o C). Top right figure: demonstration of standard significant difference (**) between the two data sets 
(BSA phantoms at 10 % concentration, both represent the Z-spectrum at 2.75ppm and pH value 7.0. In light blue 
the sample at 35.5o C and in black at 38.5o C). Bottom left figure: demonstration of low significant difference (*) 
between the two data sets (BSA phantoms at 10 % concentration, both represent the Z-spectrum at 1.4ppm and 
pH value 6.4. In red the sample at 35.5o C and in black at 38.5o C). Bottom right figure: demonstration of no 
significant difference (~) between the two data sets (BSA phantoms at 10 % concentration, both represent the Z-
spectrum at 3.5ppm and pH value 7.3. In blue the sample at 35.5o C and in black at 38.5o C).  
 
4.3.  Results & Discussion 
A representative selection of results from the BSA phantom study are presented here. 
These include data on rotated vs non rotated phantoms (spatial reproducibility 
section), data acquired at two different temperatures (temperature dependence 
section), with different pH values (pH dependence section), for different 
concentrations (concentration dependence section) as well as scanned with a range of 
saturation power (B1 power dependence section). 
 
81 
 
Spatial reproducibility  
Data comparison between rotated and non-rotated phantoms show no significant 
differences (CL < 0.68) for the CEST values (for box plots of the statistical analysis 
refer to following figures 39, 40, 41 and 42). See figure 38 for Z-Spectrum per pH value, 
where the rotated phantom data are overlapping the non-rotated ones. This suggests 
that the relative location of different phantoms within the RF coil does not 
compromise the CEST results, nor favour different locations. Therefore is fair to 
assume that any significant differences are related more to the parameters changed 
due to the experiments rather than the location of the phantoms in the RF coil. 
 
Figure 38: shows four Z-Spectra pairs. Each figure contains two Z-Spectra, from the same phantom, as figure 30 
demonstrates (rotated and not rotated). All four phantoms have a concentration of 5%, scanned at 38.5o C and with 
a saturation power of 1.1 μT (B1 power equivalent). pH values per phantom are 7.3, 7.0, 6.7 and 6.4 listed from top 
left figure clockwise. NB: the Z-Spectra are plot as the average of all the values per pixel and standard errors are 
also plotted on each side of the mean. See zoomed version (between 3 to 4 ppm, centred at 3.5ppm) of each figure 
for better resolution. It applies similarly for the entire frequency spectra.  
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Figure 39: Shows the CEST values at 1.4ppm from water for each of the 4 pH values and for both rotated (coloured 
depending on the pH value) versus non-rotated (coloured black) phantoms. No significant difference (CL>0.68) is 
observed for all the phantoms. Note that the level of significance is noted in the star annotation as explained in 
section 4.2.3. 
 
 
Figure 40: Shows the CEST values at 2.75ppm from water for each of the 4 pH values and for both rotated (coloured 
depending on the pH value) versus non-rotated (coloured black) phantoms. No significant difference (CL>0.68) is 
observed for all the phantoms. Note that the level of significance is noted in the star annotation as explained in 
section 4.2.3. 
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Figure 41: Shows the CEST values at 3.5ppm from water for each of the 4 pH values and for both rotated (coloured 
depending on the pH value) versus non-rotated (coloured black) phantoms. No significant difference (CL>0.68) is 
observed for all the phantoms. Note that the level of significance is noted in the star annotation as explained in 
section 4.2.3. 
 
 
Figure 42: Shows the CEST values at -3.5ppm from water for each of the 4 pH values and for both rotated (coloured 
depending on the pH value) versus non-rotated (coloured black) phantoms. No significant difference (CL>0.68) is 
observed for all the phantoms. Note that the level of significance is noted in the star annotation as explained in 
section 4.2.3. 
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Temperature dependence 
Comparison of CEST data at 10% concentration scanned at different temperatures 
show significant differences within the range of 2.2ppm and up to 3.5ppm from water. 
There is a general increasing trend for the Z-Spectrum in that range when the 
phantoms are heated to 38.5oC compared to the CEST values at 35.5oC. Figure 43 
shows the difference between temperatures for a set of phantoms with different pH 
values at 2.75ppm where all phantoms show statistical significance. 
 
Figure 43: Shows the CEST values at 2.75ppm from water for each of the 4 pH values for a comparison of scanning 
at 35.5o C (coloured depending on the pH value) and 38.5o C (coloured black). Significant difference is observed to 
all four sets with high being for the lower pH value samples (6.7 and 6.4 respectively).The samples shown here were 
scanned after a saturation train of pulses with 1.1μT B1 power equivalence. Note that the level of significance is 
noted in the star annotation as explained in section 4.2.3. 
Figure 45 displays the Z-spectra of the four phantoms with different pH value. No 
significant difference is observed in the Aliphatic range (-2 to -4ppm) which suggests 
no temperature dependence (also see figure 44 which displays the CEST values at -
3.5ppm from water, within the Aliphatic range). In fact, no other significance 
differences are observed other than within the range of 2.2 to 3.5ppm.  
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Figure 44:Shows the CEST values at -3.5ppm from water for each of the 4 pH values comparing samples scanned 
at 35.5o C (coloured depending on the pH value) and 38.5o C (coloured black), showing no significant differences. 
The samples shown here were scanned after a saturation train of pulses with 1.1μT B1 power equivalence. Note 
that the level of significance is noted in the star annotation as explained in section 4.2.3. 
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Figure 45: shows four Z-Spectra pairs. Each figure contains two Z-Spectra, from the same phantom, one with 
temperature maintained at 35.5oC (coloured depending on the pH per phantom) and the other one maintained at 
38.5oC (coloured black). All four phantoms have a concentration of 10%, scanned with a saturation power of 1.1 
μT (B1 power equivalent). pH values per phantom are 7.3, 7.0, 6.7 and 6.4 listed from top left figure clockwise. NB: 
the Z-Spectra are plot as the average of all the values per pixel and standard errors are also plotted on each side of 
the mean. See zoomed version (between 2.2 to 3.5 ppm, centred at 2.65ppm) of each figure for better resolution on 
the region where significant differences are observed (figure 43 for level of significance) between spectra (the rest 
frequencies of the z-spectra are found with no significant differences when comparing temperature dependence). 
Data acquired with different saturation powers (0.7, 0.9 and 1μT of B1 power 
equivalent) were found to have the same trends as the data shown for 1.1 μT of power 
(figures 43, 44 and 45) but with CEST values at different absolute values. Figure 46 
below summarizes the results from all four powers.  
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Figure 46: Shows the CEST asymmetry integrated between 2.5 and 3ppm (centred at 2.75ppm) for data acquired 
at 35.5oC and 38.5oC and with different saturation power each time (0.7, 0.9, 1.0 and 1.1 μT accordingly). Different 
pH values are given with different colours as figure indicates.  
 
Concentration dependence 
As expected from the theory (section 2.3), the CEST effect is dependent on the 
concentration. In general terms, the higher the concentration, the bigger the CEST 
effect observed. Figure 47 shows how the different concentrations of BSA affect the 
Z-Spectra while other parameters, such as pH, temperature or saturation power were 
not altered. At low concentrations the relationship is approximately linear, but when 
concentrations become larger, the shape is better described with a 2nd order 
polynomial [17]. From the Z-Spectra in figure 47, it can be also inferred that the 
aliphatic side is also concentration dependent due to the negative side of the Z-
Spectra increasing with concentration as well. 
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Figure 47: Shows four sets of Z-Spectra, each at a different pH value, indicated with different colours (dark blue 
for pH of 7.3, light blue for pH of 7.0, green for pH of 6.7 and red for pH of 6.4). Each set contains Z-spectra with 
different BSA concentration (solid line for10%, dashed line for 7.5%, dotted line for 5% and dashed-dotted line for 
the smallest concentration of 2.5%). Observe how the shape of each Z-spectrum does not change, but is shallower 
(driven by bigger CEST effect) when the BSA concentration increases. This is valid for both the aliphatic and the 
rest of the exchangeable sites. NB: the Z-Spectra are plot as the average of all the values per pixel and standard 
errors are also plotted on each side of the mean. 
For demonstration, the saturation power used was 1.1μT, but similar trends apply to 
the rest of the saturation powers tested, including 0.4, 0.7 and 1 μT (see figure 48 for 
summary at all powers in the frequency range of 2.5 to 3ppm). 
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Figure 48: this is a summary showing the same samples scanned at different saturation powers (0.4, 0.7, 0.9, 1.0 
and 1.1 μT). The figure contains four pH values for all four concentrations of BSA. Look how other than the very 
small power (0.4 μT) which was not sufficient saturation, the rest of the powers give the same trend regarding the 
concentration dependence of the BSA phantoms. 
Figure 49 shows the tendency of the CEST signal with different BSA concentrations 
in the range of 2.5 to 3ppm (centred at 2.75ppm). Data with different pH values are 
presented including illustrative comparison of fitting curves for one of the data sets 
(pH 6.4 in red). The Bayesian Information Criterion16 (BIC) [85] was used as a tool for 
deciding whether the data followed more a 2nd order polynomial than linear 
relationship. Three relationships were tested with the BCI approach: linear, 2nd order 
and 3rd order polynomial. The results revealed lower BIC values associated with the 
2nd order polynomial with values {-13.37, -15.68 and -14.30} for 1st, 2nd and 3rd order 
polynomials respectively. Best fitting yields the lowest BIC, therefore the 2nd order 
polynomial was judged as the most appropriate for the data sets displayed in figure 
shown below.  
                                                          
16 The BIC assessment gives a value to various known fitting curves in order to decide on the most 
appropriate number of parameters for the fitting curve of a data set.  
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Figure 49: Both figures show the relationship of the CEST effect at the range of 2.5 to 3ppm (centred at 2.75ppm). 
Data with different pH values are presented at different colours (pH 7.3 in green, pH 7 in purple, pH 6.7 in blue 
and pH 6.4 in red). Right and Left images are identical in terms of data, but differ in the fitting type. Figure on the 
left shows data fitting with a 2nd order polynomial, while figure on the right shows data fitting to a linear 
relationship (illustrative fitting curves for one data set out four: pH 6.4). While the linear interpolation gives a 
fitting coefficient R2 of -0.988, the 2nd order polynomial fitting appears improved with an R2=0.999 goodness of fit 
(GOF). The relationship of the CEST effect with concentration can be approximated with a linear curve at low 
concentrations [17]. 
Note that relaxation values (T1 and T2) were not varied, therefore they do have an 
effect on the Z-Spectra. As the concentration of the samples increases, the T1 and T2 
values of the samples were found to decrease (see figure 50 for the relationships of 
both relaxation times with different concentrations of BSA). This decrease in 
relaxation values is partly responsible for the symmetric broadening of the FWHM of 
Z-Spectra (at ~ ±1ppm centred at zero). In fact, FWHM was found to decrease with 
longer relaxation times. Figure 51 displays the relationship of FWHM with each of 
the relaxation times (T2 and T1 respectively). 
 
Figure 50: left figure shows the relationship of T2 values with concentration of BSA and right figure the relationship 
of T1 values with concentration of BSA. Both figures correspond to sample values of pH 7.3 and CEST was 
performed with saturation power of 1.1μT. In both cases there is a trend for higher relaxation values at lower 
concentrations. 
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Figure 51: left figure shows the relationship of T2 values with the Z-Spectra FWHM and right figure the 
relationship of T1 values with the Z-Spectra FWHM. Both figures correspond to sample values of pH 7.3 and CEST 
was performed with saturation power of 1.1μT. In both cases there is a trend for lower FWHM values with 
increasing values of T1 and T2. 
While the relationship of T2 with the FWHM is expected due to the Lorentzian 
relationship which can be deduce from the Bloch-McConnell equations (equation 19), 
the relationship of T1 with FWHM was surprising. To further investigate the effect of 
FWHM with T1 and T2 relaxation times the theoretical model was used. This allows 
an even more controlled experiment compared to the phantom work, where the BSA 
sample concentration as well as T1 and T2 values could be set as individual 
parameters. Figure 52 displays the relationship of FWHM to each relaxation time (T2 
on the left and T1 on the right) from a five17 pool model of the Bloch-McConnell 
equations. The parameters of the model were chosen to be as realistic as possible, 
based on the BSA phantom of 5% at pH value 7.3 (T1=3500ms and T2=100ms), which 
is also the pH value corresponding to the data presented in figure 51 above. 
Parameters concerning the CEST pools are listed in table 8. 
 
 
 
 
 
                                                          
17 The number of pools used in the model was chosen according to the peaks observed in the Z-Spectra 
(figure 54).  
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Pool No. Frequency 
[ppm] 
Pool size  
(ratio to water) 
Exchange rate 
[Hz] 
1 (water) 0 1 0 
2 (Amide) 2.2 0.0017 22 
3 (Amine) 2.9 0.0025 400 
4 (Amide) 3.6 0.0017 22 
5 (Aliphatic) -3.5 0.04 4.5 
 
Table 8: Summarises the parameter details for all the pools used. The concentration of the exchangeable pool was 
considered as 5% of the water (ratio of the initial magnetisations M0 available), at a pH value of 7.3. T1 and T2 were 
considered as 3500 and 100 ms respectively.  
 
 
Figure 52: is an illustration of how the behaviour of FWHM is predicted from the Bloch-McConnell model with a 
range of T1 (right image) and T2 values (left image). FWHM was deduced from the Z-Spectra in the same way as 
for the experimental data (Lorentzian line-shape fitting of the water peak). The B1 used was 1.1μT, the same as the 
experimental B1. 
From the comparison of figures 51 and 52 correlation coefficient graphs were created 
shown in figure 53. One can clearly see that FWHM compared to T2 values between 
experimental and theoretical results follow similar trends (correlation factor of 0.31, 
p<0.001) whereas in the case of T1 an inverse correlation is observed (correlation factor 
of -0.1, p<0.001). However, when looking at figure 53 (relationship on the right), it 
might be inferred that yet another (or many) factors affect the relationship, hence its 
slightly exponential shape. Therefore is more likely that the behaviour of T1 compared 
to FWHM is mostly attributed to the difference in concentrations (see figure 50 
compared to figure 51); not surprising as it is mentioned already that at least the 
sample’s concentration affects the relaxation values.  
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Figure 53: shows the correlation graphs when comparing the experimental vs theoretical results of the FWHM 
deduced from the Z-Spectra. On the left, the relationship was obtained when comparing the two fitted relationships 
that arose from the left hand side of figures 51 & 52. On the right, the relationship was obtained when comparing 
the two fitted relationships that arose from the right hand side of the same figures. 
 
 pH dependence 
One of the most interesting results from this phantom study was the behaviour of the 
Z-Spectra when the pH was altered. Figure 54 shows a summary of the effects 
observed when BSA at 2.5% concentration was buffered at four different pH values 
and scanned simultaneously with the CEST sequence at B1 saturation power 
equivalence of 0.9μT. As expected peaks are more or less enhanced depending on the 
pH.  
Statistical significance of the observed peaks for different pH was performed as 
described in section 4.2.3 and the results are summarised in the form of boxplots 
(figure 55). At pH value of 7.3 (shown in blue), two visible CEST peaks exist, at 
3.6ppm and at 2.2ppm. The slightly lower pH of value 7.0 (shown in light blue), 
reveals a less enhanced peak at 3.6ppm , another one of similar CEST effect (as at 7.3 
pH value) at 2.2ppm but also a ‘hint’ of a peak around 2.8ppm. This almost invisible 
peak becomes more defined when the pH decreases even more, with a value of pH at 
6.7 (shown in green). At this pH value, there is no observed peak at 3.6ppm anymore, 
but a defined peak around 2.9ppm and also a slightly shifted peak (compared to the 
higher pH values) at 2.3ppm. Finally, at a pH value of 6.4 (shown in red) the peak 
previously defined at 2.9ppm shifts slightly closer to 2.8ppm, giving a strong CEST 
signal. Also the peak around 2.3ppm remains visible but less enhanced. 
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From these observations it can be inferred that the peak resonating around 3.6ppm 
must be of very slow exchange rate (on the order of Amide exchange), as a decrease 
in pH reduces the exchange enough; therefore it is no longer within the range of 
optimum CEST (see section 2.3). As a surprise comes the peak at 2.2ppm which also 
behaves as if it was of slow exchange rate. This is due to the fact that it also decreases 
as pH decreases, but does not disappear completely. One could conclude that the 
exchange rate of the peak at 2.2ppm still lies within the lower limits of optimal 
exchange rates. It was also surprising to observe a third peak resonating around 
2.9ppm. The specific peak seems to behave more like a fast exchangeable peak. This 
is because when the pH decreases the peak is more enhanced, suggesting that 
lowering its exchange rate, places it within the optimum exchange regime for the 
CEST effect.  
The experimental findings (top image, blue outline), seem to agree with the modelled 
outcome (in orange outline, bottom image), using a five-pool model with the 
parameters listed in table 9. A five pool model was chosen based on the number of 
peaks experimentally observed. 
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Figure 54: Illustration of four Z-Spectra each corresponding to a different pH value of BSA with concentration of 
2.5%, scanned with a saturation pulse train of 0.9μT. CEST peaks differ depending on the pH value of the sample 
giving more, or less peak enhancement Top set of figures (in blue) experimental data, bottom set of figures (in 
orange) modelled data from a five-pool model. 
Pool No. Frequency 
[ppm] 
Pool size   
(ratio to 
water) 
Exchange rate 
[Hz], at pH=7 
T1 [ms] T2 [ms] 
1 (Water) 0 1 n/a 1850 37 
2 (Amide) 2.2 0.0017 22 1500 10 
2 (Amine) 2.9 0.0025 400 1500 10 
4 (Amide) 3.6 0.0017 22 1500 10 
5 (Aliphatic) -3.5 0.04 4.5 260 0.3 
 
Table 9: Summary of the parameters used per pool for the BSA phantom behaviour with different pH. Equations 
15 and 16 were used to model the exchange rate dependence on pH. 
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Figure 55: Displays boxplot analysis at the four frequency offsets discussed (2.2, 2.9, 3.6 and -3.5 ppm respectively). 
Statistical significance tests were applied for different pH values of the same frequency offsets and are given here 
in the star annotation.  
There was also some minor shifting observed between the peak of 2.2 and 2.8ppm. At 
this stage it is not clear whether the shift is real or apparent due to the different CEST 
weighting of the two peaks involved, or even an induced error due to the fitting. The 
general model (see section 2.4) assumes little or no exchange between sites other than 
with water. This is mainly due to an assumption of soluble substances with much less 
concentration than water. However BSA is a very rich and complex structure which 
does not necessary dissolve completely, leading to areas around the protein with 
potentially more protein hydrogens available for exchange than water hydrogens. 
This could therefore allow exchange between the two peaks, which if fast enough, it 
could potentially become the cause of peak shifting (as explained in section 2.3, 
factors affecting the exchange rate).  
Note that no significant differences (CL<0.68) were observed at the aliphatic peak, 
suggesting that it is not pH dependent. Similar effects were observed at all four 
concentrations. 
B1 power dependence 
Investigation of the CEST effect with different B1 saturation powers showed larger 
effect when higher B1 saturation power was applied, as figure 56 reveals.  
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Figure 56: shows a series of CEST scanning at different saturation B1 powers. Two phantoms are shown here, with 
pH values of 7.3 (blue data set) and 6.4 (red data set). Highly significant correlation for both curves (p<0.001, 
Pearson’s correlation coefficient, for two-tailed test, n=9) suggests linear relationship between saturation power 
and CEST for the range of 2.5-3ppm and at low powers. See also Appendix F.  
However careful considerations must be taken into account before deducing general 
conclusions. Although is not shown through these experiments, the theory suggests 
that there is an optimal B1 power for each exchange rate (see section 3.1.2). Therefore, 
it is expected even for the curves shown here, to reach a maximum peak and not 
continue in this linear manner indefinitely. The optimum peak depends on the 
exchange rate, therefore is likely to differ for different exchangeable sites. 
4.4.  Conclusions 
A range of experiments were conducted on a set of BSA phantoms in order to 
investigate the CEST effects under different physiological conditions and for different 
setups.  
In summary, CEST was tested for spatial reproducibility showing no significant 
differences in various positions within the RF coil. There were also significant 
differences observed when different concentrations of BSA were assessed and when 
samples were scanned at different temperatures. Additionally, unexpected behaviour 
of the Z-Spectrum profile was observed for solutions of different pH values where 
peaks seemed to reduce in amplitude or possibly shift (due to the coalescence 
principle)  
The main conclusion from this work is that when attempting to deduce quantitative 
values for different parameters from CEST experiments, one must be aware that 
equivalent CEST values can arise from different combinations of concentration, pH, 
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temperature and the applied B1 saturation power. One must also take into account 
the T1 and T2 values of the specific tissue, and how those will affect the CEST profile. 
It is therefore very important to have estimated or directly measured as many of these 
parameters as possible, in order to obtain reliable, non-confounded inferences from 
the CEST data. 
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Chapter 5. Investigation of the CEST signal in the 
spine of mice with neurodegenerative diseases 
 
This chapter describes the implementation of CEST dedicated to the mouse spine. It 
also outlines the results from the study of two neurodegenerative disease mouse 
models provided by the Graham Watts laboratories led by Prof Linda Greensmith, a 
model of Amyotrophic Lateral Sclerosis (ALS) and a model of Spinal and Bulbar 
Muscular Atrophy (SBMA). Both mice models are characterised by protein level 
changes within the spine of affected mice. The CEST technique is known to be 
sensitive to, among others, the concentration of exchangeable protons. Considering 
that proteins contain many Amide and Amine groups, CEST was chosen as the 
appropriate method for assessing the protein changes. Differences in Z-Spectra of 
healthy compared to affected mice might relate to the potential changes in protein 
concentration within the spines.  
5.1.  Experimental procedures 
This section offers a description of the experimental setup optimised for the in-vivo 
scanning of the mouse spine with the CEST sequence (see 5.1.1). In addition, a brief 
section is included on CEST data processing (section 5.1.2) with Matlab codes written 
jointly by Francisco Torrealdea (PhD student, Institute of Neurology) and myself. 
Finally there is a summary of the procedures followed in order to get quantitative 
values of protein concentrations from the spinal cords (section 5.1.3). The protein 
quantification procedures were performed by Phillip Smethurst (PhD student, 
Institute of Neurology) as part of the collaborative project: ‘The SOD1 mouse model of 
Amyotrophic Lateral Sclerosis’, see section 5.2 and also by Anna Gray (PhD student, 
Institute of Neurology) as part of the collaborative project: ‘Spinal and Bulbar Muscular 
Atrophy mouse model’, see section 5.3. 
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5.1.1. CEST sequence for the mouse spine 
The saturation part of the CEST protocol consisted of 100 Gaussian shaped pulses 
(duration 50ms and inter-pulse delay of 5ms), each at a flip angle of 540o (giving the 
equivalent of 0.9 μT of B1 mean amplitude, see table 6). The CEST acquisition was 
repeated for 77 frequency offsets linearly spaced within ±6ppm starting from -6ppm 
alternating to the corresponding positive point and finishing with zero. This range 
was judged enough to cover the aliphatic side (from about -2.5 up to -5 ppm) and also 
the positive Amines (around 1.8 to 2.2 ppm) and Amides (from 3 to 4 ppm). B0 
correction was performed by finding the minimum point of the Z-Spectrum and 
setting that to the frequency of water (zero). Additionally five frequency offsets at 
200ppm (far away from any potential MT effects) were acquired for normalisation 
purposes (Total number of frequency offsets, NF = 82).  
Due to the size of the mouse spine, a spectroscopic CEST sequence was judged to be 
the most suited for these studies. Therefore the saturation scheme was followed by a 
single voxel ‘point resolved’ spectroscopic readout (PRESS), modified version of the 
EXPRESS sequence previously reported by Walker-Samuel et al [86]. The PRESS 
readout uses three selective excitation pulses (90o applied along the slice selection 
direction and 180o pulses along the other two orthogonal directions). The signal was 
acquired at the second echo (TE2=8ms), with 100 sampling points at a spectral 
bandwidth of 1000Hz. Refer to the following diagram, figure 57 for a detailed 
description of the acquisition protocol. 
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Figure 57: is a schematic of the CEST acquisition applied in the mouse spine. All RF pulses are displayed in green 
and gradients in black. Orange colour indicates the number of saturation pulses applied with an inter-pulse delay 
(in red) of 5ms (total number of saturation pulses, NP=100). FAsat indicates the flip angle (540o) with B1 power 
equivalence of 0.9μT, as also given in table 6. TE1=TE2=8ms with signal acquired following TE2 with 100 sampling 
points and at a spectral bandwidth of 1000Hz.Total number of frequency offsets (NF=82), displayed in purple. The 
pink box following the saturation train of pulses indicates the respiration pattern check prior allowing for the 
readout.  
 
Triggering for respiration 
Spine MRI is very susceptible to motion, mainly due to breathing. Thus, prior the 
readout, respiration triggering was necessary. Figure 58 shows the typical breathing 
pattern of a mouse under anaesthesia. In orange is an illustration of the respiration 
plateau, i.e. the time within this pattern that data collection is allowed when 
respiration triggering is enabled. However conventional respiration triggering 
becomes problematic in CEST applications for two reasons.  
First, the signal must be acquired immediately after the saturation scheme to avoid 
magnetisation recovery which will lead to losses in CEST contrast. With conventional 
respiration triggering enabled and by taking into account the average breathing 
pattern of a average mouse (≈ 80 breaths/minute), there is a chance of waiting time 
from 0 up to 0.25 seconds between the saturation scheme and the readout due to the 
fact that data acquisition is only permitted during the respiration plateau (orange part 
of figure 58). This is an estimated value considering a plateau of 0.5 seconds during 
the complete breath cycle (0.75s), which leaves a time between plateaus of 0.25s. 
Additionally, if there was to be some delay between saturation and readout, it certainly 
should not be random. Thus the above scenario which offers a delay of 0-0.75s does 
not seem ideal. 
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Figure 58: schematic representation of the respiration pattern of a mouse, under anaesthesia while being scanned. 
The mouse is placed laying on its back, and Isoflurane levels are maintained at about 1.3% in a mixture of pure 
oxygen and air (20% oxygen). In orange, an illustration of what is referred to as ‘plateau’, i.e. the time in the 
breathing pattern which signal is allowed to be acquired. Typically under these conditions mice respiration remains 
at a rate of 80 breaths per minute, which means that between each plateau there could be approximately 0.25 
seconds.  
To overcome these problems and achieve respiration triggering while the delay 
between saturation and readout is always constant, and at the minimum value 
possible, the protocol had to be adjusted. This somewhat altered protocol included 
additional saturation pulses, following the main saturation scheme of 100 pulses (5.5 
seconds), which were applied one at a time if the respiration triggering condition was 
not enabled yet. Figure 59 below gives a logical diagram explaining how respiration 
triggering was achieved for the CEST experiments in the mouse spine.  
 
Figure 59: illustration of respiration triggering check. Following the main saturation scheme, a signal is sent to 
check whether it is OK to proceed to readout. If the mouse respiration is within the plateau then PRESS readout is 
applied. Otherwise, one additional saturation pulse is applied, maintaining the saturation at steady state. At the 
end of the saturation pulse, another respiration check is performed. According to the respiration pattern of the 
typical mouse discussed above, this process might take up to an additional 0.25 seconds adding to the system a 
maximum of 13 extra saturation pulses. 
The above method describing how to trigger for respiration while conducting a CEST 
experiment might raise some concerns on the effect of the additional saturation time 
added for different frequency offsets. However simulations were performed in order 
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to study the evolution of water magnetisation under different saturation times, which 
showed no effective differences between the application of 5.5 seconds (case were no 
additional saturation time would be needed other than the 100 pulses) and the 
additional 0.25 seconds of saturation (case were the maximum extra saturation time 
would be needed with 13 extra pulses). This is because following 5.5 seconds of 
saturation the signal is already close to steady state and the additional saturation will 
not have a considerable effect on the CEST contrast. Figure 60 shows the simulated 
data for two frequency offsets: at 2 and 3.5 ppm from water using a two pool model 
(pool A to be water and pool B the exchangeable site at a frequency offset given in 
ppm from water). Section 2.4.1 gives a detailed description of the theoretical model 
based on the Bloch-McConnell equations.  
 
Figure 60: displays the simulated data from two frequency offsets, using a two pool Bloch-McConnell equations 
model. Top figure: the evolution of Z magnetisation when pool B is set to 2ppm and is connected to pool A with an 
exchange rate of 2000Hz. A saturation train of pulses is applied at 2ppm (on resonance to the exchangeable pool 
B). In green is the evolution of the water signal when additional pulses are added (more than 100), to model the 
case of respiration triggering. In red is the evolution of the water signal when no additional pulses are added. 
Instead, a wait time is introduced prior the readout which corresponds to the waiting for conventional triggering; 
within that time, the magnetisation recovers with T1. Bottom figure: the evolution of Z magnetisation when pool B 
is set to 3.5ppm and is connected to pool A with an exchange rate of 30Hz. A saturation train of pulses is applied 
at 3.5ppm (on resonance to the exchangeable pool B). Green and red correspond to with and without triggering for 
spine, similar to the top figure. Other parameters used: T1a=1700ms, T2a=32ms [87], T1b=1000ms, T2b=10ms, 
Saturation scheme: Gaussian pulses (5σ as applied in the 9.4T MRI scanner) of 50ms duration and with 5ms inter-
pulse delay. Pool B at a concentration of 100mM.  
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Observe the evolution of the signal in green (both graphs above) between 5.5 and 5.75 
(5.5 plus 0.25) seconds. The change corresponds to 0.15% for the 2ppm case (from a 
signal value of 0.9546 to 0.9532) and 0.18% for the 3.5ppm case (from a signal value of 
0.9546 to 0.9532). On the contrary, if no saturation is to be used during triggering, as 
simulated and shown in red the relaxation effect dominates and reduces the CEST 
contrast. The change for the 2ppm case is 0.67% (from a signal value of 0.9546 to 
0.9609) and for the 3.5ppm case the change corresponds to 2.19% (from signal value 
0.8523 to 0.8710)  
In conclusion, when using the triggering scheme which allows the application of 
additional saturation pulses, the system remains in a state of saturation (and also 
steady state) until signal readout is considered acceptable. In addition the delay 
between the saturation train and the readout is always constant, allowing the same 
signal recovery for all the frequency offsets.  
Voxel optimisation 
Spinal cord CEST lead to another major problem: outer volume suppression (OVS) 
restriction. Due to the nature of CEST as mentioned in the previous section, the 
readout must follow as soon as saturation is applied. If one choses to apply outer 
volume suppression as well, the delay between saturation and readout would 
increase. To minimise additional delays no OVS was applied. Instead, to ensure that 
no signal was received from the ‘outer volume’, the voxel size was optimised in a 
separate experiment, to give the same signal as when compared with the same voxel 
following OVS. A voxel of 1x1x4mm3 was found to be suited in order to avoid outer 
volume contributions. 
Shimming was manually performed for all the experiments within the selected voxel 
(respiration triggering enabled), to a linewidth of 38 ±3 Hz (0.095 ± 0.008 ppm). 
Additionally, manual power calibration and frequency shift correction were 
performed within the voxel of interest. 
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5.1.2. Post-Processing of CEST data 
A minimum of three data sets were acquired per animal. In addition, when data were 
subjectively judged to be of lower quality than the average, up to three more sets were 
also acquired. This was done to further decrease artefacts due to breathing or other 
movement. Raw data were uploaded in Matlab for post-processing. The water signal 
acquired per frequency offset was fitted to a Lorentzian line shape and integration 
was done over the range ±. 0.025 ppm from the maximum water signal. The integrated 
value was used as the water MZ value for the corresponding frequency offset. 
All the repeated data acquired per mouse were averaged with weighting in order to 
minimise the effect of outliers. The weighting factor was calculated per point 
depending on its relative distance to the rest of the points. This method was decided 
after careful observation of the data sets which showed that occasionally the 
measured signal read was clearly erroneous due to some physiological movement. 
The simple illustration below (figure 61) shows four points collected at the same 
frequency offset (f). While three of the points (A, B and C) are much closer to each 
other with similar MZ values, point D (in red) is of much lower MZ value than the rest. 
Therefore point D is almost not taken into account when the weighted averaging 
method is used (the impact factor of point D is calculated to be much smaller 
compared to the rest points). Equation 26 gives the calculated Impact Factor  (IF) for 
a given point (i), by taking into account the summation of the distance of all points j 
from the point i. 
 
Figure 61: illustration of four points collected from the same frequency offset (f). It is clear how points A, B and C 
(green, blue and black respectively) are of much closer MZ values compared to point D. With the weighted averaging 
method described in this section an impact factor is assigned per point, inversely proportional to the distance 
between the points. 
𝐼𝐹(𝑖) = [∑ |𝑥𝑖 − 𝑥𝑗|𝑗 ]
𝑝
    ( 26) 
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where IF is the Impact Factor per (i) point and j corresponds to the entire set of points 
per frequency offset. P was assigned to the value of -2 after a few trials with different 
values in order to determine a factor that was giving less weighting but not complete 
elimination of the outlying points. Once the IF values were determined per data point, 
a weighted average value was calculated for all frequency offsets as given in equation 
27 below. 
𝑀𝑍(𝑓) =
∑ 𝐼𝐹𝑖(𝑓).𝑥𝑖(𝑓)𝑖
∑ 𝐼𝐹(𝑓)𝑖
    ( 27) 
where MZ corresponds to the weighted average of Z magnetisation per frequency 
offset, f when i data points were collected individually (x). 
Figure 62 shows an example case where four data sets were acquired (shown in blue, 
red, green and pink respectively). The black line shows the weighted average of the 
four data sets. The data points in circles indicate the outliers which do not represent 
the realistic trend of the Z-Spectra and therefore their IF value was calculated to be 
very low compared to the rest of the data. If conventional data averaging was used, 
the outliers would compromise the shape of the Z-Spectrum by creating false peaks 
at random frequency offsets. 
 
Figure 62: shows an example case were four data sets were acquired from the spine (Lumbar section) of a control 
mouse (shown in blue, red green and pink respectively). In black, the weighted average of the four data sets, prior 
to any additional smoothing. The circled points correspond to data acquisition during movement which results to 
instantaneous water signal change (due to changes of shimming as well as voxel mismatch). If conventional 
averaging were used, these outliers would affect the shape of the Z-spectrum by creating false peaks at different 
frequencies.  
Following weighted averaging, the Z Spectra were normalised to the point acquired 
at 200ppm and fitted to a smoothing spline function. Z-Spectra were then B0 corrected 
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and interpolated to 1001 points for further interpretation at different frequency offsets 
including the MTR values (equation 21) between 3.3 to 3.7 ppm (centred at 3.5ppm, 
were Amide peaks resonate) and between 1.8 to 2.2 ppm (centred at 2.0ppm, were 
Amine peaks resonate). 
5.1.3. Post-Mortem protein quantification 
Following MRI scans, mice were euthanized with 0.1ml of Pentorbarbitone and 
cardially perfused with 0.9% saline. Spinal cords were then extracted and dissected 
into the sections of interest (depending on the voxel positioning from the CEST scan). 
The dissected sections were snap frozen in liquid nitrogen and stored at -800C for use 
when all samples are gathered at the end of each project.   
SOD1 mouse model protocol (by Phillip Smethurst, PhD student, Institute of 
Neurology) 
Analysis of the protein levels required separation into soluble and insoluble fractions. 
As such, spinal cord segments were weighted and extracted in 1:20 (weight/volume) 
of TEN buffer18 containing 0.5% NP-4019 and 1x protease inhibitor cocktail. Samples 
are then sonicated on ice using a probe sonicator (Soniprep 150). The lysate was then 
ultracentrifuged at 100000xg for five minutes and the supernatant was kept as the 
soluble fraction. The pellet was then re-suspended in 500μl of 1x TEN buffer with 1% 
of NP-40 and 1x protease inhibitor by sonication as before, then ultracentrifuged 
again at 100000xg for five more minutes. The pellet was then resuspended in equal 
volume of water and sonicated as before. Total soluble and insoluble protein 
concentrations were determined using the Bicinchoninic acid (BCA) protein assay 
method and Bovine Serum Albumin as the standard [88]. In addition, 50 μg of protein 
was loaded to the gel for western blotting. Soluble and insoluble SOD1 protein 
fractions were estimated with the anti-SOD1 antibody and beta actin (β-actin) as the 
standard [89]. SOD1 staining was only applied to the SOD1 transgenic mice.  BCA 
results for total protein fractions are reported as mg of protein per ml of dilution (1:20) 
                                                          
18 10mM Tris, 1mM EDTA, 100mM NaCl at pH=8.0 
19 A mild detergent commonly used to break open cell membranes 
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while western blot results for SOD1 protein fractions are relative to the protein loaded 
and therefore are given in a.u. 
SBMA mouse model protocol (by Anna Gray, PhD student, Institute of 
Neurology) 
During the SBMA study the primary focus was on total soluble proteins, therefore no 
insoluble proteins were quantified and no western blotting was perform for specific 
protein staining. The protocol used for BCA assay was slightly altered as the tissue 
was extracted in 1:4 (weight/volume) in TEN buffer (instead of 1:20 as previously 
described). Results are reported in mg of protein per ml of dilution.  
It is important to understand that the results of the two mouse studies cannot be 
compared between them as they were performed at different times and following 
slightly different protocols. Nonetheless, they are suitable for comparison of the 
relative protein levels of mice within the same study.  
 
5.2.  Amyotrophic Lateral Sclerosis mouse model 
This section describes all the experiments done when studying the CEST signal in a 
genetically modified SOD1 mutant mouse model, which closely resembles the human 
form of ALS, a devastating Motor Neuron Disease (MND) with no current reliable 
biomarker. The project aimed to differentiate diseased from control animals by 
exploring the endogenous CEST signal in the spinal cord and relating the findings to 
the levels of post mortem protein. 
5.2.1. Introduction 
ALS is a neurodegenerative disease which affects the motor neurons and usually 
leads to total paralysis, including the inability to swallow or even breathe without 
machine support; typically ALS patients die from respiratory failure within two to 
ten years [90]. ALS is considered mostly sporadic (not hereditary) with a small 
fraction (5 - 10%) diagnosed as familial (fALS). To date about 5000 people are 
diagnosed with ALS in the UK alone [91, 92] at an estimated prevalence of 3:100000 
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very similar to that of Multiple Sclerosis (MS), which is widely considered to be one 
of the most common MNDs [93]. Extensive research is concentrated on finding early 
diagnostic markers for MNDs, which would enable treatment to begin earlier and 
help improve the quality of life for late disease stages.  
To this day ALS has no pre-symptomatic diagnostic tool and the processes 
responsible for the disease are not yet fully understood yet despite ongoing research 
in the field. Major advances have taken place in developing rodent models which 
resemble ALS since the discovery of various Copper/Zinc superoxide dismutase 1 
(Cu/Zn SOD1) gene mutations [94] from the fALS cases. Currently, the SOD1 model 
seems to be most established to study the ALS neuropathology because similar 
disease characteristics are observed in humans and rodents [95, 96, 97]. These include 
glial and motor neuron loss in the spine and brain, mitochondrial dysfunction and 
neuromuscular malfunction leading to limb paralysis [98, 99].  
5.2.2. The SOD1-G93A mouse model 
The SOD1-G93A mouse model used for this study, remains the most well-established 
of all the SOD1 models generated through the years. This is due to its age related 
motor phenotype which resembles the human neuropathology better than any other 
SOD1 model tested [97].  
The genetically modified SOD1 mice overexpress the human form of SOD1 protein 
and as a result, cytosolic aggregates of SOD1-rich fibril inclusions are formed and 
accumulate in the spinal cord within months of birth [100]. Specifically, reports have 
revealed the increased formation of unfolded proteins by day 50 from birth for the 
transgenic animals [101] with the majority of aggregates (such as filament proteins 
alpha-internexin and periphenin) seen in the cervical and thoracic regions of the 
spinal cord. At severe stages of the disease similar levels are seen in all spinal cord 
regions, including the lumbar and sacral regions.  
Nucleation- Polymerisation Model 
Insoluble protein concentrations from these animals can be associated with the so-
called ‘Nucleation-polymerisation model’. This model is found to apply to various 
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neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and Huntington’s 
diseases, as well as frontotemporal lobar degeneration and Amyotrophic lateral 
sclerosis [102]. It has been verified in-vitro (cell culture), and used as a guide-model 
in the further understanding of the different diseases mentioned above. Figure 63 is 
an illustration of the model, where monomers and native form proteins undergo 
conformational changes and misfoldings (Nucleation phase), which grow at a rapid 
pace to form fibrils and aggregates (Polymerisation or Elongation phase). 
 
 
Figure 63: is an illustration of the Nucleation-polymerisation model. Nucleation is the phase in which 
conformational change and protein misfolding occurs. During the polymerisation phase, the already misfolded 
proteins create fibrils which grow very rapidly to form mature fibrils and aggregates. The graph shows how protein 
aggregation changes with age: In green is a healthy aging process where aggregates form but at a low pace compared 
to the disease process (in red) which shows a much more rapid growth and at earlier stage. Figure reproduced from 
Kumar and Walter, 2011 [103]. 
Studies suggest that prior to protein aggregation the SOD1 proteins exist in soluble 
form and only form large aggregates when the disease is already at late stages [104, 
105] & [106]. Proteins in aggregated form could potentially result in less accessibility 
in some of the hydrogens for interaction with the free surrounding water. As the 
CEST technique is sensitive to exchangeable groups such as Amides and Amines, it 
was considered as a potential method to investigate the total protein changes within 
the spinal cord of mice before the formation of SOD1 aggregates which could restrict 
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the exchange between water and protein hydrogens. If successful, it could serve as a 
potential early biomarker of the disease. 
5.2.3. Methods 
Two groups of mice were used in this study, human mutate SOD1 (n=21) and healthy 
controls, also referred to as wild type (WT), as they carry the WT form of SOD1 (n=21). 
Each group was furthermore split into three subgroups (of n=7), for the purposes of 
different disease time course scanning. This was done so post-mortem protein 
quantification could be performed at different stages. Subgroup A (n=7 wt & n=7 
SOD1) was scanned at 45±1 days of age which is considered an early stage in terms 
of protein aggregation for this model and also pre-symptomatic for the disease. 
Subgroup B (n=7 wt & n=7 SOD1) was scanned at 90±1 days of age, still considered 
pre-symptomatic, just a few days before the 105 days which is reported to be the time 
when the first clinical signs occur [107]. Lastly, subgroup C (n=7 wt & n=7 SOD1) was 
scanned at 120±1 days of age which is considered to be symptomatic and near the end 
stage of the disease [108].  
Anaesthesia was initially induced with 3% Isoflurane and the mice were kept 
anaesthetised during the entire scanning procedure with 1.3% isoflurane in a mixture 
of pure oxygen and air (Additional oxygen comprises 20% of the mixture). Mice were 
placed on their back (to minimise motion artefacts) on a small cylindrical bed and 
kept anaesthetised through a mouth mask. Respiration was monitored through a 
pressure pad and kept at around 80 breaths per minute by adjusting the isoflurane 
percentage. Body temperature was maintained at 37oC through a system of hot air 
receiving feedback through a temperature probe which was placed next to the mouse. 
All procedures were conducted under an approved protocol from the Home Office. 
Mice were scanned in all three planes for voxel positioning (voxel size: 1x1x4mm3) 
and the signal within the voxel was shimmed achieving a linewidth of 38 ±3 Hz. CEST 
scans were performed with the parameters and setup described in section 5.1.1. CEST 
data were acquired from the Lumbar enlargement, located between vertebrae T11-L1. 
This region is deemed to be the most susceptible to protein aggregation in SOD1 
animals [100]. The voxel location is illustrated in figure 64 below, shown in green. 
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Figure 64: shows a localiser image of a control mouse in sagittal slice plan. Voxel location shown in green, is placed 
between T11-L1 vertebrae which is known as the Lumbar enlargement. 
All scans were performed on a horizontal 9.4T MRI scanner (Agilent Technologies) 
with a receive/transmit volume coil of internal diameter of 33mm (Rapid Biomedical). 
Following scanning, all mice were culled for post-mortem protein quantification as 
already mentioned in section 5.1.3.  
CEST data were post processed as described in section 5.1.2 and MTR percentage 
values were calculated at 3.5ppm for all mice.  
5.2.4. Results & Discussion 
This section summarises the comparison of CEST to the post-mortem protein 
concentrations of the total soluble fractions found in the Lumbar region per mouse 
group respectively (WT and SOD1 for 45, 90 and 120 days of age). The insoluble 
protein concentrations are also presented, as they offer valuable information about 
the disease and in addition may be related to the soluble protein concentrations. 
CEST versus total soluble protein levels 
The calculated MTR values at 3.5ppm show no significant differences (p>0.1) in either 
the control or SOD1 mice through the time course of the disease. Figure 65 
summarises the CEST results acquired in the Lumbar enlargement and furthermore 
reports the total soluble protein levels from the post-mortem analysis following MRI.  
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Figure 65: shows comparisons between the CEST results (boxplots in blue) and total soluble protein levels 
(boxplots in green). Control mice are shown on the top two figures while SOD1 mice are shown on the bottom 
ones. Each figure contains three boxplots: 45, 90 and 120 days of age respectively.  
The MTR percentages consistently remain around 11% for both groups. These 
findings are supported by the total soluble protein fractions which show the same 
pattern as CEST: no significant changes (p>0.1) either in control or SOD1 mice. For 
the control animals, the protein levels remained between 4 and 4.5 mg/ml throughout 
their entire lifespan. Likewise, no increase was observed either from the SOD1 
animals, although there is a trend for slightly higher protein levels (values between 
4.5 and 5 mg/ml). This difference however is not significant and is not reflected in the 
CEST data either. 
Reproducibility of Z-Spectra during in vivo experiments 
In addition to the CEST signal analysed as the MTR at 3.5ppm one might consider to 
investigate different frequency ranges such as the aliphatic frequency range (centred 
around -3.5ppm) which may give information about the aggregates/insoluble 
proteins (as investigated in the human brain [109]), or the Amine range (centred at 
2ppm), which could give information about the fast exchangeable (soluble) proteins. 
In fact, no differences were found comparing the average Z-Spectra of control and 
115 
 
SOD1 at the three different time points. As it can be seen in the following figures (66, 
67 and 68), Z-Spectra are in complete overlap within error, which suggests that the 
lack of detectable differences is not due to poor measurement accuracy. The nicely 
demarcated features in these spectra indicate the level of reproducibility of the CEST 
method, with no differentiation between SOD1 and control mice.  
 
Figure 66: shows the average Z-Spectra acquired from the Lumbar enlargement of the SOD1 (in solid red line) and 
the control (in dashed blue line) mice at 45 days of age. Note the standard error is illustrated per data set as a 
shaded region, of the same colour for each mouse group respectively. 
 
Figure 67: shows the average Z-Spectra acquired from the Lumbar enlargement of the SOD1 (in solid red line) and 
the control (in dashed blue line) mice at 90 days of age. Note the standard error is illustrated per data set as a 
shaded region, of the same colour for each mouse group respectively. 
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Figure 68: shows the average Z-Spectra acquired from the Lumbar enlargement of the SOD1 (in solid red line) and 
the control (in dashed blue line) mice at 120 days of age. Note the standard error is illustrated per data set as a 
shaded region, of the same colour for each mouse group respectively. 
 
Insoluble protein levels 
The insoluble protein fractions, formed by aggregates and fibrils, were also obtained 
by western blots as described in section 5.1.3. The insoluble part of protein is not 
detectable with the CEST technique, as it does not exist in an aqueous solution which 
would allow chemical exchange of protons. However, they were still analysed as they 
give valuable information about the disease mechanism and help toward a deeper 
understanding of the protein accumulation process throughout the disease time 
course. Figure 69 shows the total insoluble protein concentrations of the control (top 
figure) and SOD1 mice (bottom) at the different time points (45, 90 and 120 days of 
age) and figure 70 shows the SOD1 specific insoluble protein concentrations. 
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Figure 69: Total insoluble concentrations from control mice (top figure) and SOD1 mice (bottom figure). At 45 
days of age both mice groups appear to have similar levels of insoluble protein within the spine (concentration of 
2mg/ml). As the mice age, their insoluble protein concentration increases (from 2 to about 3 mg/ml). In control 
mice the increase is not significant (the variation across individual mice is too large) neither at 90 nor 120 days of 
age. However, in the case of SOD1 mice, the increase in concentration from 45 to 90 days of age is significant 
(p<0.05). Similar levels are maintained from 90 to 120 days of age for the SOD1 mice (no further increase).  
General trends in total insoluble protein concentrations indicate a slight increase from 
45 to 90 days of age. In control animals, the increase is not significant neither for 90 
nor for 120 days of age; it is only a trend (2mg/ml, slightly increasing to 2.2mg/ml at 
90 days old and reaching 2.8mg/ml at 120 days old) with high variability across 
specific mice. In SOD1 animals however, the increase in total insoluble protein levels 
is significant (p<0.05) from 45 to 90 days of age (from 2 to 3mg/ml). This is supported 
by Kieran et al [101], claiming an increased formation of unfolded proteins by day 50. 
If changes in soluble proteins were to occur prior the increase in aggregation as theory 
suggests [102], they would have occurred between 45 and 90 days of age. No further 
significant difference is observed from 90 to 120 days of age, the protein levels remain 
around 3mg/ml.  
Moreover, comparisons of the SOD1 only insoluble protein in the transgenic mice, 
show a significant difference between 90 and 120 days of age (p<0.01). No differences 
were observed between 45 and 90 days old mice. From the protein values it seems 
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that although the SOD1 insoluble protein is increased, there was no similar increase 
in the total insoluble protein levels between 90 and 120 days of age.  
 
Figure 70: SOD1 insoluble concentrations from transgenic mice reveals a significant increase (p<0.01) in 
concentration between 90 and 120 days of age (from a mean value of 0.35 to 0.78l). Similar levels are maintained 
from 45 to 90 days of age for the SOD1 mice.  
This increase in SOD1 protein leads to a further consideration of how SOD1 mice 
react, as it seems to compromise by changing the levels of other proteins in order to 
keep the total concentration at the same level. However, figure 70 suggests that (as 
previously stated for the total insoluble protein case), if soluble protein levels were to 
change prior to the formation of aggregates, it would have occurred between 90 and 
120 days of age. Whether that would also have resulted in an increase in the total 
soluble protein concentration, is unclear.  
5.2.5. Conclusions 
From the results discussed above, no significant differences were found between 
control and SOD1 mice at any of the three time points investigated with the CEST 
technique. In addition, no significant differences were observed in soluble protein 
levels either, while insoluble protein level changes where observed. This might be an 
indication that the SOD1 mouse model is not the most appropriate one for the 
validation of the CEST technique in vivo due to the very short life span of the affected 
mice, which is on average between 120 and 130 days only. As figure 69 shows, the 
increase in insoluble protein levels occurred between 45 and 90 days of age, 
suggesting the possibility of soluble protein formation within that period. Therefore, 
scanning at 45 days of age may have been earlier than the soluble protein formation 
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(if there was any) point. Similarly, at 90 days of age, the soluble proteins could have 
already formed aggregates, in which case their concentration would not be elevated 
any more. Due to the fast onset of the specific disease model, any changes in soluble 
proteins might have occurred very rapidly (within one day or two), and hence be very 
difficult to track.  
If further work is to be carried out with this animal model, a study on protein levels 
should be done with samples taken at more time points, before any further CEST data 
are collected. This should include protein quantification (both soluble and insoluble) 
of mice aged between 45 and 90 days, as differences are likely to exist (figure 69). 
Likewise, protein quantification should also be done between 90 and 120 days of age, 
as the results in figure 70 suggest an increase in SOD1 insoluble levels. These would 
lead to better justified conclusions for whether the CEST technique would be suited 
for this disease model, depending on the soluble protein levels observed. On the 
contrary, if no further work is to be carried out with the SOD1 mouse model and 
alternative ones are to be considered, they should ideally be of slower disease 
progression. If such a model allows slower rates of protein concentration changes, it 
might give more flexibility for detection with the CEST technique. 
In summary, there is no conclusive evidence from this study whether the CEST 
technique is suitable for the detection of accumulated protein within the spinal cord 
of SOD1 mice. However despite the inconclusive results already discussed, this study 
showed that for the purposes of mice spinal cord CEST, a challenging application due 
to the size of the voxels and the highly inhomogeneous environments, the CEST 
measurement was reproducible and of high stability. Furthermore, the CEST 
measurements were validated by the direct measurements of protein fractions, which 
verified no significant differences between mice and throughout the disease time-
course.  
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5.3.  Spinal and Bulbar Muscular Atrophy mouse model 
This section describes all the experiments performed when studying the CEST signal 
in an additional genetically modified mouse model, the SBMA, which exhibits the 
main characteristic features of the human form of spinal and bulbar muscular atrophy 
disease. Similar to ALS (studied previously, section 5.2), the SBMA disorder is an 
MND with no current reproducible biomarker or disease altering treatment. In 
contrast to the SOD1 mice with a disease lifespan of 130 days maximum, SBMA are 
slower to progress, with a disease lifespan of about 18 months in mice. It is known to 
be caused by polyglutamine repeat expansion in the Androgen receptor (AR 
mutations), a polymer with plenty of Amine and Amide groups detectable with the 
CEST technique. Therefore, the SBMA model was suggested as an alternative option 
for the validation of the CEST technique in-vivo as the results from the SOD1 model 
were unclear (sections 5.2.4 and 5.2.5 for discussion and conclusion of this work, 
respectively). 
This project aimed to differentiate diseased from control animals by exploring the 
endogenous CEST signal in the spinal cord and relating the findings to the levels of 
post mortem protein quantification through protein assays. In addition, volumetric 
scans were done in order to evaluate muscular loss with disease progression in the 
lower limb.  
5.3.1. The AR100 SBMA mouse model 
SBMA is a devastating hereditary, male only neurodegenerative disease, with an 
estimate prevalence of 1 in 50000 [110, 111]. During the disease onset the individual 
experiences weakness of facial, bulbar and limb muscles due to motor neuron loss 
and degeneration in the spinal cord and brain stem [112, 111]. SBMA is known to be 
caused by the uncontrolled expansion of polyglutamine tract (group specific antigen 
- GAG repeat20) in the AR gene (x-linked), and is hence an exclusively male disease 
[113].  
                                                          
20 Responsible for the coding of core protein structures. 
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Currently there is no treatment for the SBMA or any other polyglutamine - based 
disease (nine reported so far, including SBMA [114]), despite the numerous research 
studies either finished or on-going. However, many studies have shown encouraging, 
but not significantly conclusive, results in delaying the onset of the disease or 
improving the quality of life due to symptom suppression. Encouraging results were 
presented in the study by Banno et al, 2009 [115] showing improved swallowing and 
functional activities in patients, invigorated by a pre-clinical study on SBMA mice 
treated with Leuprorelin, a drug shown to reduce polyglutamine expansion and 
spinal cord inclusions, published by Katsuno et al, 2003 [116]. However, a repeat of 
the study in 2010 by Katsuno et al, did not have the same outcome with inconclusive 
results in terms of symptom suppression [117]. A clinical trial with the 5-α-reductase 
inhibitor dutasteride was also done, suggesting that preventing the conversion of 
testosterone to dihydrotestosterone (DHT) could have great benefits for the patients; 
however, the outcome out of a two year study was inconclusive [118]. More 
encouraging has been the study reported by Jochum et al 2012, which showed in an 
SBMA fly model reduction in polyglutamine oligomers by the administration of 
melatonin, [119]. More recently, a study reported by Malik et al 2013, showed 
significant improvement when Arimoclomol was used. Arimoclomol is believed to 
be promoting the re-folding of proteins and also discarding the toxic ones [111]. This 
drug has also shown to improve symptoms in patients with ALS [101, 107] and is 
currently in trials in the USA [120].  
Since the SBMA disease is hereditary, the highest demand is not in diagnostic tools; 
a gene examination can verify the disease at pre-symptomatic stages. However, the 
demand is high in non-invasive biomarkers, which would help with disease 
progression monitoring and drug test response, both for pre-clinical and clinical 
studies. The CEST technique could possibly provide information related to the 
protein levels arising from the polyglutamine expansion in the spinal cord and brain 
stem of affected individuals. 
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5.3.2. Methods 
Two groups of mice participated in the study, AR mutant mice, SBMA (n=12) and 
healthy controls (n=6). All mice were scanned at 10 months of age and repeat scans 
were performed at 12 months of age, [111]. Between 10 and 12 months, the SBMA 
mice received daily treatment: Half of the mice (n=6) were treated with Arimoclomol 
[107] and the rest of the group (n=6) were on vehicle treatment, given just saline 
instead. Arimoclomol was administrated daily via the intra-peritoneal (IP) route with 
a dose of 10mg/kg dissolved in saline. The specific two month period was chosen 
according to earlier studies by Anna Gray (PhD student, Institute of Neurology) on 
muscle tension of SBMA mice, showing how muscle force and weight decrease at 
maximum rates by 12 months of age. This implies that the 12 month time point is a 
characteristic disease stage before symptoms worsen. Following the second scan, 
mice were culled and spinal cords were extracted. Half of the mice per group were 
dedicated to protein quantifications (n=3 from controls and similarly from 
Arimoclomol treatment and saline treatment as well), section 5.1.3 . The rest of the 
mice were used for histological analysis for the purposes of a different study. No 
protein quantification was planned for the mice at 10 months as the study was 
longitudinal. However, due to the nature of the results (section 5.3.3), three control 
mice were added to the study, which were scanned at 10 months only and culled for 
protein quantification. Table 10 summarises the mice numbers per time point 
 
Control 
mice 
SBMA mice 
Arimoclomol Vehicle 
Scan age 10 12 10 12 10 12 
MRI scan 9 6* 6 6* 6 6* 
Protein 
Quantification 
3 3 --- 3 --- 3 
 
Table 10: summarises the number of mice used for the purpose of the SBMA study, both for the CEST-MRI 
scanning and also the protein quantification. Where the star sign is indicated (*), mice were scanned for the second 
time. 
The procedure for anaesthesia and mouse monitoring was identical to that for the 
SOD1 mouse study (methods section, 5.2.3). 
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All scans were performed on a horizontal 9.4T MRI scanner (Agilent Technologies) 
with a receive/transmit volume coil of internal diameter of 33mm (Rapid 
Biomedical).Mice were scanned in all three planes for voxel positioning (voxel size: 
1x1x4mm3) and the signal within the voxel was shimmed achieving a linewidth of 38 
±3 Hz. CEST scans were performed with parameters and setup as described in section 
5.1.1. CEST data were acquired from the Lumbar enlargement, located between 
vertebrae T11-L1. The voxel location is illustrated in figure 64, shown in green.  
Following spinal cord CEST acquisition mice were repositioned, this time aiming to 
scan the left calf muscle (between the ankle and the knee). Shimming was repeated 
(voxel size = 15x15x16mm3), to about 50±3 Hz linewidth. Forty images of 0.4mm 
thickness (with no slice gap) were acquired with a fast spin echo multi slice (FSEMS) 
sequence placed between the knee and ankle, perpendicular to the calf bone as shown 
in figure 71 (Matrix size = 256x256, FOV = 15x15mm2, TR=825ms, TE=25ms, NE= 
8/excitation).  
 
Figure 71: anatomical image of the mouse limb, sagittal orientation. The green box is an illustration of the shim 
voxel and the total area scanned with the FSEMS sequence for the volumetric study between the ankle (on the left) 
and the knee. The calf bone is shown in black within the green voxel. 
All procedures described, were conducted under an approved protocol from the 
Home Office.  
CEST data were post-processed as already described in section 5.1.2 and the peaks at 
2 and 3.5mm (MTR values as described in equation 21) were calculated for all mice 
groups. In addition volumes of the lower (Right) limb were calculated by Anna Gray 
(PhD student, Institute of Neurology) using the anatomical images acquired.  
5.3.3. Results & discussion 
This section summarises the comparison of CEST to the post-mortem protein 
concentrations of the total soluble fractions found in the Lumbar region per mouse 
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group respectively (control and SBMA for 10 and 12 months of age). In addition the 
volumetric results of the lower limb, are also presented. 
For the 10 month scan point, SBMA animals (n=12) are presented as the pre-treatment 
group, and later on (12 month scan point) the animals are presented in two separate 
groups depending on the treatment they received between the two months 
(Arimoclomol or vehicle respectively). 
CEST versus total soluble protein levels 
CEST analysed at 3.5ppm shows no significant differences (p>0.05) between healthy 
controls and SBMA mice, neither at 10 months of age (pre- treatment period) nor at 
12 months (following a 2 month treatment/placebo period). All CEST values remain 
between 1.1-1.3 ± 0.17 percent. Figure 72 gives the results obtained from the CEST 
peak at 3.5ppm for all mice groups. 
 
Figure 72: CEST peak value at 3.5ppm from water. The chart shows both age groups: 10 and 12 month of age for 
control (in blue) and SBMA mice each time (pre-treatment in orange, post-treatment in red and green for 
Arimoclomol and vehicle respectively). No significant differences of the CEST signal at 3.5ppm are observed 
between the groups. Mean values per group: 1.18±0.17 in healthy controls at 10 month of age. 1.16±0.42 in pre-
treatment SBMA mice, 1.28±0.35 in healthy controls at 12 month of age, 1.14±0.26 in Arimoclomol treated and 
1.07±0.08 in vehicle treated. 
In addition, CEST was analysed at the frequency of 2ppm from water. As figure 73 
describes, significant differences were observed (p<0.05) when comparing the control 
group of 10 months old with any of the other groups. The CEST analysis reveals an 
elevated signal of 0.87±0.04 percent compared to the signal observed from the rest of 
the mice which corresponded to 0.32±0.03 (pre-treated mice), 0.47±0.04 (12 month old 
controls), 0.52±0.04 (Arimoclomol treated) and 0.50±0.02 percent (vehicle treated). No 
significant differences were observed between healthy controls and SBMA affected 
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mice at 12 months of age. Also no significant differences were observed between mice 
with different treatment type (Arimoclomol or Vehicle).  
 
Figure 73: CEST peak value at 2ppm from water. The chart shows both age groups: 10 and 12 month of age for 
control (in blue) and SBMA mice each time (pre-treatment in orange, post-treatment in red and green for 
Arimoclomol and vehicle respectively), in the same way as figure 72. Significant differences (unpaired T test) were 
observed between 10 month old control mice and the rest of the groups (p<0.05). Mean values per group: 0.87±0.04 
in healthy controls at 10 month of age. 0.32±0.03 in pre-treatment SBMA mice, 0.47±0.04 in healthy controls at 
12 month of age, 0.52±0.04 in Arimoclomol treated and 0.50±0.02 in vehicle treated. No significant differences of 
mice at 12 months of age. 
The unpredicted elevated 2ppm CEST signal of the 10 month old control mice, raised 
suspicion among the research group and cross-matching to protein soluble proteins 
was considered necessary. Therefore, three additional controls (mentioned in the 
study description, section 5.2.3) where added in the protocol. These mice were only 
scanned at 10 months of age and then sacrificed for protein quantification (all results 
already include the additional mice). 
The following figures show the average Z-Spectra acquired from the mouse spinal 
cord at 10 (figure 74) and 12 (figure 75) months of age.  
 
Figure 74: Averaged Z-spectra from the Lumbar enlargement of the spinal cord of healthy controls (in blue) and 
SBMA mice pre-treatment (in red). Significant difference (p<0.05) at 2ppm is observed between healthy and SBMA 
mice, however no significant differences are observed either at the amide peak (3.5ppm) or the aliphatic peak (-2.5 
to -5 ppm). 
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Figure 75: Averaged Z-spectra from the Lumbar enlargement of the spinal cord of healthy controls (in blue) and 
SBMA mice at 12 months of age, following daily treatment over a 2 month period (Arimoclomol treatment in green, 
and vehicle treatment in red). No significant differences are observed at any frequency point between the three 
groups.  
The only significant difference is observed when comparing the Z-spectra of 10 
months age (figure 74) between 1.8 and 2.2 ppm (centred at 2ppm, peak 
corresponding to Amines). This is the same results summarised by figure 73 but, as a 
more complete data set; here it is obvious that no significant differences are observed 
when comparing any other frequency offset, including the aliphatic frequency range. 
Similarly, figure 75 shows no significant differences at any frequency offset when 
comparing the Z-Spectra of mice at 12 months of age. 
Total soluble protein levels quantified as described in section 5.1.3, are summarised 
in figure 76 for control mice at 10 month old as well as for control and treated mice at 
the 12 month scan point. No samples were taken from the SBMA mice at 10 months 
of age (pre-treatment stage) as mice were kept alive until their 12 month. Results show 
significantly (p<0.05) increased protein concentration (17.3±0.9 mg/ml) in healthy 
controls at 10 months of age compared to the protein concentrations at 12 month of 
age for all the groups: 15.3±0.03 mg/ml (healthy controls 12 months old), 
14.6±0.3mg/ml (Arimoclomol treatment) and 13.4±1.3mg/ml (vehicle treatment).  
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Figure 76: Total soluble protein concentrations in the spinal cord of mice quantified by protein assays (top figure). 
The chart shows both age groups: 10 and 12 month of age for control (in blue), post-treatment in red and green for 
Arimoclomol and vehicle respectively); same colour code as figures above. Significant differences (unpaired T test) 
were observed between 10 month old control mice and the rest of the groups (p<0.05). Mean values per group: 
17±0.9 mg/ml (healthy control of 10 month age). 15.3±0.03 mg/ml (healthy controls of 12 months age), 14.6±0.3 
mg/ml (Arimoclomol treatment, SBMA mice) and 13.4±1.3 mg/ml (vehicle treatment, SBMA mice). No significant 
differences between mice at 12 months of age. Bottom figure the relationship of CEST with soluble protein levels 
at 2ppm (in blue) and 3.5ppm (in red). Pearson’s correlation (no significance, p<0.1 for both relationships) 
assuming two-tailed test (n=7). See also Appendix F.   
The total soluble protein fractions (post mortem) in figure 76 agree with the CEST 
results at 2ppm frequency offset (in vivo) in figure 73. In a similar manner, the CEST 
signal and the soluble proteins correspond to high values at 10 months of age for the 
control group, which seem to decrease two months later (month 12 of the same control 
group). This is quite an unforeseen result as one would expect no significant 
differences in control mice between the age of 10 and 12 months. Indeed changes do 
occur during normal aging and degeneration processes cause protein levels to 
decrease within the spinal cord of otherwise healthy individuals [121, 122] , but mice 
at 10 or 12 months old are not considered to have different physiology. A typical 
laboratory mouse has a life span of about 2-3 years [123], thus between 10 and 12 
months of age mice are considered young adults. While stating that, no reference 
could be found on the expected protein levels of healthy mice at these two age points. 
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Additionally, no significant differences were found with the CEST technique between 
mice groups at 12 months of age, verified by protein assays supporting no significant 
differences in protein concentrations between the same groups. Finally regarding the 
treatment, no significant changes were observed between Arimoclomol and vehicle 
treated mice (p>0.05) neither with the CEST technique nor through protein assays.  
Lower limb volume with disease onset 
The following results were analysed by Anna Gray (PhD student, Institute of 
Neurology) and data were collected by myself and Francisco Torrealdea (PhD 
student, Institute of Neurology) during the SBMA spinal cord study. These data were 
considered as an additional way of controlling for the treatment period. Figure 77 
summarises the calculated volumes obtained by the muscle structural imaging. 
Volume calculations were done by manually drawing regions of interest around the 
muscle (excluding bones) and summing the areas for all slices between the knee and 
the ankle of the mouse limb.  
 
Figure 77: Volume of lower limb muscle measured form the left leg of mice (between the ankle and knee). The chart 
shows both age groups: 10 and 12 month of age for control (in blue), post-treatment in red and green for 
Arimoclomol and vehicle respectively); same colour code as figures above. Significant differences were observed 
between healthy controls and SBMA mice per age groups (p<0.001). Mean values per group: 331.39±13.78 mm3 
(healthy control of 10 month age), 184.16±13.61mm3 (SBMA pre-treated, 10 months old), 332.6±23.66mm3 
(healthy controls of 12 months age), 204.53±44.57mm3 (Arimoclomol treatment, SBMA mice) and 
184.54±28.88mm3 (vehicle treatment, SBMA mice). No significant differences were observed in muscle volumes 
between healthy controls at 10 and 12 months of age.  
No significant differences (p>0.05) were observed between healthy controls of 10 and 
12 months of age, while highly significant differences were noted between healthy 
controls and SBMA mice at the same ages (p<0.001). As for CEST and protein 
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concentrations regarding the treatment, no significant changes were observed in 
muscle volumes between Arimoclomol and vehicle treated mice (p>0.05).  
5.3.4. Conclusions 
CEST measurements at 2ppm (Amine range) were found to agree with protein 
concentrations within the spinal cord of mice. The amine range is usually associated 
with smaller proteins and amino acids which allow a faster transfer rate with water. 
No differences were found in the Amide range (3.5ppm) or the aliphatic range 
(centred at -3.5ppm), which could be an indication of no changes in long chained 
proteins (slower exchange rates). 
In addition, all means of measures (including CEST, protein assays and volumetric 
analysis) revealed no significant changes between treated (Arimoclomol) and non-
treated (vehicle) mice, suggesting that either the drug, the dose or length of treatment 
was not the optimum. 
Despite the unexplained differences between healthy controls at the two scan points, 
it is very encouraging to observe the trend between the 2ppm CEST measurements 
and the post-mortem protein fractions. To our knowledge, this is the only study 
performed in the spinal cord of mice relating CEST to the soluble protein levels.  
5.4.  General Chapter Conclusions 
Chapter 5, includes a description on the implementation of spine CEST of in-vivo 
disease assessment in mice. The mouse spinal cord is a challenging region to scan, 
due to the highly inhomogeneous fields, physiological movement and small size. 
Thus reproducible results from the spine are already considered as a significant 
achievement.  
This chapter also includes two studies, a fast disease onset mouse model of ALS, 
prone to the accumulation of SOD1 proteins in the spinal cord and also a slow disease 
onset mouse model of SBMA, prone to the accumulation of polyglutamine expansions 
in the spinal cord and brain stem. Both diseases are characterised by the accumulation 
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of protein in the process of aggregate fibril formation, thus were thought to be good 
candidates for validating the CEST technique. 
The SOD1 study gave inconclusive results regarding the detection of differences 
between healthy controls and SOD1 affected mice with the CEST technique. 
Nevertheless the results were not discouraging due to the fact that protein assays 
match the CEST results by also giving no differences between groups. 
The SBMA study was conducted following the inconclusive results of the first study, 
with the aim of shedding some light on whether the CEST technique is appropriate 
as a biomarker in neurodegenerative diseases. The results revealed that, despite the 
absence of significant differences between different treatments of SBMA affected 
mice, differences were observed with the CEST technique between healthy controls 
and sick mice at the pre-symptomatic stage (10 months of age). These findings were 
also supported by protein assays, revealing a linear trend between the CEST signal 
and the soluble protein concentrations for the two mice groups.  
In summary, this chapter demonstrates encouraging results demonstrating that it 
may be possible to associate protein concentrations in the spinal cord to CEST 
measurements. To our knowledge this is the first time CEST signal was correlated 
with quantified protein concentrations within the spinal cord. Reliable and 
reproducible non-invasive biomarkers in neurodegenerative diseases are still in high 
demand and a method such as CEST could possibly help in monitoring disease 
progression and drug testing in the future. 
  
131 
 
  
132 
 
Chapter 6. Brain pH mapping 
 
This chapter is focused on the implementation of CEST as a measure of pH in the 
piglet brain in a model of Hypoxic Ischemic Encephalopathy (HIE). Following HI, the 
brain undergoes dramatic metabolic disturbances leading to alterations in tissue pH.  
Change of tissue pH is a good early biomarker of the severity of the condition; 
therefore it is important to develop techniques that track brain pH changes. [124, 125]. 
31P NMR allows quantitative pH measurements, however the technique only 
provides at best limited spatial information [126, 127] and in addition multinuclear 
capabilities are not widely available in the clinic due to the added costs incurred, 
therefore 31P measurements are not as widely possible as 1H ones. To achieve the aims 
of higher spatial resolution and more general applicability, CEST was considered as 
a potential alternative technique. The sensitivity of CEST to pH has been reported in 
various papers as discussed in section 1.1 and has also been demonstrated in the 
phantom chapter (section 4.3). Thus this project aims at developing a method for non-
invasive mapping of regional pH in the neonatal piglet brain undergoing HI using 
CEST-MRI. 
6.1.  Introduction  
HIE in the newborn infant is associated with high mortality and morbidity rates 
worldwide with a prevalence of 4 in 1000 neonates suffering asphyxiation before or 
at birth resulting in neonatal encephalopathy  (NE). NE has a survival rate of 40% of 
which at least 25% suffer long term neurodevelopmental sequelae such as cerebral 
palsy21 or other severe disabilities (including deafness, blindness, epilepsy, global 
developmental delay, autism, as well as cognition, memory and fine motor skill 
problems), [128, 129, 130] & [131]. A well-established piglet model of HIE has 
recurrently been used over the past 20 years [132, 133, 130] & [129] for the study of 
NE. Newborn piglets are similar to neonates regarding the brain size, vasculature and 
                                                          
21 A motor condition which causes physical disabilities in human development. 
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maturity levels [126, 129]. Due to these similarities, all other life monitoring 
equipment used (apart from the MRI scanners) for piglet experiments are identical to 
hospital equipment, resulting in direct clinical translation of new treatments to 
neonates.  
Currently mild hypothermia22 is the most frequent, and effective-proven treatment in 
neonates suffering NE [128]. However, the neuroprotective success rate with this 
method is 2 in 7 babies [134], suggesting the need for additional treatments to produce 
a synergistic effect along with hypothermia treatment. As crucial as the development 
of a new treatment is, advanced monitoring methods are also of great need in order 
to assess treatment effectiveness in animal models and eventually in the clinic.  
Among the different biomarkers investigated for assessing HIE is tissue pH. It is 
known that metabolic acidosis is observed during prolonged asphyxia. Studies in 
rodents suggest that alterations in pH continue to occur even days after HIE, 
indicating overall alkalosis or further acidosis in the brain [135, 136]. However the 
detection of regional pH changes is currently either time consuming, with limited 
spatial resolution [137, 126] or requires invasive technology [138].It is therefore of 
great importance to develop non-invasive pH mapping techniques offering higher 
resolution within a reasonable acquisition time. Toward this goal, CEST is 
investigated as a potential neuroimaging technique to better understand ischemic 
tissue by looking into the signal changes due to pH alteration.  
6.2.  Experimental procedures 
Newborn male piglets (n=16), aged <24h, were surgically prepared and placed in the 
MRI scanner (9.4T Agilent Technologies, bore diameter 305mm). Surgical preparation 
is briefly described in section 6.2.1 (animal preparation); a more extensive description 
of the surgical procedure can be found in Lorek et al 1994, [132]. HI was induced by 
occlusion of both common carotid arteries (ischemia)23 and reduction of inspired 
oxygen fraction to 6% (hypoxia). 31P MRS was acquired at baseline (10 minutes), 
                                                          
22 Gradual reduction of the body core temperature to 33.5oC for a period of about 72 hours. 
23 Partial ischemia due to the physiology of the piglet brain as the middle cerebral artery is not 
occluded  
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during HI and for 1 hour afterwards with 1 minute time resolution using an elliptical 
31P-tuned surface coil (6.5x 5.5cm). Description of the 31P protocol is found in section 
6.2.3. During HI the inspired oxygen fraction was titrated in order to maintain the 
height of the nucleotide-triphosphate (NTP) signal on the 31P MRS between 30% and 
40% of the baseline value for 12.5 minutes [131]. CEST scans were acquired at baseline 
(before HI), 1 hour after initiation of HI and (for piglets that survived) at 24h post HIE 
[61] with a volume transmit coil of internal diameter 150mm and an elliptical surface 
transmit/receive coil with dimentions 6.5cmx5.5cm (Rapid Biomedical); the CEST 
protocol is described in section 6.2.2. In addition, blood samples were taken at all scan 
points, which were used for physiological monitoring and to obtain measurements 
such as blood pH, glucose and lactate levels. All animal experiments were performed 
under an approved UK Home office protocol.  
6.2.1. Animal preparation 
Animal surgery and monitoring was performed by the preclinical neonatal 
neuroprotection research group, led by Prof Nicola Robertson (Institute for Women’s 
Health): Dr Kevin Broad (post doctoral research fellow), Dr Go Kawano 
(neonatologist), Dr Mojgan Ezzati (neonatologist), Dr Igor Fierens (intensivist), Dr 
Jamshid Rostami (surgeon) and Dr Daniel Alonso Alconada (research associate).  
Initial sedation was achieved by intramuscular midazolam (0.2mg/kg) and 4% v/v 
isoflurane given through a face mask for tracheostomy and intubation. Piglets were 
ventilated to maintain partial oxygen pressure (PaO2) at 8-13kPa and carbon dioxide 
(PaCO2) at 4.5-6.5kPa. A venous catheter (umbilical) was placed for fluid infusion 
(10% dextrose, 60/ml/kg/day), fentanyl (3-6μg/kg/h) and antibiotics (benzylpenicillin 
50mg/kg and gentamicin 2.5mg/kg, both every 12 hours). Heart rate and blood 
pressure were monitored by an arterial catheter (umblilical); arterial blood pressure 
was maintained higher than 40mm Hg with infusions of inotropes and colloid 
(Gelofusin, B Braun Medical Ltd). Animals also received arterial infusion of 0.9% 
saline solution (1ml/hour). 
Both common carotid arteries were isolated (at the same level as vertebra C4-fourth 
Cervical) and remotely controlled vascular occludes (OC2A, in-vivo Metric) were 
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placed around them. During the surgical procedure isoflurane was maintained at 3% 
and for the rest of the experiment at 2%. Body temperature was monitored with a 
rectal temperature probe and maintained at 38.5oC with a hot water blanket system 
(SAII instruments). All animals were continuously monitored and received intensive 
care throughout the experiments. 
6.2.2. CEST protocol 
The CEST protocol was optimised and tested by Francisco Torrealdea (PhD student, 
Institute of Neurology) and myself. CEST data were acquired by Dr Alan Bainbridge 
(Clinical scientist, UCLH), Dr David Price (Clinical scientist, UCLH), Miss Magdalena 
Sokolska (PhD student, Institute of Neurology) and myself. 
The CEST acquisition used during the HIE experiments consisted of 80 Gaussian 
shaped saturation pulses. Each pulse was applied for 50ms (with 5ms inter-pulse 
delay) with a FA=540o, equivalent to 0.9μT mean amplitude. Saturation was followed 
by a GE readout with TE=2ms (minimum allowed by the 305mm gradient set) and 
TRRO= 4.1ms (section 4.2.2.1). Phase encoding during readout was chosen to be of 
centric order (section 3.1.3), matrix size 128x128 with FOV = 80x80mm2, 
thickness=4mm (number of slices= 3). Prior to the readout, no inter-pulse delay was 
added in order to maximise the CEST contrast achieved. The CEST sequence was 
repeated for 77 frequency offsets ranging between ±6.08 ppm centred at water with 
steps of 0.16 ppm (64 Hz at 9.4T). Frequencies were alternated from positive to 
negative to compensate for any potential B0 field drifts, starting from the furthest 
positive point (+6.08ppm) and continuing all the way to 0 ppm. Total TR per 
frequency (TRtot) was 4441ms. Figure 34 shows a schematic of the CEST sequence 
used. In addition reference images were acquired (at frequency 200ppm from water) 
with the same FOV for registration and normalisation purposes. Shimming was 
performed on a voxel covering the FOV within the brain achieving a linewidth of 
<20Hz for all the experiments. 
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CEST slice positioning 
As the experimental procedure was designed to collect both CEST data and 31P 
spectra, it was necessary to switch RF coils for each part of the experiments. In 
addition, at the end of the first day the piglet was taken back to the lab for overnight 
monitoring and returned the next day for further scanning. Thus, there was potential 
for the animal to have considerable positional shifts between scan points, and 
registration was mandatory prior to CEST processing. In addition, a single CEST slice 
required 5.7 minutes and as a consequence a limited number of slices were acquired 
per scan (three in total). Therefore it was crucial for the animals to be repositioned as 
accurately as possible for all scans, in a reliable and reproducible way.  
Positioning scans were acquired in all planes. In the coronal plane, the CEST FOV was 
placed with an angle such that it was perpendicular to the midline of the brain 
(midline of the brain is indicated with light blue in figure 78). In the sagittal plane, the 
central slice was chosen (i.e.: the slice in which the spinal cord appears thickest) and 
the FOV was placed precisely in the middle of the brain in order to include the basal 
ganglia and the cortical area within the three slices [139].  
Figure 78 illustrates the FOV in all three planes (coronal, sagittal and axial in a, b and 
c respectively).  
 
Figure 78: Illustration of the FOV used (shown in orange) for the piglet CEST experiments FOV is shown in all 
three planes: coronal (a), sagittal (b) and axial (c).  
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CEST data processing 
CEST data were imported into Matlab for post processing and images were sorted 
according to the frequency offset from -6 to + 6 ppm. The three slices acquired per 
time-point (baseline, 1 hour and 24 hours after HI) were used for registration 
purposes; only the slice corresponding to the middle of the brain was used for further 
analysis. Time-points of 1 and 24 hours post HIE were registered to the baseline 
images. Registration was performed manually by selecting at least six similar points 
per image applying a global transformation to all the pixels (translation and rotation 
of the images, with no distortion correction). Assuming stability of the piglet 
throughout the CEST acquisition, the same transformation was applied for the entire 
Z-Spectrum. 
Pixel by pixel fitting (smoothing spline function) was performed along the frequency 
offset dimension, following registration. Data were further interpolated to 1001 points 
(increase of the Z-Spectra resolution from 0.16 to 0.012 ppm) and normalised to the 
reference images (200ppm). 
CEST of Amide groups (APT) has been reported as pH dependent via the exchange 
rate through a base-catalysed relationship (equation 15 and Section 2.3), [9]. The 
APTasym (MTRasym at 3.5ppm, as described in section 3.2, equation 22), is more 
often used for pH-weighted images. However, this method is highly weighted by the 
negative side (aliphatic range) of the Z-Spectrum and although not sensitive to pH, it 
can vary with concentration and different folding states of the proteins [82, 140]. In 
addition the inherent signal mainly of the aliphatic range is of much higher value than 
the APT signal change due to pH, making the visual presentation not as clear as it 
could be. Figure 79 shows the same data set (case a from group A, section 6.3) 
analysed at 3.5ppm looking at the height of the peak (APT*, top set of images) 
compared to the APTasym (bottom set of images).  
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Figure 79: Illustrative data set analysed with the APT* method (top pair of images) and with the APTasym method 
(bottom pair). Units are arbitrary, corresponding to the height of the peak and value of the Z-Spectrum asymmetry 
respectively. From the two pairs it is clear that the APT* method is not contaminated by the anatomical features of 
the brain.   
Therefore for the investigation of pH, CEST data were analysed by measuring the 
height of the Amide peak (APT*) at 3.5ppm (described in section 3.2). Figure 80 shows 
the behaviour of Amide peak under HIE in the cortical region of piglet bran, 
indicating reduction of the peak.  
 
Figure 80: Demonstrative data from cortical region ROI of a piglet undergoing HIE (pHi =5.7 post HIE). In blue 
the baseline (pre-insult) and in red 1hour post HIE. This figure illustrates how the amide peak (in circle) 
‘disappears’ following HIE. This behaviour is compatible with exchange rate reduction due to pH decrease (equation 
15). 
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6.2.3. 31P MRS protocol 
31P MRS protocol was optimised and tested by Dr Alan Bainbridge (Clinical scientist, 
UCLH), [141]. Spectra were acquired by Dr Alan Bainbridge (Clinical scientist, 
UCLH), Dr David Price (Clinical scientist, UCLH) and Miss Magdalena Sokolska 
(PhD student, Institute of Neurology).  
The 31P MRS data were acquired with an elliptical transmit/receive surface RF coil 
(diameter 10cm) with a single pulse acquisition (hard pulse). TR = 10s, six repetitions 
(NR), giving a temporal resolution of 1 minute per acquisition. No voxel selection was 
used; the signal was acquired from the sensitive volume of the RF coil (see section 
6.2.4). Shimming was done globally with the 1H surface RF coil used during the CEST 
acquisition (section 6.2.2), achieving a linewidth of <20Hz. 
31P MRS data processing 
31P MRS data were analysed by Dr Alan Bainbridge and myself [141] using Advanced 
Method for Accurate, Robust and Efficient Spectral fitting (AMARES) and prior 
knowledge data as described by Vanhamme et al 1997, [142] as implemented in the 
jMRUI software [143].  
The NTP multiplet structure was fitted according to prior knowledge data; α- and γ-
NTP were fitted to doublets and β-NTP to a triplet. NTP consists of 70% of Adenosine 
triphosphate  (ATP) as reported by Mandel & Edel-Harth in 1966, [144]; thus the NTP 
changes mainly reflect changes in ATP, [141, 145]. Inorganic Phosphate (Pi) was fitted 
with four separate components and Phosphocreatine (PCr) with a single component.  
Intracellular pH (pHi) was quantified using the Henderson-Hasselbalch equation 
[124], given below (equation 28).  
𝑝𝐻𝑖 = 6.67 + 𝑙𝑜𝑔10 (
𝛿−3.29
5.68−𝛿
)    ( 28) 
where δ is the chemical shift between Pi and PCr peaks, as also shown in figure 81. Pi 
peak was calculated as the weighted average (peak shift multiplied by the square of 
the amplitude) chemical shift of all four Pi peaks such as shown in equation 29 below.  
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𝑃𝑖 =
∑ 𝑓𝑗.𝐴𝑗
2
𝑗
∑ 𝐴𝑗
2
𝑗
     ( 29) 
where fj is the chemical shift and Ai the corresponding amplitude for each peak [141, 
126].  
 
Figure 81: Expanded 31P MRS spectrum of the piglet brain (baseline acquisition), illustrating the peaks and the Pi-
PCr shift (δ) from which the pHi is quantified. Note that ATP changes mainly reflect to NTP changes as explained 
above. 
 
6.2.4. Comparison of CEST data to 31P MRS 
A phantom with pure Orthophosphoric acid (H3PO4) was scanned in order to identify 
the sensitive volume of the phosphorous RF coil. The phantom was of similar size 
and loading 24to the piglet head for a better approximation of the source signal of 31P 
MRS data. 
A 3D-gradient echo sequence was used with TR=10s and TE=1.5ms (set to the 
minimum possible). FOV was 100x100x100mm3 and matrix size 64x32x32, giving a 
spatial resolution of 1.56x3.125x3.125mm3. 
Figure 82 demonstrates the phosphorus signal in three planes (xz, yz and xy). The 
sensitive volume of the phosphorous coil was found to cover only the top cortical area 
of the brain (as shown in figure 83) with 85% of the signal calculated to reach 
penetration depth of 31.25mm (from pixel 10-30 in planes X-Z and Y-Z). 
                                                          
24 Loading was achieved by adding salt to the solution and comparing with a piglet brain 
loading profile using a network analyser (Agilent technologies) 
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Figure 82: demonstration of the phosphorous signal origin in three planes (xz, yz and xy). The signal intensity 
graphs are colour coded; graph on the left (in blue) corresponds to the signal intensity in the Z direction and graph 
on the right (in pink) corresponds to the signal intensity in the xy plane, as illustrated in the images.  
The CEST signal was therefore averaged in this area, in order to best match the source 
tissue of the two pH measurements, as demonstrated in figure 83.  
 
Figure 83: Axial image of the piglet brain showing the area in which the CEST signal was averaged (in orange). 
Despite the APT* reflecting the exchange rate changes due to pH alteration, it is not 
a direct quantitative measurement. To further understand the APT* measurement 
when only pH is changed (according to equation 15), data were simulated using a 
four pool model derived from the Bloch-McConnell equations (section 2.4). The 
simulation was repeated three times for different T1 values (1480, 1850 and 2200ms) 
to investigate the APT* value change. The rest of the parameters used were kept the 
same and are summarised in table 11 below. 
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Pool No. Frequency 
[ppm] 
Pool size   
(ratio to 
water) 
T1 [ms] T2 [ms] 
1 (Water) 0 1 1480, 1850, 2220 37 
2 (Amine) 2 0.0025 1500 10 
3 (Amide) 3.5 0.0017 1500 10 
4 
(Aliphatic) 
-3.5 0.04 260 0.3 
 
Table 11: Summary of the parameters used per pool for modelling the piglet brain. 
 
6.2.5. Comparison of CEST data to 1H MRS 
1H MRS protocol was optimised and tested by Dr Alan Bainbridge (Clinical scientist, 
UCLH). Spectra were acquired by Dr Alan Bainbridge (Clinical scientist, UCLH), Dr 
David Price (Clinical scientist, UCLH) and Miss Magdalena Sokolska (PhD student, 
Institute of Neurology), part of the HIE experiment. 1H MRS were acquired 48 hours 
post-HIE on the surviving piglets. All the analysis was done by Dr Alan Bainbridge 
and ratios of Lactate/N-acetylaspartate (NAA) are used here for comparison to APT*.  
The protocol is described by De Vita et al 2005 [146]. Briefly, 1H MRS data were 
acquired with a LASER (Localisation by adiabatic selective refocusing) sequence [147, 
148], with VAPOR water suppression [149]. TR=5000ms, TE= 288ms and spectral 
bandwidth of 4006 Hz. Two voxels were acquired as illustrated in figure 84, in the 
cortical region (green) and thalamic region (blue). Comparison data for the available 
piglets are demonstrated in the results section. 
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Figure 84: Axial image of the piglet brain showing the two voxels used for 1H MRS. Cortical region (in green) and 
thalamic region (in blue). 
 
6.2.6. Piglet categorisation 
Piglets were categorised in two groups depending on the outcome of the insult 
characterized by the summation of the β-NTP peaks (three β-NTP peaks in total). 
Piglets in which the β-NTP peak height failed to recover to at least 75% of its baseline 
were considered as not fully recovered and placed in group A, while the rest cases were 
classified as fully recovered and placed in group B. The percentages were calculated by 
averaging the β-NTP amplitude value at baseline (10 spectra in total), comparing 
them to the average amplitude value of the last 10 spectra at 1 hour post HI. Figure 
85 shows examples of a fully recovered HIE piglet case (left graph) and a not fully 
recovered HIE piglet case (right graph).  
 
Figure 85: the β-NTP evolution in time for two piglets. On the left (in blue) the β-NTP peak recovers to 94% of 
the baseline; the piglet’ HI is considered fully recovered (group A). On the right (in red) the β-NTP peak recovers 
to 61% of the baseline; the piglet’ HI is considered not fully recovered (group B) in this case. 10 spectra were 
acquired at baseline (10 minutes in total). Time zero corresponds to the start of the insult. Once the β-NTP peak 
reached 40% of the baseline, it was maintained for 12.5 minutes (12 spectra acquired during this period). The rest 
of the time-points correspond to 1 hour of scanning during the recovery period (60 spectra). 
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6.3.  Results & Discussion  
Out of sixteen piglets that were part of this study, seven were classified as as group 
A cases (shown in figure 86) and the rest as group B cases (shown in figure 87), 
characterised as described in section Error! Reference source not found.. Figures 86 
and 87, show the value of the APT peak height (APT* at 3.5ppm) from the three scan-
points (baseline, 1 hour post-HIE and for the piglets that survived 24 hours post-HIE). 
Throughout the experiments, APT* values ranged from 0 to 0.04 [arbitrary units (a.u.) 
of the peak height] with 0.04 giving the most defined peak and 0 giving no peak 
(similar to figure 80).  
Cases are compared to Arterial blood gas levels of lactate, glucose, and pH values. 
Lactate provides additional proof of poor tissue oxygenation and possible cell 
damage [150]. Similar to lactate, serum pH levels also provides information on 
acidosis; if serum pH values are lower than 7.35 and are combined with high lactate 
levels, hypoxia is assumed [151, 152].  
Group A HIE cases 
A clear reduction in the APT signal is observed following HI in six out of the seven 
cases of group A. Although the piglets suffered global HI, it is clear from figure 86 
that the APT signal patterns in the brain are localised. Specifically, cases a-e show 
signal drop in the cortical area (from mean baseline value 0.018±0.002 reduced to 
0.011±0.005), on data acquired 1 hour post-HI. The cortical area is known to be 
extremely sensitive to ischemia; 5 minutes of oxygen and blood restriction is enough 
to damage pyramidal neurons within the cortex, leading to apoptosis [153], chapter 
2]. Cases f & g show decrease of the APT signal across the entire brain 1 hour post-
HI. The two animals did not survive for the 24 hour post-HI scan, suggesting they 
suffered more protracted HI compared to the rest of the cases. More severe HI results 
in damage of the neurons in the thalamic area, brainstem, and eventually the entire 
brain [153], chapter 2 & [154], leading to a complete and irreversible brain function 
loss [155]. Arterial blood measurements of Lactate levels also confirm the greater 
severity in these two animals with higher concentrations than normally expected 
(11.73 and 12.07 mM respectively); the mean value of Lactate across all animals at 1 
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hour post-HI was measured to be 4.36±1.24mM. Figure 88 (top figure) outlines the 
mean values of Lactate levels.  
It is also worth noting that the baseline APT images were generally flat compared to 
the post-HI images (mean APT* value = 0.018±0.002), suggesting no changes in the 
APT peak across the brain before HI. However, the baseline APT image of case g 
shows unexpected contrast between the left and right hemispheres: left hemisphere 
gives a mean APT* value of 0.012 while the right hemisphere 0.028. The elevated 
blood lactate levels (7.7mM when 2.87±1.41mM mean Lactate concentration at 
baseline) of this specific piglet leads to the conclusion of the potential presence of 
brain damage prior the induction of HIE (either during the surgical operation, or even 
during birth). Such damage might be able to explain the left-right difference in APT* 
shown in this piglet. 
Group B HIE cases 
Animals considered as fully recovered (group B) are summarised in figure 87. 
Similarly to cases of group A, APT* measured 1 hour post-HIE is decreased compare 
to the baseline. Particularly in cases b, c, d & f, the APT* signal is decreased in the 
cortical area (as seen in cases a-e in group A). Furthermore, blood lactate levels 
measured 1.5 hour post-HIE in these four cases indicate levels higher than the average 
(5.99, 6.74, 6.47 & 5.02 mM respectively), with levels similar to group A exhibiting 
analogous APT* images. This might suggest that while the piglets recovered in terms 
of the NTP peak 1 hour after HIE, the APT technique can provide contrast which 
might be related to the irreversible cell damage caused during insult [156]. On the 
contrary, APT* images corresponding to animals g, h & i show on average flat 
response, with no signal decrease 1 hour post ischemia. The very low lactate values 
corresponding to the three cases (1.76, 2.05 & 1.75 mM respectively), might relate to a 
lesser brain injury due to HI. 
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Figure 86: GROUP A: Summary of all HIE cases (a - g) characterised as ‘not fully recovered. Images correspond 
to the APT* value (height at 3.5ppm) for the baseline, 1 hour and 24 hours post-HIE. The APT* scale ranges 
between 0-0.04 units of height of the Z-Spectra analysed per pixel. Where no image is shown, experiment was 
terminated due to the animal’s death. Cases a-e present APT* maps of reduced signal compared to the baselines, 
localised in the cortical area. Cases f & g show APT* maps less localised but with reduced signal in the entire brain 
compared to the baseline scans. Animals of cases f & g did not survive for the 24h post-HIE.  
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Figure 87: GROUP B: Summary of all HIE cases (a - i) characterised as ‘fully recovered’. Images correspond to the 
APT* value (peak height at 3.5ppm) for the baseline, 1 hour and 24 hours post-HIE. The APT* scale ranges between 
0-0.04 units of height of the Z-Spectra analysed per pixel. Two main subcategories can be distinguished by visual 
observation of the APT* maps: cases a-f where APT* signal reduces in post-HIE scans compared to the baseline 
and cases g-i where the APT* maps show much less APT* signal reduction (flat response compared to the baseline). 
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Figure 88: Shows the evolution of Lactate, pH and Glucose levels during the experiments. Blood samples were taken 
for analysis at baseline, during HIE, straight after, 1 hour and 24 hours post-HIE. Lactate (in blue) shows 
significant increase during and straight after insult (p<0.001) compared to the baseline values and post-HIE. Blood 
pH values (in orange) remain at similar levels (7.43) apart from the time straight after HIE, were the mean value 
dropped to 7.33 (p<0.05 compared to baseline values). Lastly, Glucose levels (in green), were elevated during and 
remained elevated after HIE (p<0.01). At 24 hours post insult animals varied in glucose levels with the majority 
maintaining values around 10mM but in three cases the glucose levels were found to reach more than 25mM (and 
up to 35mM). Data per piglet are included In Appendix E. 
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Factors affecting the APT signal 
At least half of the piglets characterised as fully recovered, display similar patterns to 
the ones of group A (not fully recovered), emphasising the fact that encephalopathy 
episodes cannot be categorised only according on the NTP recovery at 1 hour post 
HI. Identifying the origins of the APT signal will furthermore help in understanding 
the physiological changes occurring after HI. As already discussed in section 2.3 
(‘factors affecting the CEST signal’), and reported by various papers [74, 30, 45], the 
sensitivity of CEST signal to a range of factors adds a level of complexity in any 
attempt for pH quantification; such factors are discussed in this section. 
Temperature dependence  
It is known that during vessel occlusion the brain temperature drops; studies report 
up to 5oC of temperature difference compared to the core body temperature which is 
maintained at normothermia25 [157, 158, 159]. This would have been an issue if CEST 
data were acquired during HIE. However CEST data were acquired 1 hour post-HI, 
at which time brain temperature is expected to be restored to normal levels [159]. In 
addition, studies have shown that the deep brain temperature correlates with the core 
body temperature when perfusion is restored (i.e. not during HI) in both animal 
models [160, 161, 162, 163] and neurosurgical patients [164, 165]. Since the animals 
were kept at 38.5oC (body core temperature) during the experiments, it is assumed 
that deep brain temperature is maintained at 38.5oC for the CEST data collection 
(baseline, 1 hour and 24 hours post HI).  
Perfusion changes 
For the duration of HI and for some time after, perfusion in the brain is highly 
disturbed. This is of course due to the actual vessel occlusion but also due to the 
recovery process the brain experiences afterward [166, 167]. Immediately following 
HI, perfusion increases up to 150% of the baseline value [166, 168] followed by a 
reduction to 80% of the baseline around 50 minutes post-HIE. Hypoperfusion 
duration is related to the severity of the insult [169], but can last for several hours 
                                                          
25 Normal body temperature 
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post-HI, with similar levels of hypoperfusion in grey and white matter [170]. While 
the absolute APT values may vary from animal to animal due to different 
hypoperfusion levels, this will not contribute to the regional contrast of APT images 
as perfusion is estimated to be at similar level across the brain.  
Metabolite concentration 
One of the main characteristics of the CEST signal is its dependence on the 
concentration of the substrates containing exchangeable protons, as reported by Wolff 
and Balaban in 1990 [1], and followed by numerous subsequent studies [30, 45, 74]. 
The relationship of concentration to CEST is explained in section 2.3 and also part of 
Chapter 4, which is dedicated to the concentration dependence on BSA of the CEST 
signal. Any change in metabolite concentration can significantly alter the CEST effect.  
During the experiments, blood samples were taken and glucose levels were 
measured, summarised in figure 88 (bottom graph, in green). A significant rise 
(p<0.05) in blood glucose concentration is found post HI, which is otherwise 
maintained during the time course of the experiments. However, if the change in 
glucose levels found in the circulating blood was corresponding to equivalent 
changes in brain glucose concentration and therefore affecting the outcome of the 
results, it would do so in an opposite trend compared to what has been reported post-
HIE for the animals in this study (i.e. the elevated glucose levels would have resulted 
in an increase in the CEST signal). Additionally, the glucose resonance frequency 
range does not extend to 3.5ppm, the frequency investigated during this study [56, 
17].  
Moreover, no changes in the negative side of the Z-spectra (aliphatic range) were 
observed (illustration of overlapping signals from the aliphatic range in figure 80), 
while the APT peak was reduced post-HI. Aliphatic* was calculated in the same way 
as APT* at -3.5ppm. Figure 89 demonstrates the average APT* (in red) and Aliphatic* 
(in green) calculated from the cortical watershed region in the piglet brain (n=16). 
While APT* is significantly changed post-HIE (p<0.001 and p<0.01 for 1 hour and 24 
hours respectively), no significant changes are observed in the Aliphatic* (p>0.1 for 
both post-HI measurements). 
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Figure 89: mean APT* (in red) and Aliphatic* (in green) values calculated from the cortical watershed region of 
the piglet brain (All piglets included). APT*shows significant signal decrease post-HIE (p<0.001 1-hour and 
p<0.01 24 hours post-HIE). Aliphatic* shows no significant differences post-HIE (p>0.1 for both 1hour and 24 
hours post-HIE). 
The findings of Chapter 4 and also a study by Jin et al 2013 [70] suggest that the 
aliphatic side of the BSA Z-spectra is concentration dependent but relatively pH-
insensitive. This leads to the conclusion that post-HI the concentration of proteins was 
not altered and thus the reduction in the APT* signal was not likely to have occurred 
due to protein concentration changes (no reduction observed in the signal originating 
from the aliphatic peak).  
Relaxation times 
Changes in T1 and T2 values of the tissue also lead to modification of the CEST signal. 
Following an ischemic episode, the relaxation times of brain tissue might deviate from 
baseline values due to calcification [171], lipid release [172], haemorrhage and 
inflammation [145]. Unfortunately T1 maps were not acquired as a part of this study, 
however simulations were performed (see figure 93) and are presented below in this 
section, suggesting that a change in T1 value of ± 20% from the original value does not 
have a significant effect in the APT* contrast. Similarly, T2 maps were also not 
acquired however, FWHM measurements were taken (as previously described in 
section 4.2.2.3 of the phantom study, and associated to T2 in figure 51 ). Figure 90 
shows the mean FWHM calculated from the same region as APT* (cortical watershed 
region in the brain). No significant changes (p>0.1) were observed post-HI, hence is 
assumed that no significant T2 changes occurred during the time-course of the 
experiments.  
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Figure 90: the mean FWHM values calculated from the same region as the APT* measurements. No significant 
differences were observed comparing the baseline FWHM to any of the post-HIE FWHM. 
 
Association of APT* signal to tissue pH 
Disturbances of metabolism during HI directly leads to the alteration of tissue pH as 
already discussed (see section 6.1, introduction), [173, 174]. As described in section 
2.3 (‘Factors affecting the CEST signal’), APT is sensitive to pH changes via the base-
catalysed exchange rates of protons [9] and has been considered as a method for 
obtaining pH-weighted contrast by various groups; it has been applied to stroke rat 
models [175, 176, 69] and human studies [177, 178].  
This section links the APT* signal calculated from the CEST data to pH quantified 
from 31P MRS, assuming that the APT signal is mostly originating from the 
intracellular compartment [9]. 
Data in figure 91 display the relationship of the APT* signal averaged from the 
cortical watershed region in the piglet brain (figure 83) and pH measurements from 
a similar region (see section 6.2.4). A logarithmic relationship was chosen as the 
exchange rate is known to vary in this manner (p<0.001). The relationship deduced is 
given in equation 30 below and was used to calibrate the pH scale of APT* images. 
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Figure 91: Correlation of pH values with the APT* signal from all the animals in the study. A logarithmic 
relationship was chosen as the exchange rate is expected to vary in a similar manner (see equation 15 and figure 
14). Pearson’s correlation coefficient r indicates high statistical significance (p<0.001) for two-tailed test (n=52). 
See also Appendix F. 
𝑝𝐻𝑖 = 0.6345 ∙ 𝑙𝑛(𝐴𝑃𝑇∗) + 9.7589   ( 30) 
Three sample piglet data (from figures 86 & 87) are shown in figure 92 to demonstrate 
the pH scale calibrated from the APT* images.  
 
Figure 92: Calibrated pH maps from equation 30. (i) Corresponds to animal (a) of group A (not fully recovered), 
(ii & iii) animals (a) and (i) of group B (fully recovered) respectively.  
In addition, the simulated data of APT* change with pH are shown in figure 93 for 
three T1 values of the water pool. Different values were investigated as T1 data were 
not available for the animals (section Relaxation times, 6.3).  
154 
 
 
Figure 93: Simulated APT* with pH variation for three different T1 values for the water pool (1850ms, 1480ms 
and 2220ms corresponding to blue, red and green line respectively).  
From the simulated data, a variation in the APT* signal can be seen for different 
T1.values, suggesting that for full pH quantification T1 maps are also needed. 
However, the pH range from the experimental data is on average between 6 and 7 (as 
shown in figure 91), where the APT* trend remains very similar for different T1 
values. In addition any alteration due to T1 is likely to be less than the variation caused 
by measurement noise.  
APT* signal compared to Lactate/NAA 
The ratio between Lactate/NAA has been associated with secondary energy failure26 
in HIE sufferers [179]. Mean APT* values 1 hour post-HI from the corresponding 
regions of the two MRS voxels (cortical and thalamic) are compared to the 1H MRS 
data acquired 48 hours post-HI. Out of sixteen animals, eleven were available for 
comparison: group A cases (b), (d), (e) and group B all except case (e). 
An inverse correlation is found (see figure 94, with a Pearson’s correlation coefficient, 
ρ=0.67, p<0.02), with low APT* value present in regions of high Lactate/NAA ratios. 
Lactate is generally accepted as an indicator of anaerobic glycolysis [180] and NAA is 
believed to be a neuronal marker [146]. Hence the correlation suggests that the 
                                                          
26 Brain injury occurring with a delay from the initial HI event 
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APT*signal may also be partially informing on the combined effect of neuronal 
damage due to lactate production. 
 
Figure 94: Comparison of Lactate/NAA data measured 48 hours post-HIE to APT*measured 1 hour post-HIE. 
Pearson’s correlation coefficient r= 0.6778 indicates significance (p<0.02) for two-tailed test (n=12). See also 
Appendix F. 
 
6.4.  Conclusions 
In this chapter the CEST technique was investigated in piglets suffering HI episodes 
as a potential biomarker of brain injury and pH alteration. Following HI, the APT* 
signal was shown to be decreased in the cortical region of the piglet brain in both 
groups (A & B). Data were compared and found to agree with blood lactate 
concentration but not with blood pH. It was concluded that APT may be informing 
on brain injury following HI.  
In addition, the possibility of pH brain mapping was explored. The APT* signal was 
shown to be associated with the intracellular pH (chemical shift of Pi to PCr in 31P 
MRS) via a logarithmic relationship and with the extracellular pH (lactate/NAA in 1H 
MRS) via an inversed linear relationship. Eventually, if APT* is further shown to give 
important information on brain injury and pH, it would provide a supplementary 
diagnostic tool in the clinic for the assessment of neonatal HIE and for monitoring 
treatment effectiveness. However as discussed above, absolute pH quantification is 
challenging as the CEST effect is sensitive to numerous factors. Parameters such as 
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T1, T2 values, brain perfusion and temperature must be either tightly controlled or 
monitored to enable APT-CEST to provide semi-quantifiable pH measures in the 
clinic.  
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Chapter 7. Summary and directions for the future 
 
A summary of the work done for this PhD thesis is outlined in this chapter, along 
with a discussion for future plans regarding research and applications of the CEST 
technique. 
7.1.  Summary of the PhD thesis 
Being a relatively new MRI technique, the mechanisms involved in saturation 
experiments via chemical exchange are not yet fully understood. Hence there is still 
a requirement for basic research to investigate these effects.  
The primary aim of this PhD thesis was to investigate the endogenous CEST signals 
and explore the utilisation of the technique for in-vivo neurological applications. This 
was achieved by studying the Bloch-McConnell equations (section 2.4) through a 
theoretical model implemented for the purposes of this PhD and relating the outcome 
to the BSA phantom study findings (Chapter 4).  
An additional aim was to explore the CEST effects in the spine of mice with 
neurodegenerative diseases (specifically ALS and SBMA, Chapter 5) to identify 
potential early (pre-symptomatic stage) biomarkers, related to soluble protein 
accumulation. The spinal cord is a particularly challenging area of scanning due to its 
size, inhomogeneous B0 and B1 fields and physiological movements. A new sequence 
was therefore developed for this application, which accounts for physiological 
movement during data acquisition by using a respiration triggering scheme adapted 
for saturation experiments (Chapter 5, section 5.1.1).  
Post-processing methodology was also implemented to weight down outliers in the 
spine-CEST data caused by motion (section 5.1.2). In both disease models, no changes 
were observed between affected mice at the different time points checked; findings 
were confirmed with post-mortem protein quantifications. Surprisingly, differences 
were observed between the control mice of 10 and 12 months of age; outcomes were 
also supported by post-mortem protein quantifications which revealed similar trends 
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in protein concentrations at the two scan-points. To our knowledge this is the first 
time such subtle protein changes have been found to correlate with CEST data from 
animal models. These findings were also surprising as such changes in the 
proteasome were not expected. 
The last aim of this Ph.D was to study another facet of the endogenous CEST signal, 
namely its dependence in pH. For this, we studied the CEST signal in piglets 
undergoing HI, a model of neonatal encephalopathy and related the findings to pH 
alterations as measured by 31P MRS following HI. This would ideally provide spatial 
information on the pH changes following ischemia and therefore allow better 
monitoring of the neonates if the technique is to be translated to the clinic. For the 
purposes of this work an imaging CEST sequence was implemented and adopted for 
the piglet brain (Chapter 6). In addition, a new method was proposed to analyse the 
CEST data (APTp/APT* in section 3.2), which is not confounded by any other 
endogenous contributions but is (mostly) related to the changes due to the induced 
HI. 
7.2.  Future work directions 
Research in the CEST field has been exponentially increasing within the last decade, 
however there are still many questions to tackle and numerous areas to explore 
within the CEST world. Basic science is still required as the CEST effects are not yet 
fully understood.  
CEST validation research 
A small example is found in our work done with the BSA phantom (Chapter 4), where 
the behaviour of the Z-Spectra in different pH environments is unclear. More CEST 
experiments are required as well as comparison with other methods, such as NMR 
spectroscopy, in order to understand better the underpinnings and subtle variations 
of the CEST dependence on pH. 
Another example would be to explore the CEST signal in amino acids compared to 
polymers (i.e: lysine to poly-L-Lysine, glutamine to poly-L-glutamine, etc). Such 
experiment would help understand the changes in the CEST signal between small 
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mobile molecules and larger molecules (of the same species). So far, a simple 
multiplication effect has always been estimated, however protein folding might alter 
access of water protons to exchangeable sites and therefore lead to large variations in 
the CEST effects with the number of exchanging sites. 
Many CEST areas of interest were not covered within this thesis, including CEST 
effects in liposomes (lipoCEST) [45], hyperCEST, paraCEST agents [30], glucoCEST, 
[17] etc. Nonetheless, a large amount of research is focused on contrast-based CEST 
imaging, with agents that may serve as temperature or pH probes and contribute to 
pharmacokinetic studies. 
More pre-clinical studies should also be conducted, such as extended work in the 
spinal cord of mice with larger cohorts, looking at the CEST signal in comparison to 
post-mortem protein quantification and other MRI techniques such as MT, T1 and T2 
maps. This would be an important step in understanding the nature of the CEST 
signal and the potential future application of the CEST technique in 
neurodegenerative diseases. As a long-term plan one would expect to implement 
spine-CEST in the clinic to study neurodegenerative diseases in patients, but only 
after better understanding of the basic physiology of the proteasome has been 
gathered in animals. 
Regarding the work conducted in the piglet brain (Chapter 6), it would be interesting 
to use a dual-tuned 1H and 31P RF coil to avoid changing during the experiments. This 
would improve the experiments in terms of better reproducibility (less imaging 
registration issues), while interleaved CEST, 31P MSR and 1H MRS can be acquired for 
a better comparison between APT*, pHi and Lactate/NAA levels. Eventually, the 
method should translate into the clinic for neonates suffering HI. 
 
 
Standardisation of the CEST technique  
As the CEST technique grows among research institutions and work is translated into 
the clinic, the need for standardised measurements becomes more urgent. As 
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discussed in this work, many methods can be used in order to achieve CEST contrast 
(section 3.1) and even more techniques have been implemented for the interpretation 
of the signal (section 3.2). Even looking throughout this thesis, a few different 
procedures have been reported for measuring the CEST signal. The problem starts 
when there is a need for data comparison across sites, which is complicated if data 
were acquired with different protocols, or even just analysed in different ways. The 
variation might come from something as simple as the normalisation of the Z-Spectra, 
or the frequency integration range. Therefore, it is crucial for the field to study the 
effects of all parameters, including RF coil transmission and reception, signal readout, 
saturation methods and data analysis.  
Finally, the clinical potential of the technique needs to be more extensively explored. 
With the current standards, there are currently important limitations due to B1 and 
B0 inhomogeneities as well as SAR limitations to overcome. Efforts for harmonising 
clinical protocols need to be implemented and only by doing this can the CEST 
technique grow into a truly valuable contrast mechanism that can be used widely and 
routinely in hospitals across the world. 
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Appendix A – ‘The multipool Bloch McConnell model’ 
 
The Bloch-McConnell equation system describing the total magnetisation M, is given 
in a matrix form such that  
𝑑𝑀
𝑑𝑡
= 𝐴 ∙ 𝑀 − 𝐵 
The system can be expanded following the same pattern for n number of pools. 
Considering below a 5 pool model (Pools A-E) the equation system can be written as 
 
where  
 
where 𝑀𝑥
𝐴,𝐵,𝐶,𝐷,𝐸 ,𝑀𝑦
𝐴,𝐵,𝐶,𝐷,𝐸 ,𝑀𝑧
𝐴,𝐵,𝐶,𝐷,𝐸 are the magnetisation components of pools A-E 
at time t along the x, y and z axis respectively. The loss of magnetisation in pool A is 
described by 𝐾𝑎𝑏
 .𝑀𝑧
𝑏 and the gain in pool B is described by 𝐾𝑏𝑎
 .𝑀𝑧
𝑎 (the same applies 
for all the other pools in the same manner). 𝛥𝜔𝑎,𝑏,𝑐,ⅆ,𝑒 = 𝜔𝑅𝐹 − 𝜔𝑎,𝑏,𝑐,ⅆ,𝑒 is the 
resonance frequency of the corresponding exchangeable site pool given relative to the 
RF frame (𝜔𝑅𝐹 corresponds to the frequency of the applied RF pulse). If pool A 
corresponds to water, then 𝜔𝑎 = 0. 
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The equation system above considers interaction between pools B-E with A, where A 
is considered to be the main water pool and B-E any other exchangeable site pools 
present. No interaction between other pools has been taken into account. Illustration 
of such a system is given in (Appendix B, ‘Simulation of the Bloch-McConnell model’, 
Steady State solution). 
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Appendix B – ‘Steady State Solution of the Bloch-
McConnell model. Simulation of 8 pools’ 
 
The following is an example script used as an eight-pool steady state model. It is based 
on the Bloch-McConnell system of equations as given in Appendix A but expanded 
to accommodate eight exchangeable site pools. This model also includes a connection 
between pools C and D, used to study the interaction between sites other than the 
free water. 
 
%% 8 Pool Bloch-McConnell model STEADY STATE 
interaction_CD=0; %to add a connection between pools C and D 
%constants 
gamma=42.576*10^6*2*pi; %[Radians s-1 T-1], B0=9.4; %T, w0=gamma*B0; np=1001; 
One_ppm= 3.995259712500000e+02; %9.4T Queen Square house  
%% B1equivalet for Agilent Gaussian 
nsigma=5.84; %number of sigmas the pulse shape uses. Calculated from shape lib. 
FA=540; FA=FA*pi/180; %to radians Duration=50; Duration=Duration/1000; %to secs 
IntDelay=1; IntDelay=IntDelay/1000; %to secs 
sigma=Duration/nsigma;, intePercentage=erf(nsigma/sqrt(2)); 
B1eq=sqrt(FA^2*sqrt(pi)/(2*pi*sigma*gamma^2*(Duration+IntDelay)*intePercentage)); 
B1=B1eq; w1=gamma*B1 %w1 goes in rad/s BUT delta ,ppmc and exRates in Hz. in the equations delta is multiplied 
by 2pi 
%Relative concentration  
M0a=1; %water; glucoseMolarity=160;%in mMolar 
%pool sizes 
M0b=3*M0a/100; %MT pool M0c=3/3*glucoseMolarity/(1000*55); %Glucose 
poolsM0d=3/4*glucoseMolarity/(1000*55); 
M0e=0*glucoseMolarity/(1000*55);M0f=1*M0a/25; M0g=0*M0a/50; M0h=1*glucoseMolarity/(1000*55); % 
Mall= M0a+M0b+M0c+M0d+M0e+M0f+M0g; 
pH=7 
%% Relaxation Times of each spin species  
T1a=1.85*1.2; %s T1b=0.01;%for MT, T1c=1.5;T1d=1.5;T1e=1.8;T1f=0.26; T1g=0.1;T1h=1.5; 
T2a=3.2*exp(-M0b*140); T2b=0.00001/2;for MT T2c=0.035; T2d=0.035;T2e=0.0007;T2f=0.00034;T2g=0.00034; T2h=0.4; 
Tranfer rates 
% K0=0;Ka=25;Kb=1.2*10^10;pKw=14; % values that allow lower exchange rates for acidic environments 
K0=1000;Ka=25;Kb=0.7*10^10;pKw=14; % values that match Chan, van Zijl MRM2012 
KexG=K0+Ka*10.^(-pH)+Kb*10.^(pH-pKw); 
Rb=50;   %fot MT Rg=KexG*0.55;  %s^(-1)Rg=KexG*0.75;Rh=KexG*1; 
Re=4.5; %for fat or NOE 
%from pH mapping based on the ratiometric amide and amine relationship from 
%endogenous CEST  Kim Desmond1, Greg Stanisz 1,2 
% pH=[6.4 6.7 7 7.3] 
AminesEx=10.^(pH-5.2);  AminesEx=10.^(pH-4.4); %At 2ppm, Rc=1*AminesEx; 
AmidesEx=5.57*10.^(pH-7.2); AmidesEx=5.57*10.^(pH-6.4); % At 3.5 ppm, Rd=1*AmidesEx; 
Rinteract=100000 %pH independent. For NH2 to NH exchange rate [H+] 
 
%% Saturation efficiency to account for relaxation in XY plane 
alphab=w1^2/(w1^2+Rb^2*T2b); alphac=w1^2/(w1^2+Rc^2*T2c); alphad=w1^2/(w1^2+Rd^2*T2d); 
alphae=w1^2/(w1^2+Re^2*T2e); alphaf=w1^2/(w1^2+Rf^2*T2f); alphag=w1^2/(w1^2+Rg^2*T2g); 
alphah=w1^2/(w1^2+Rh^2*T2h); 
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M0b=M0b*alphab; M0c=M0c*alphac; M0d=M0d*alphad; M0e=M0e*alphae; M0f=M0f*alphaf; M0g=M0g*alphag; 
M0h=M0h*alphah; 
%% CEST pool off resonance frequency from water pool  
ppmb=0; ppmc=+2.1; ppmd=3.6; ppme=-3.5; ppmf=1.3; ppmg=3; ppmh=1; 
 
dcb=w0*10^-6/(2*pi)*ppmb; dcc=w0*10^-6/(2*pi)*ppmc; dcd=w0*10^-6/(2*pi)*ppmd; dce=w0*10^-6/(2*pi)*ppme; 
dcf=w0*10^-6/(2*pi)*ppmf; dcg=w0*10^-6/(2*pi)*ppmg; dch=w0*10^-6/(2*pi)*ppmh; 
%for the cone picture 
% wrf=w0*(1+ppm*10^-6); 
% B0eff=(w0-wrf)/gamma; %in Z direction 
%Beff=[B1,0,B0eff]; 
%%%%%%%%%%%%% 
MM=zeros(22,np); Rrfb=zeros(1,np); D=zeros(1,np); ppm=zeros(1,np);maxoffsetppm=2432/One_ppm; 
for p=1:np 
            ppm=2*maxoffsetppm/(np-1)*(p-1)-maxoffsetppm;     
            D=w0*10^-6/(2*pi)*ppm; 
            %% Superlorentzian function 
            q=10000; 
            % p=1000; 
            o = linspace(0, pi/2, q); 
            value=sin(o).*(2/pi).^0.5*T2b./abs(3*cos(o).^2-1).*exp(-2*(2*pi*(D-dcb).*T2b./(abs(3*cos(o).^2-1))).^2);  
            da=pi/(2*(q-1)).*value; Amt=sum(da); %superlorentzian function for every D  
            Rrfb(1,p)=Amt*w1^2*pi; %Rrfb(1,p)=1*Amt*w1^2; not sure if we have to multiply by w1^2 
            % %% 8 pool system   
            %% Tranfer rates 
            Rbp=Rb*Rrfb(1,p);%Rb; %fot MT 
            Rcp=Rc;%s^(-1) 
            Rdp=Rd; 
            Rep=Re;  
            Rfp=Rf; 
            Rgp=Rg; 
            Rhp=Rh; 
  
            dm1=[(-1/T2a-Rc*M0c-Rd*M0d-Re*M0e-Rf*M0f-Rg*M0g-Rh*M0h),-
2*pi*D,0,0,Rc*M0a,0,0,Rd*M0a,0,0,Re*M0a,0,0,Rf*M0a,0,0,Rg*M0a,0,0,Rh*M0a,0,0]; 
            dm2=[2*pi*D,(-1/T2a-Rc*M0c-Rd*M0d-Re*M0e-Rf*M0f-Rg*M0g-Rh*M0h),-
w1,0,0,Rc*M0a,0,0,Rd*M0a,0,0,Re*M0a,0,0,Rf*M0a,0,0,Rg*M0a,0,0,Rh*M0a,0]; 
            dm3=[0,w1,(-1/T1a-Rbp*M0b-Rcp*M0c-Rdp*M0d-Rep*M0e-Rf*M0f-Rg*M0g-
Rh*M0h),Rbp*M0a,0,0,Rcp*M0a,0,0,Rdp*M0a,0,0,Rep*M0a,0,0,Rfp*M0a,0,0,Rgp*M0a,0,0,Rhp*M0a]; 
  
            dm6=[0,0,Rbp*M0b,(-1/T1b-Rrfb(1,p)-Rbp*M0a),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]; 
  
            if interaction_CD==1  
                    dm7=[Rc*M0c,0,0,0,(-1/T2c-Rc*M0a-Rinteract*M0d),-2*pi*(D-
dcc),0,Rinteract*M0c,0,0,0,0,0,0,0,0,0,0,0,0,0,0]; 
                    dm8=[0,Rc*M0c,0,0,2*pi*(D-dcc),(-1/T2c-Rc*M0a-Rinteract*M0d),-
w1,0,Rinteract*M0c,0,0,0,0,0,0,0,0,0,0,0,0,0]; 
                    dm9=[0,0,Rcp*M0c,0,0,w1,(-1/T1c-Rcp*M0a-Rinteract*M0d),0,0,Rinteract*M0c,0,0,0,0,0,0,0,0,0,0,0,0]; 
  
                    dm10=[Rd*M0d,0,0,0,Rinteract*M0d,0,0,(-1/T2d-Rd*M0a-Rinteract*M0c),-2*pi*(D-
dcd),0,0,0,0,0,0,0,0,0,0,0,0,0]; 
                    dm11=[0,Rd*M0d,0,0,0,Rinteract*M0d,0,2*pi*(D-dcd),(-1/T2d-Rd*M0a-Rinteract*M0c),-
w1,0,0,0,0,0,0,0,0,0,0,0,0]; 
                    dm12=[0,0,Rdp*M0d,0,0,0,Rinteract*M0d,0,w1,(-1/T1d-Rdp*M0a-Rinteract*M0c),0,0,0,0,0,0,0,0,0,0,0,0]; 
                    else 
                    dm7=[Rc*M0c,0,0,0,(-1/T2c-Rc*M0a),-2*pi*(D-dcc),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]; 
                    dm8=[0,Rc*M0c,0,0,2*pi*(D-dcc),(-1/T2c-Rc*M0a),-w1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]; 
                    dm9=[0,0,Rcp*M0c,0,0,w1,(-1/T1c-Rcp*M0a),0,0,0,0,0,0,0,0,0,0,0,0,0,0,0]; 
  
                    dm10=[Rd*M0d,0,0,0,0,0,0,(-1/T2d-Rd*M0a),-2*pi*(D-dcd),0,0,0,0,0,0,0,0,0,0,0,0,0]; 
                    dm11=[0,Rd*M0d,0,0,0,0,0,2*pi*(D-dcd),(-1/T2d-Rd*M0a),-w1,0,0,0,0,0,0,0,0,0,0,0,0]; 
                    dm12=[0,0,Rdp*M0d,0,0,0,0,0,w1,(-1/T1d-Rdp*M0a),0,0,0,0,0,0,0,0,0,0,0,0]; 
            end 
                        %Interaction between Pool C and Pool D             
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            dm13=[Re*M0e,0,0,0,0,0,0,0,0,0,(-1/T2e-Re*M0a),-2*pi*(D-dce),0,0,0,0,0,0,0,0,0,0]; 
            dm14=[0,Re*M0e,0,0,0,0,0,0,0,0,2*pi*(D-dce),(-1/T2e-Re*M0a),-w1,0,0,0,0,0,0,0,0,0]; 
            dm15=[0,0,Rep*M0e,0,0,0,0,0,0,0,0,w1,(-1/T1e-Rep*M0a),0,0,0,0,0,0,0,0,0]; 
  
            dm16=[Rf*M0f,0,0,0,0,0,0,0,0,0,0,0,0,(-1/T2f-Rf*M0a),-2*pi*(D-dcf),0,0,0,0,0,0,0]; 
            dm17=[0,Rf*M0f,0,0,0,0,0,0,0,0,0,0,0,2*pi*(D-dcf),(-1/T2f-Rf*M0a),-w1,0,0,0,0,0,0]; 
            dm18=[0,0,Rfp*M0f,0,0,0,0,0,0,0,0,0,0,0,w1,(-1/T1f-Rfp*M0a),0,0,0,0,0,0]; 
  
            dm19=[Rg*M0g,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,(-1/T2g-Rg*M0a),-2*pi*(D-dcg),0,0,0,0]; 
            dm20=[0,Rg*M0g,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2*pi*(D-dcg),(-1/T2g-Rg*M0a),-w1,0,0,0]; 
            dm21=[0,0,Rgp*M0g,0,0,0,0,0,0,0,0,0,0,0,0,0,0,w1,(-1/T1g-Rgp*M0a),0,0,0]; 
  
            dm22=[Rh*M0h,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,(-1/T2h-Rh*M0a),-2*pi*(D-dch),0]; 
            dm23=[0,Rh*M0h,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2*pi*(D-dch),(-1/T2h-Rh*M0a),-w1]; 
            dm24=[0,0,Rhp*M0h,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,w1,(-1/T1h-Rhp*M0a)]; 
            %% 
            
A=[dm1;dm2;dm3;dm6;dm7;dm8;dm9;dm10;dm11;dm12;dm13;dm14;dm15;dm16;dm17;dm18;dm19;dm20;dm21;d
m22;dm23;dm24]; 
            B=[0;0;M0a/T1a;M0b/T1b;0;0;M0c/T1c;0;0;M0d/T1d;0;0;M0e/T1e;0;0;M0f/T1f;0;0;M0g/T1g;0;0;M0h/T1h]; 
            M=A\(-B);  %"matrix division" 
            MM(:,p)=M; 
end 
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Appendix C – ‘Dynamic Solution of the Bloch-
McConnell model. Simulation of 2 pools’ 
 
A dynamical model was also used to simulate saturation train lengths, readout pulses 
and to study the evolution of magnetisation in time. The following piece of code is 
written based on a two pool system. 
%% 2Pool Bloch-McConnell model DYNAMIC SOLUTION 
gamma=42.576*10^6*2*pi; %[ s-1 T-1] 
FlipA=1540; num_gauss=200; interpuseDelay=5*10^-3; duration=50*10^-3; 
ppm=2; %Rf pulse off resonance frequency from water pool  
ppmc=2; %CEST pool off resonance frequency from water pool  
M0a=1; 
molarity=200;%[mMolar] 
M0c=3/3*molarity/(1000*55); %Glucose pools 
Ex1=30; %exchange rate of water and cest pools 
T2a=0.032; T1a=1.7; T2c=0.01; T1c=1; 
tspan = [-0.5 10]; 
M0(1,:)=[0,0,M0a,0,0,M0c]; 
for offset=1:1; 
    ppm=-4.1+offset/10; %Rf pulse off resonance frequency from water pool  
    ppm=3.5; 
    [t, M] = ode45(@sixequations, tspan, M0(1,:));  
    All_M{offset}=M; 
    All_t{offset}=t; 
end 
%%%%%%%%  Definition of the equation function %%%%%%%%%%%% 
function dM=sixequations(t,M) 
        dM=zeros(6,1); B0=9.4; w0=gamma*B0; D=w0*10^-6/(2*pi)*ppm; 
        dc=w0*10^-6/(2*pi)*ppmc; 
        t0=0;  tmax=(t0+duration/2); 
        s=duration/5.86; FA=FlipA*pi/180; Amp=FA/(s*sqrt(2*pi)*gamma); %FA in Rad 
        yy=0; %for the begining of the loop 
        for n=1:num_gauss 
        yy=yy+exp(-((t-(tmax+(n-1)*(duration+interpuseDelay)))/s).^2/2); 
        end 
        B1=Amp*yy; 
        %% Square pulse a  
         ti=0.3; tf=5;Ba=0; if (ti <= t) && (tf > t), Ba=B1;, end 
         Square pulse b 
         delay=0.00372; ti2=tf+delay; tf2=0.55+delay; Bb=0; 
         if  (ti2 <= t) && (tf2 > t);, Bb=0*1*B1; end 
          B1=Ba+Bb; 
        %%Triangular  pulse 
         tia=0.0; tfb=0.05; tfa=(tfb-tia)/2; tib=tfa; B1=0; 
         if (tia <= t) && (tfa >= t);,B1=200*5*20*0.1175*10^-6*t;,end 
         if  (tib < t) && (tfb > t) , B1=200*5*20*0.1175*10^-6*(2*tfa-t);end  
         %%Pulse Sequence 
        mtcrusher=3*10^-3; %time duration at the end of sat pulse train. 
        Bef_Read=0.008; %time delay before the readout pulse. 
        Aft_Read=4.5*10^-3;  %time delay after the readout pulse. 
         %%% Saturation pulses train 
        SatFlip=7000; %in degree. 
        SatPulse=50*10^-3; %time duration of the sat pulse. 
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        SatDelay=4*10^-6; %time duration between sat pulses. 
         SatFlipRad=SatFlip*pi/180; 
        %B1c_Sat=SatFlipRad/(gamma*(SatPulse+SatDelay)); i thinks its worng 
        sigmaSat=SatPulse/7;  A_Sat=SatFlipRad/(sqrt(2*pi)*gamma*sigmaSat); 
        b0=4*10^-6;  t0=3.5*sigmaSat;  b=0; B1=0; %just to start with 
         for p=1:10  
            spike=A_Sat*(exp(-(t-t0-b-Aft_Read).^2/(2*sigmaSat^2))); 
            b=b+b0+SatPulse+SatDelay; 
            B1=B1+spike; 
        end 
        % Readout pulse 
        ReadFlip=20;  %in degree too. 
        ReadPulse=20*10^-3; %time duration of the readout pulse. 
        Bef_Read=12*10^-6; 
        mtcrusher=12*10^-6; 
        sigmaRead=ReadPulse/7; 
        ReadFlipRad=ReadFlip*pi/180; 
        %B1c_Read=ReadFlipRad/(gamma*(ReadPulse)); % [T] For 20 degrees, 2ms pulse  
        A_Read=ReadFlipRad/(sqrt(2*pi)*gamma*sigmaRead); 
        Readout=A_Read*(exp(-(t-(mtcrusher+Bef_Read+ReadPulse/2)-b).^2/(2*sigmaRead^2))); 
        B1=B1+Readout; 
        TR=b0+p*(SatPulse*SatDelay)+mtcrusher+Bef_Read+Aft_Read+ReadPulse; 
        w1=gamma*B1; 
        if (w1==0) 
            D=0; dc=0; 
        end 
        if t> num_gauss*(duration+interpuseDelay) %%sets the offset of the readout pulse to the water freq 
            D=0; 
        end 
        % 2-Pool model equations 
        dM(1)=(-1/T2a-Ex1*M0c)*M(1)+(-2*pi*D)*M(2)+Ex1*M0a*M(4); 
        dM(2)=2*pi*D*M(1)+(-1/T2a-Ex1*M0c)*M(2)-w1*M(3)+Ex1*M0a*M(5); 
        dM(3)=w1*M(2)+(-1/T1a-Ex1*M0c)*M(3)+Ex1*M0a*M(6)+M0a/T1a; 
  
        dM(4)=Ex1*M0c*M(1)+(-1/T2c-Ex1*M0a)*M(4)-2*pi*(D-dc)*M(5); 
        dM(5)=Ex1*M0c*M(2)+2*pi*(D-dc)*M(4)+(-1/T2c-Ex1*M0a)*M(5)-w1*M(6); 
        dM(6)=Ex1*M0c*M(3)+w1*M(5)+(-1/T1c-Ex1*M0a)*M(6)+M0c/T1c; 
end 
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Appendix D – ‘B1 Calculations. Continuous to pulsed 
saturation’ 
 
The saturation power of an RF pulse of any shape B1(t) is calculated as the equivalent 
power of a hard pulse of duration Δt. Often in literature, the equivalent power is given 
as B1eq (T) such as 
𝑃 ∝
∫ 𝐵1
2(𝑡)𝑑𝑡
𝛥𝑡
0
𝛥𝑡
= 𝐵1𝑒𝑞
2  
Experiments in this study were performed with a train of Gaussian pulses; the 
equation below shows the B1eq for such pulses. 
B1eq =
𝜃
𝛾√2√𝜋𝜎(𝑡𝑔𝑎𝑢𝑠𝑠 + 𝑡ⅆ𝑒𝑙𝑎𝑦) ∙ 𝑓𝑒𝑟𝑟(𝑛𝜎/√2)
  
where θ is the flip angle (in rad), γ the gyromagnetic ratio (in rad/s/T), σ the standard 
deviation of the Gaussian pulse, nσ the number of standard deviations included in the 
pulse width (for the experiments conducted in this study, nσ =5.84). The duration of 
the Gaussian pulse, tgauss and the interpulse delay, tdelay are both given in ms. 
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Appendix E – ‘Arterial blood measurements for piglets 
of Chapter 6’ 
 
TABLE 1: Lactate levels given in mM concentration for group A (gA) and group B (gB). 
Piglet Baseline During HIE Post HIE 1.5h Post HIE 24h Post HIE 
a (gB) 1.69 9.46 9.79 1.70 5.47 
b (gB) 4.99 8.92 10.59 5.99 5.80 
c (gB)  5.78  6.74 1.62 
d (gB) 2.38 4.44 14.07 6.47 10.17 
f (gB) 1.72 5.51 9.21 5.02 3.06 
g (gB)  9.65  1.77 4.18 
h (gB)  12.73  0.95 2.79 
i (gB) 3.42 9.01 10.93 1.75 7.29 
b (gA) 0.70 2.67 7.08 1.86 1.65 
c (gA) 3.44 1.98 4.07 3.81 1.92 
d (gA) 3.3 8.38 9.88 7.411 2.84 
e (gA) 2.06 10.68 8.85 7.75 1.40 
f (gA) 4.96 11.8 6.84 5.52 2.98 
g (gA) 7.7    11.14 
TABLE 2: pH values for for group A (gA) and group B (gB). 
Piglet Baseline During HIE Post HIE 1.5h Post HIE 24h Post HIE 
a (gB) 7.339 7.600  7.450 7.530 
b (gB)  7.507 7.277 7.424 7.483 
c (gB)  7.561 7.409 7.795 7.411 
d (gB) 7.595 7.412 7.435 7.482 7.749 
f (gB)  7.394 7.447 7.489 7.463 
g (gB) 7.409 7.195 7.256 7.412 7.438 
h (gB) 7.337 7.283 7.251 7.197 7.152 
i (gB) 7.397 7.216 7.265 7.345 7.832 
b (gA) 7.235 7.300  7.360 7.050 
c (gA) 7.760 7.633 7.430 7.545 7.420 
d (gA) 7.35 7.058  7.411 7.490 
e (gA)  7.400   7.264 
f (gA)  7.414 7.169 7.270 7.295 
g (gA) 7.494 7.408 7.398 7.440 7.446 
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TABLE 3: Glucose levels in mM concentration for for group A (gA) and group B (gB). 
Piglet Baseline During HIE Post HIE 1.5h Post HIE 24h Post HIE 
a (gB) 8.2   8.5 12.3 
b (gB)  6.9 8.3 7.0 6.3 
c (gB) 10 11.8  7.6 9.8 
d (gB)  10.4   13.3 
f (gB)  6.6 7.2 7.2 8.7 
g (gB) 5.2 6.1 5.7 4.8 26.2 
h (gB) 6.9 6.5  7.0 5.3 
i (gB)  7.9 8.1 9.3 5.7 
b (gA)  7.1 7.1 7.4 9.8 
c (gA) 3.7 8.5 8.5 7.5 11.8 
d (gA)  11.6 11 9.6 7.2 
e (gA)  12.9 12.8 12.5 34.3 
f (gA) 6.3 8.9 11 11 27.1 
g (gA) 6.4 9 9.8 7.2 9.0 
 
NB: Blood measurements were taken as consistently as possible by the team 
responsible for the welfare of the animals. However potential issues, physiological or 
technical would not always allow for these measurements to be taken in time. The 
data provided have been collected from matching time points. In addition there were 
no data collected on piglet a(gA). 
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Appendix F – Critical Values for Pearson’s correlation 
r’ 
 
 
          Level of Significance for a Two-Tailed Test (p 
value) 
 
df 0.2 0.1 0.05 0.02 0.01 0.001 
1 0.951 0.988 0.997 0.9995 0.9999 0.999999 
2 0.8 0.9 0.95 0.98 0.99 0.999 
3 0.687 0.805 0.878 0.934 0.959 0.991 
4 0.608 0.729 0.811 0.882 0.917 0.974 
5 0.551 0.669 0.755 0.833 0.875 0.951 
6 0.507 0.621 0.707 0.789 0.834 0.925 
7 0.472 0.582 0.666 0.75 0.798 0.898 
8 0.443 0.549 0.632 0.715 0.765 0.872 
9 0.419 0.521 0.602 0.685 0.735 0.847 
10 0.398 0.497 0.576 0.658 0.708 0.823 
11 0.38 0.476 0.553 0.634 0.684 0.801 
12 0.365 0.457 0.532 0.612 0.661 0.78 
13 0.351 0.441 0.514 0.592 0.641 0.76 
14 0.338 0.426 0.497 0.574 0.623 0.742 
15 0.327 0.412 0.482 0.558 0.606 0.725 
16 0.317 0.4 0.468 0.542 0.59 0.708 
17 0.308 0.389 0.456 0.529 0.575 0.693 
18 0.299 0.378 0.444 0.515 0.561 0.679 
19 0.291 0.369 0.433 0.503 0.549 0.665 
20 0.284 0.36 0.423 0.492 0.537 0.652 
21 0.277 0.352 0.413 0.482 0.526 0.64 
22 0.271 0.344 0.404 0.472 0.515 0.629 
23 0.265 0.337 0.396 0.462 0.505 0.618 
24 0.26 0.33 0.388 0.453 0.496 0.607 
25 0.255 0.323 0.381 0.445 0.487 0.597 
26 0.25 0.317 0.374 0.437 0.479 0.588 
27 0.245 0.311 0.367 0.43 0.471 0.579 
28 0.241 0.306 0.361 0.423 0.463 0.57 
29 0.237 0.301 0.355 0.416 0.456 0.562 
30 0.233 0.296 0.349 0.409 0.449 0.554 
40 0.202 0.257 0.304 0.358 0.393 0.49 
60 0.165 0.211 0.25 0.295 0.325 0.408 
120 0.117 0.15 0.178 0.21 0.232 0.294 
  ∞ 0.057 0.073 0.087 0.103 0.114 0.146 
where df=n-2 (n, number of data points). NB: Infinite was calculated at df=500. 
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